data_2lob_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lob _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.92 138.8 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-O 122.098 0.951 . . . . 0.0 111.903 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 13.6 mtt-85 -138.34 116.64 11.91 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.319 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.6 OUTLIER -96.65 119.86 35.91 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.567 1.175 . . . . 0.0 113.171 -178.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.542 ' CG1' ' HA3' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.64 117.95 56.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 112.533 -2.121 . . . . 0.0 108.303 177.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mp -95.3 110.21 22.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.106 0.479 . . . . 0.0 111.483 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 69' ' ' CYS . 1.2 tt -113.52 112.29 23.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.641 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.429 ' HG ' ' CB ' ' A' ' 104' ' ' GLU . 3.9 mp -117.13 101.58 8.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.727 0.775 . . . . 0.0 111.614 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.38 130.86 45.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.538 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 38' ' ' HIS . 55.3 mt-10 -137.97 160.27 39.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.803 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 38' ' ' HIS . 0.8 OUTLIER 59.59 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.531 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 58.2 m-70 -34.47 -55.63 0.53 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.643 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 4.9 tp10 94.54 172.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.92 163.83 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.1 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.47 HD21 HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -105.7 -82.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.749 0.309 . . . . 0.0 111.364 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.44 22.86 1.04 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.47 HG23 HD21 ' A' ' 41' ' ' LEU . 13.5 tt -135.18 158.27 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 C-N-CA 122.79 0.436 . . . . 0.0 109.849 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.49 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 41.1 t -130.74 146.19 52.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.988 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.574 ' O ' ' CE1' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -139.88 159.09 26.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 CA-C-O 122.189 0.995 . . . . 0.0 112.634 -179.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.75 ' HA ' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -161.74 137.27 7.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.748 178.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' HG21 ' A' ' 53' ' ' VAL . . . 151.4 168.96 16.48 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.492 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 141.03 -164.62 26.44 Favored Glycine 0 C--N 1.304 -1.238 0 CA-C-N 114.367 -0.917 . . . . 0.0 112.125 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -76.89 -17.44 58.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 0.0 110.041 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HB2' ' HD3' ' A' ' 90' ' ' LYS . 2.7 tt0 -71.94 -42.7 66.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.947 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.749 ' NE2' ' OD1' ' B' ' 117' ' ' ASP . 21.3 m-70 -99.62 12.01 37.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.41 0.624 . . . . 0.0 110.178 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.93 23.9 40.12 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.75 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.8 OUTLIER -131.83 173.63 5.65 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 121.923 0.868 . . . . 0.0 113.079 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.552 ' O ' HG23 ' A' ' 53' ' ' VAL . 4.4 Cg_exo -87.2 160.45 8.47 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.644 3.563 . . . . 0.0 108.256 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.889 ' CD1' ' HA ' ' A' ' 91' ' ' HIS . 25.2 mm -73.2 99.87 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.188 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.506 ' CD1' ' HB2' ' A' ' 54' ' ' PRO . 6.9 mp -104.38 141.4 36.4 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.486 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.6 mp -71.12 129.3 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.198 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.63 -18.71 3.86 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.509 ' OE2' ' NH2' ' B' ' 119' ' ' ARG . 1.3 tt0 -137.27 115.88 12.07 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.737 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CG2' ' HB3' ' A' ' 66' ' ' ALA . 2.8 mm -129.03 108.78 17.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.143 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.924 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 65.3 m-70 -70.0 137.15 87.23 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.089 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.44 145.15 80.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.212 1.941 . . . . 0.0 111.307 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.66 6.27 4.71 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.745 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 1.136 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -96.85 167.1 12.67 Favored Pre-proline 0 N--CA 1.429 -1.495 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 10.8 Cg_exo -11.7 -9.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 124.745 3.63 . . . . 0.0 116.079 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 1.136 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.4 -35.69 21.17 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.44 -5.47 20.31 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.082 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HG2' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -93.05 -26.48 17.47 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.339 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.587 ' HB2' HD13 ' A' ' 33' ' ' LEU . 41.6 t -106.79 6.13 29.24 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 45.05 14.22 0.04 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.075 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.542 ' HA3' ' CG1' ' A' ' 31' ' ' VAL . . . -144.9 7.03 1.64 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 119.605 -1.283 . . . . 0.0 114.86 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.863 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 8.2 mt -97.18 151.09 20.16 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 118.216 1.008 . . . . 0.0 109.428 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.92 130.76 0.06 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.268 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 57' ' ' ILE . 2.1 p -58.92 159.12 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.638 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.478 ' N ' ' CG2' ' A' ' 74' ' ' VAL . . . 106.91 -23.98 26.34 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.724 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.88 149.65 22.54 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.676 0.75 . . . . 0.0 110.022 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 110' ' ' VAL . . . -89.3 131.84 35.2 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.52 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.714 HG23 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -104.3 138.35 29.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.276 -178.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.635 HD21 ' N ' ' A' ' 79' ' ' LEU . 0.5 OUTLIER -148.22 -2.96 0.51 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.818 -177.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 1.028 ' CB ' ' HA ' ' A' ' 84' ' ' VAL . . . -157.2 138.05 13.32 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.872 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 21.5 t -140.28 143.85 28.78 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.11 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.533 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 5.6 p30 46.09 26.21 0.4 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.372 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.401 ' C ' ' CG1' ' A' ' 84' ' ' VAL . . . 128.05 44.86 0.21 Allowed Glycine 0 N--CA 1.464 0.525 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.38 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 1.028 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 1.5 p 43.37 77.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.452 1.101 . . . . 0.0 112.242 -177.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.621 ' H ' ' H ' ' A' ' 81' ' ' VAL . 19.8 m120 -130.98 92.76 3.27 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.613 ' CD1' ' HA ' ' A' ' 79' ' ' LEU . 2.0 mt -123.16 92.19 3.64 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 171.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.517 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -65.07 141.17 58.83 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.531 -176.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.16 96.33 10.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.084 -1.416 . . . . 0.0 114.475 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.837 HG22 ' HG3' ' A' ' 90' ' ' LYS . 0.9 OUTLIER -157.6 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 112.601 -2.09 . . . . 0.0 105.828 174.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.837 ' HG3' HG22 ' A' ' 89' ' ' THR . 25.2 mttm -132.48 168.28 18.47 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.889 ' HA ' ' CD1' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -47.36 -34.7 7.24 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.358 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.605 ' HA ' ' HB ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -58.43 -15.49 11.02 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.577 -177.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.719 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 9.6 mm-40 -64.16 -23.29 67.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.492 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -86.89 -39.42 15.81 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 92' ' ' LYS . 4.4 t -58.01 -46.02 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -61.95 -37.0 83.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.429 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 101' ' ' GLN . 1.0 OUTLIER -69.85 -47.15 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.746 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.667 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 2.7 pp -76.74 -35.99 57.42 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.432 ' N ' HD12 ' A' ' 98' ' ' LEU . 17.3 t -61.03 -54.23 47.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 101' ' ' GLN . 7.1 mm100 -85.12 -16.98 38.7 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.667 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 1.1 pt20 -54.63 -112.23 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.576 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.413 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 1.0 OUTLIER -147.47 177.32 9.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.99 -4.42 7.47 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.449 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.429 ' CB ' ' HG ' ' A' ' 34' ' ' LEU . 32.1 tt0 -103.17 116.73 33.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.548 0.69 . . . . 0.0 111.306 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.701 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 26.1 mm -103.22 112.45 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.872 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -95.28 122.54 38.08 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.701 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 44.0 m-85 -109.99 117.81 34.76 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.702 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 29' ' ' ARG . 1.3 mt-10 -108.66 115.85 30.88 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 29' ' ' ARG . 10.4 m -121.68 147.89 25.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 114.562 -1.199 . . . . 0.0 114.192 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.53 ' CG2' HD23 ' A' ' 79' ' ' LEU . 27.6 m -117.4 152.1 19.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 113.649 -1.614 . . . . 0.0 111.342 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -82.19 126.75 32.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.096 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . 0.749 ' OD1' ' NE2' ' A' ' 51' ' ' HIS . 8.4 m-20 . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 118.819 -0.61 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' THR . . . . . 0.718 ' HB ' ' NE2' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -167.66 166.59 13.84 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -178.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' ARG . . . . . 0.924 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -131.86 123.63 27.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.071 -1.877 . . . . 0.0 108.663 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.499 ' N ' HD13 ' B' ' 120' ' ' LEU . 1.1 mp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.92 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 tt -80.19 138.71 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 122.024 0.916 . . . . 0.0 112.047 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -136.33 121.74 19.38 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.688 -1.597 . . . . 0.0 109.948 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -104.49 119.4 38.89 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.273 1.035 . . . . 0.0 112.475 -178.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.507 ' CG1' ' HA3' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.53 117.84 55.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 113.311 -1.768 . . . . 0.0 108.38 177.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mp -96.24 113.8 25.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.099 0.476 . . . . 0.0 111.438 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.475 ' CD1' ' HA ' ' A' ' 65' ' ' PRO . 2.2 tt -113.07 109.22 18.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.441 ' HG ' ' CB ' ' A' ' 104' ' ' GLU . 3.1 mp -116.02 104.73 11.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.922 0.868 . . . . 0.0 110.961 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.76 161.32 13.71 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.704 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.97 136.17 33.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.626 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 47.7 25.3 0.67 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.516 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 2.4 m170 46.26 29.57 0.86 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.197 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.9 81.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.816 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' HIS . . . 55.61 170.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.382 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 HG21 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -108.59 -76.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.699 0.749 . . . . 0.0 111.38 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 121.64 23.88 2.47 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.467 HG21 HD23 ' A' ' 41' ' ' LEU . 14.9 tt -135.5 158.31 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -130.88 148.07 52.6 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.498 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.572 ' HB ' HG21 ' A' ' 55' ' ' ILE . 0.8 OUTLIER -135.0 159.01 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.265 -178.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.483 ' CA ' ' CE1' ' A' ' 91' ' ' HIS . 67.5 p -156.22 137.33 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.36 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 54' ' ' PRO . . . 151.85 169.1 16.96 Favored Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.314 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 144.73 -166.75 27.31 Favored Glycine 0 C--N 1.303 -1.297 0 CA-C-N 114.567 -0.816 . . . . 0.0 111.449 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.405 ' CB ' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -76.72 -14.76 59.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.983 0.392 . . . . 0.0 110.95 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -75.53 -41.41 55.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 110.27 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.49 ' O ' ' CG1' ' A' ' 53' ' ' VAL . 13.9 m-70 -98.9 11.32 39.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.519 0.676 . . . . 0.0 110.161 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.18 23.24 32.18 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.565 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.563 ' CG2' ' O ' ' A' ' 54' ' ' PRO . 1.1 m -128.19 170.94 9.33 Favored Pre-proline 0 CA--C 1.512 -0.496 0 CA-C-O 121.959 0.885 . . . . 0.0 113.014 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.571 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 7.5 Cg_exo -83.09 173.72 9.82 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.579 3.519 . . . . 0.0 108.132 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.572 HG21 ' HB ' ' A' ' 45' ' ' ILE . 39.4 mm -72.76 107.71 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.524 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.475 HD21 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.86 145.83 34.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -177.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 74' ' ' VAL . 3.8 mp -71.87 130.73 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.8 t -132.18 -22.45 2.27 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.465 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 0.2 OUTLIER -137.4 115.84 11.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.252 0.548 . . . . 0.0 110.21 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 66' ' ' ALA . 3.4 mm -125.43 107.06 17.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.72 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.984 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 39.2 m-70 -71.41 137.04 83.72 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.39 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.43 141.36 89.77 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.157 1.905 . . . . 0.0 111.227 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.33 0.92 8.62 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.609 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 1.112 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -96.43 167.36 12.42 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 6.2 Cg_exo -10.92 -9.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 125.075 3.85 . . . . 0.0 116.216 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 1.112 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.02 -35.83 21.67 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -102.14 -8.7 21.14 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.494 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -92.69 -26.44 17.79 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.439 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.723 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . 42.9 t -107.6 6.14 27.62 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 44.58 13.68 0.03 OUTLIER Glycine 0 C--N 1.336 0.557 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.35 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.507 ' HA3' ' CG1' ' A' ' 31' ' ' VAL . . . -149.63 12.25 1.0 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 119.431 -1.366 . . . . 0.0 115.152 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.774 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 10.0 mt -99.04 150.53 21.9 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 118.223 1.012 . . . . 0.0 110.159 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.1 t60 174.52 145.36 0.06 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.997 0.903 . . . . 0.0 111.611 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.584 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 7.3 p -65.4 147.49 12.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.951 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.79 -17.77 24.98 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.024 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -92.52 149.46 21.36 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.588 0.709 . . . . 0.0 110.324 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 109' ' ' VAL . . . -89.68 134.39 34.18 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.501 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.568 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -105.82 119.99 55.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.628 0.728 . . . . 0.0 111.608 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.457 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -96.16 -41.57 8.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.297 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 85' ' ' ASN . . . -162.61 176.94 9.85 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.927 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -140.95 154.89 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.604 178.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.743 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.2 p30 59.33 7.55 0.95 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.69 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.11 10.1 49.81 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.698 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 21.3 t -120.71 125.5 74.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.855 0.327 . . . . 0.0 110.769 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.649 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 14.6 p-10 -61.79 125.3 23.34 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.042 0.449 . . . . 0.0 109.945 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' CD1' ' H ' ' A' ' 81' ' ' VAL . 4.0 mp -106.8 86.34 2.31 Favored 'General case' 0 N--CA 1.413 -2.278 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.004 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -83.58 96.67 8.71 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.417 ' HB3' ' CB ' ' A' ' 93' ' ' GLU . 65.7 m-20 -132.61 99.31 4.6 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.675 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.405 ' OG1' ' CB ' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -56.42 -45.38 80.75 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.91 128.75 36.35 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.841 ' CD2' ' HB ' ' B' ' 118' ' ' THR . 5.5 t60 -65.44 -40.32 93.14 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.063 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 1.06 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 1.3 mmtm -62.71 -22.35 66.45 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.856 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.417 ' CB ' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -65.27 -24.18 67.24 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.986 -0.685 . . . . 0.0 109.55 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -81.92 -45.09 15.92 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.262 0.553 . . . . 0.0 110.068 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.829 HG21 ' HA ' ' A' ' 92' ' ' LYS . 2.0 t -57.31 -41.71 78.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.328 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -62.88 -38.6 91.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.003 0.906 . . . . 0.0 108.567 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.435 ' CG2' ' CD2' ' A' ' 86' ' ' LEU . 2.1 mm -69.87 -46.75 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.534 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.819 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 2.0 pp -75.21 -31.42 60.9 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.935 0.398 . . . . 0.0 111.756 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.1 t -57.13 -53.72 54.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.79 2.85 30.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.819 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -50.64 -93.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.812 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.453 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -151.31 173.66 14.23 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 38' ' ' HIS . . . -66.78 -12.14 58.98 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 119.594 -1.288 . . . . 0.0 112.881 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.441 ' CB ' ' HG ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -103.62 117.86 35.39 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.341 0.591 . . . . 0.0 111.777 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.631 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 20.2 mm -100.14 111.88 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.927 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -95.27 118.6 32.32 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.631 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 38.8 m-85 -102.49 117.57 34.98 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.532 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -103.0 115.45 30.63 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 175.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 6.9 m -124.34 156.99 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -175.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 1.8 m -128.37 152.24 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.247 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -89.0 118.53 28.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.112 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . 0.423 ' OD2' ' CE1' ' A' ' 51' ' ' HIS . 69.5 m-20 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' THR . . . . . 1.06 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 2.9 m -166.02 162.1 17.74 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' ARG . . . . . 0.984 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -135.1 129.25 33.65 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.102 178.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 45' ' ' ILE . 2.8 mp . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.705 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.78 138.6 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 122.027 0.918 . . . . 0.0 112.019 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.509 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -139.59 118.72 12.68 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 113.652 -1.613 . . . . 0.0 110.35 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -100.34 119.49 38.51 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 122.307 1.051 . . . . 0.0 112.941 -178.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.647 HG11 HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -115.62 118.05 57.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 113.308 -1.769 . . . . 0.0 107.924 176.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.24 115.82 28.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -113.72 124.33 52.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.861 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 4.8 mp -117.22 102.02 8.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.746 0.784 . . . . 0.0 111.742 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.19 161.2 13.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.3 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -137.96 148.19 45.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.027 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.432 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 13.1 t0 59.07 27.21 16.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.096 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.432 ' CG ' ' O ' ' A' ' 37' ' ' ASP . 21.0 p80 43.18 39.13 1.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.415 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.25 -21.27 47.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.92 178.81 16.41 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.532 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 65' ' ' PRO . 1.2 tp -117.81 -19.07 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.116 0.458 . . . . 0.0 111.361 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.524 ' HA2' ' ND1' ' A' ' 61' ' ' HIS . . . 57.68 32.53 65.49 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.089 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' B' ' 120' ' ' LEU . 0.4 OUTLIER -135.14 157.52 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.445 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 5.4 t -130.87 147.87 52.57 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.465 0.65 . . . . 0.0 110.657 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.768 HG13 ' HB ' ' B' ' 118' ' ' THR . 0.5 OUTLIER -137.86 157.75 32.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.934 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.611 ' N ' ' CE1' ' A' ' 91' ' ' HIS . 21.9 p -160.94 152.36 19.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.482 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 91' ' ' HIS . . . 139.16 -168.82 24.72 Favored Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.721 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 130.65 -169.03 21.54 Favored Glycine 0 C--N 1.3 -1.442 0 CA-C-N 114.098 -1.051 . . . . 0.0 113.199 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.42 -16.92 58.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.542 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 12.5 pt-20 -84.46 -34.42 23.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.973 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.568 ' CE1' ' OD2' ' B' ' 117' ' ' ASP . 27.1 m-70 -95.71 9.72 39.39 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.492 0.663 . . . . 0.0 109.726 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.2 23.48 52.88 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.897 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.7 OUTLIER -139.58 177.44 2.03 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-O 121.663 0.745 . . . . 0.0 112.862 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 53' ' ' VAL . 3.8 Cg_exo -88.21 173.21 4.86 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 124.561 3.507 . . . . 0.0 109.012 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.691 HD12 ' CG ' ' A' ' 91' ' ' HIS . 32.5 mm -72.44 99.15 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.95 139.1 41.02 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.3 mp -71.82 129.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.431 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 p -137.02 -13.85 1.6 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.781 ' OE1' ' NH1' ' B' ' 119' ' ' ARG . 0.4 OUTLIER -137.13 116.1 12.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.371 0.605 . . . . 0.0 110.532 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.461 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 3.0 mm -117.76 109.72 28.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.308 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.99 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 7.4 m170 -71.53 136.56 83.52 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.829 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -53.08 139.67 61.53 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.836 1.691 . . . . 0.0 113.071 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.76 25.14 0.19 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 114.635 -1.166 . . . . 0.0 114.308 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 1.065 ' O ' ' N ' ' A' ' 66' ' ' ALA . 7.6 mm100 -94.97 165.41 17.08 Favored Pre-proline 0 N--CA 1.419 -1.977 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 37.2 Cg_exo -30.54 2.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.273 1.982 . . . . 0.0 113.593 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 1.065 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.29 -36.41 19.35 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -101.8 -12.92 17.94 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.37 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -26.13 36.94 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.006 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.507 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -90.63 -5.03 56.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.68 8.77 0.39 Allowed Glycine 0 CA--C 1.519 0.33 0 CA-C-N 114.945 -1.025 . . . . 0.0 113.128 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.458 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -129.9 -1.66 5.37 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.691 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.647 HD22 HG11 ' A' ' 31' ' ' VAL . 4.1 mt -94.81 151.37 19.3 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 121.785 0.802 . . . . 0.0 111.518 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.4 t60 176.73 139.43 0.07 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.468 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.567 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 2.9 p -66.89 147.46 12.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 113.829 -1.532 . . . . 0.0 112.3 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.22 -21.1 10.25 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.539 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.17 150.67 22.58 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.577 0.703 . . . . 0.0 109.677 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 109' ' ' VAL . . . -88.59 130.76 35.19 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.179 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.581 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -106.62 122.77 60.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.703 0.763 . . . . 0.0 110.939 -178.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 tt -101.39 -50.63 3.7 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.217 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -148.67 176.77 10.07 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.905 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -138.88 153.22 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.691 177.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.59 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 0.0 OUTLIER 73.99 -18.1 0.42 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.532 -179.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 81' ' ' VAL . . . 118.98 9.59 8.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.752 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.602 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 20.4 t -127.96 133.03 68.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.75 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 8.2 p30 -61.09 131.87 51.96 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.527 ' CD1' ' HA ' ' A' ' 80' ' ' ALA . 5.4 mp -102.92 85.95 2.63 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 118.161 -1.415 . . . . 0.0 111.411 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.13 94.87 7.78 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 172.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.617 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 19.6 m-20 -134.3 97.52 3.86 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.511 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.701 ' OG1' ' N ' ' A' ' 90' ' ' LYS . 0.3 OUTLIER 46.19 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.087 0.946 . . . . 0.0 109.515 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.701 ' N ' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -126.97 168.04 15.07 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.132 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.714 ' CD2' ' OG1' ' B' ' 118' ' ' THR . 2.6 t-160 -46.06 -36.74 6.0 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 113.339 -1.755 . . . . 0.0 113.353 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -61.0 -23.89 65.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.617 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -64.3 -22.34 66.92 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.632 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -71.17 -46.81 60.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.001 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.85 HG23 ' OG1' ' B' ' 118' ' ' THR . 0.0 OUTLIER -59.84 -47.32 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.668 0.747 . . . . 0.0 109.68 178.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 93' ' ' GLU . 1.2 t -62.74 -36.12 81.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.898 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.417 HG22 HD21 ' A' ' 86' ' ' LEU . 1.4 mt -65.07 -47.23 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.764 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -76.35 -40.53 50.97 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.776 0.322 . . . . 0.0 110.869 179.154 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 75.3 m -55.75 -28.34 55.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.202 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -91.54 30.94 1.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER 178.1 151.62 0.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.875 0.369 . . . . 0.0 111.293 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.2 ptt-85 -126.04 160.91 28.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.41 -151.54 21.18 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.156 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 9.3 pt-20 -85.15 117.94 24.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.79 0.805 . . . . 0.0 111.901 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -98.56 121.7 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.516 0 CA-C-O 122.734 1.254 . . . . 0.0 107.814 177.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.905 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -93.5 127.71 39.27 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.3 -2.227 . . . . 0.0 108.645 -178.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 17.7 m-85 -104.32 117.62 34.64 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.024 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.67 116.26 31.63 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 7.6 m -122.13 154.77 26.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 15.7 t -118.42 132.36 68.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.918 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -81.68 107.81 14.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.105 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . 0.568 ' O ' HG21 ' A' ' 95' ' ' VAL . 6.4 m-20 . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' THR . . . . . 0.85 ' OG1' HG23 ' A' ' 95' ' ' VAL . 91.5 m -147.2 146.6 29.89 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' ARG . . . . . 0.99 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -142.87 109.35 5.36 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.523 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 43' ' ' ILE . 1.2 mp . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.852 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 tp -82.19 138.37 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 122.124 0.964 . . . . 0.0 112.105 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 5.8 mtt180 -140.22 116.9 10.88 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.928 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.47 119.42 37.98 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 122.332 1.063 . . . . 0.0 112.75 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.507 HG13 HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.96 116.89 53.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 112.966 -1.924 . . . . 0.0 107.05 176.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.14 114.36 27.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.285 0.564 . . . . 0.0 111.816 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.702 ' O ' ' HA ' ' A' ' 104' ' ' GLU . 0.7 OUTLIER -113.16 119.04 36.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.316 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 4.4 mp -110.96 101.66 10.2 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.804 0.811 . . . . 0.0 110.848 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.57 134.43 42.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.812 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 38' ' ' HIS . 15.2 mt-10 -138.84 138.08 37.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.995 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 38' ' ' HIS . 3.6 m-20 60.93 -79.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.258 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.558 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 60.0 m80 -15.47 -63.97 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.952 0.501 . . . . 0.0 112.34 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.558 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 6.0 tt0 96.82 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.656 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 48.79 -174.09 0.04 OUTLIER Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.608 -0.805 . . . . 0.0 111.935 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -125.37 -67.26 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.27 0.535 . . . . 0.0 111.416 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 64' ' ' GLN . . . 112.51 20.07 6.73 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.562 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 20.2 tt -125.18 160.52 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.149 0 CA-C-O 121.144 0.497 . . . . 0.0 110.458 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.418 ' N ' ' CG1' ' A' ' 43' ' ' ILE . 3.2 t -128.26 146.92 50.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.693 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.805 HG13 HG22 ' B' ' 118' ' ' THR . 0.6 OUTLIER -138.69 160.37 30.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.098 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.453 ' N ' ' CE1' ' A' ' 91' ' ' HIS . 66.7 p -158.75 138.77 12.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.27 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.503 ' N ' ' HD1' ' A' ' 91' ' ' HIS . . . 163.26 -141.0 6.83 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 140.96 160.98 8.51 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.15 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -80.35 -16.75 53.83 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.402 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 1.3 pt-20 -70.06 -35.81 74.53 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.394 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.466 ' CD2' ' CG ' ' A' ' 50' ' ' GLU . 21.3 m-70 -97.37 15.1 23.99 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.533 0.682 . . . . 0.0 109.833 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.73 18.34 31.34 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.554 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 54' ' ' PRO . 1.9 m -103.58 154.05 38.16 Favored Pre-proline 0 CA--C 1.513 -0.456 0 CA-C-O 122.02 0.914 . . . . 0.0 113.249 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.735 ' O ' HG22 ' A' ' 53' ' ' VAL . 22.4 Cg_exo -77.41 -172.49 1.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 124.551 3.5 . . . . 0.0 109.424 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.81 ' O ' HG23 ' A' ' 78' ' ' ILE . 50.4 mm -84.64 120.38 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.539 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -105.73 126.53 52.26 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.71 HG13 HG22 ' A' ' 78' ' ' ILE . 3.2 mt -70.34 131.44 34.26 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.17 -15.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.896 ' OE1' ' NH1' ' B' ' 119' ' ' ARG . 1.7 tt0 -137.57 116.14 12.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.092 0.472 . . . . 0.0 111.087 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.73 HG22 ' CG ' ' A' ' 64' ' ' GLN . 3.2 mm -116.19 106.09 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.708 0.766 . . . . 0.0 111.118 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.909 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 2.9 m170 -73.28 118.75 71.37 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.974 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -45.77 114.0 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.748 1.632 . . . . 0.0 110.836 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.47 ' HA2' ' CB ' ' A' ' 67' ' ' ASP . . . 105.97 1.43 39.15 Favored Glycine 0 N--CA 1.422 -2.266 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.804 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 1.154 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -94.41 166.55 15.14 Favored Pre-proline 0 CA--C 1.492 -1.266 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.826 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 69.4 Cg_exo -12.46 -9.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 124.969 3.779 . . . . 0.0 115.739 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 1.154 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.35 -35.98 19.51 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.47 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . 4.7 t70 -91.2 -12.5 35.17 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.505 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.826 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 3.7 mtt-85 -77.48 1.05 20.47 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.305 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 4.0 t 77.76 -17.28 0.58 Allowed 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 68' ' ' ARG . . . -43.79 -31.78 1.97 Allowed Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.029 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.472 ' C ' HG13 ' A' ' 31' ' ' VAL . . . 86.34 29.89 23.64 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.176 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.529 HD12 ' HB3' ' A' ' 65' ' ' PRO . 1.6 mt -90.82 151.76 21.04 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 122.255 1.026 . . . . 0.0 112.142 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.647 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.9 t60 179.85 146.96 0.24 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.33 -1.759 . . . . 0.0 111.319 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.647 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 12.0 p -67.43 158.97 5.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.607 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.418 ' N ' ' CG2' ' A' ' 74' ' ' VAL . . . 102.95 -19.18 47.57 Favored Glycine 0 C--N 1.316 -0.552 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.546 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.16 149.64 21.77 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.385 0.612 . . . . 0.0 109.989 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 109' ' ' VAL . . . -89.15 129.37 35.76 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.684 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.81 HG23 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.15 113.82 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.527 0.679 . . . . 0.0 112.279 -177.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 108' ' ' GLU . 0.2 OUTLIER -89.64 -41.35 12.01 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.991 -178.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.72 ' HB1' ' HA ' ' A' ' 85' ' ' ASN . . . -162.67 177.53 9.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -175.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 1.063 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -133.71 154.49 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.367 178.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.685 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.6 p30 57.56 7.41 0.52 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.537 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.06 13.36 39.81 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.829 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.469 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 20.7 t -123.86 118.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.976 0.388 . . . . 0.0 111.511 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.72 ' HA ' ' HB1' ' A' ' 80' ' ' ALA . 2.7 m120 -61.33 124.7 21.33 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.517 ' CD1' ' HA ' ' A' ' 80' ' ' ALA . 4.6 mp -106.41 86.36 2.34 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.439 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -102.74 94.66 5.73 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 90' ' ' LYS . 1.1 m-20 -134.04 94.39 3.24 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.686 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.531 ' C ' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER 14.72 -80.35 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 124.444 1.09 . . . . 0.0 111.92 178.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -75.09 136.39 41.15 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 113.611 -1.631 . . . . 0.0 112.038 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.927 ' CD2' ' HB ' ' B' ' 118' ' ' THR . 7.6 t60 -60.8 -36.31 78.7 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.657 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 1.008 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 1.7 mmtm -61.92 -22.6 65.73 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.267 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.485 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -64.97 -25.39 67.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.556 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -84.03 -44.16 14.4 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.637 ' HA ' ' CG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -57.2 -45.51 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.858 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.463 ' N ' ' CG1' ' A' ' 95' ' ' VAL . 14.6 t -61.42 -36.39 80.21 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.1 mt -69.49 -46.57 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.956 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.637 ' CG ' ' HA ' ' A' ' 95' ' ' VAL . 0.9 OUTLIER -75.22 -35.04 61.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.652 0.263 . . . . 0.0 111.161 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 93.5 p -57.31 -57.29 13.28 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.138 0.494 . . . . 0.0 110.439 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -66.26 -32.8 74.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.12 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -51.0 149.61 3.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.512 179.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.57 169.65 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.47 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.41 -132.13 12.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.453 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.702 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 1.1 pt-20 -84.73 126.46 33.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.598 HG22 ' CE1' ' A' ' 107' ' ' PHE . 20.7 mm -97.09 112.8 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 1.063 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -94.47 121.37 35.94 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.631 -179.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.598 ' CE1' HG22 ' A' ' 105' ' ' ILE . 34.5 m-85 -105.22 118.06 35.59 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.715 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.433 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -100.06 115.98 31.03 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 5.0 m -129.1 157.49 41.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.43 ' CG2' HD22 ' A' ' 79' ' ' LEU . 58.5 t -118.12 130.4 73.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.893 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -83.6 117.33 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.961 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.179 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' THR . . . . . 1.008 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -170.79 159.8 6.58 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' ARG . . . . . 0.909 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -124.28 165.44 17.64 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.512 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.509 HD11 HG12 ' A' ' 45' ' ' ILE . 5.9 mp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.247 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 tp -79.41 138.77 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.044 0.926 . . . . 0.0 112.028 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.466 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.9 OUTLIER -140.13 120.37 13.86 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.958 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -102.31 119.82 39.45 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 122.192 0.996 . . . . 0.0 112.661 -178.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.57 HG12 HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -113.58 117.94 56.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 113.342 -1.754 . . . . 0.0 108.673 177.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.3 112.0 23.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.41 0.624 . . . . 0.0 111.659 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -114.42 115.42 27.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.02 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -116.69 100.59 7.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.004 0.907 . . . . 0.0 109.923 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -100.78 161.81 13.34 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.474 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -86.31 160.75 19.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.475 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -41.09 -26.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 1.3 t-160 -40.61 -57.1 1.95 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 1.0 OUTLIER 101.57 160.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.468 0.707 . . . . 0.0 111.111 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.73 129.15 4.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.403 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.613 ' HB3' HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -120.35 -9.67 9.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.787 0.327 . . . . 0.0 111.673 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.475 ' HA2' ' ND1' ' A' ' 61' ' ' HIS . . . 47.09 37.62 10.34 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.703 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.613 HG23 ' HB3' ' A' ' 41' ' ' LEU . 9.3 tt -135.05 158.59 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.489 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 6.8 t -130.03 147.88 51.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.768 0.794 . . . . 0.0 111.185 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.694 ' O ' ' HE1' ' A' ' 91' ' ' HIS . 1.2 pt -138.16 160.96 32.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.729 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.487 ' HA ' ' CE1' ' A' ' 91' ' ' HIS . 7.1 p -160.64 136.48 8.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.955 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' CA ' HG22 ' A' ' 53' ' ' VAL . . . 163.01 -141.4 7.13 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 53' ' ' VAL . . . 160.69 128.68 0.97 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.1 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -74.51 -10.79 59.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 109.942 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.478 ' HG3' ' CD2' ' A' ' 51' ' ' HIS . 0.5 OUTLIER -102.65 -24.87 13.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.235 179.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.478 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 54.5 m-70 -91.61 21.3 4.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.436 0.636 . . . . 0.0 110.457 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.23 14.34 56.36 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.405 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -129.75 137.21 30.41 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.525 ' O ' HG21 ' A' ' 53' ' ' VAL . 77.7 Cg_exo -63.65 156.48 56.96 Favored 'Trans proline' 0 C--N 1.331 -0.357 0 C-N-CA 124.001 3.134 . . . . 0.0 111.069 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.536 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 24.9 mm -74.26 108.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.647 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 54' ' ' PRO . 8.0 mp -103.86 139.28 39.27 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.2 mp -72.01 131.62 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.017 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 m -136.79 -17.47 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.489 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 0.5 OUTLIER -137.27 116.11 12.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.234 0.54 . . . . 0.0 110.844 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 66' ' ' ALA . 4.2 mm -116.53 111.69 36.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.245 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.773 ' CE1' ' NH1' ' B' ' 119' ' ' ARG . 7.6 m170 -70.89 136.73 85.15 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.873 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.37 138.99 81.34 Favored 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 122.246 1.964 . . . . 0.0 113.119 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 42.19 25.33 0.25 Allowed Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.704 -1.135 . . . . 0.0 113.975 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 1.085 ' O ' ' N ' ' A' ' 66' ' ' ALA . 9.1 mm100 -95.21 165.34 17.06 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.575 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 49.1 Cg_exo -31.25 2.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.036 1.824 . . . . 0.0 113.255 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 1.085 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.15 -36.44 19.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.01 -13.95 19.67 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.346 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 29.6 mtp180 -76.19 -26.24 55.97 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.817 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.519 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 28.0 t -93.3 -1.78 55.66 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 48.85 11.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.985 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.559 ' HA3' ' CG1' ' A' ' 31' ' ' VAL . . . -136.75 5.61 3.73 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.489 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.57 HD22 HG12 ' A' ' 31' ' ' VAL . 6.3 mt -94.72 150.61 20.04 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 117.925 0.862 . . . . 0.0 109.357 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 179.6 133.22 0.1 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.627 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 75' ' ' GLY . 3.2 p -60.67 159.5 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.98 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 74' ' ' VAL . . . 105.99 -24.5 26.47 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.709 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.33 149.88 23.52 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.755 0.788 . . . . 0.0 109.874 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 110' ' ' VAL . . . -88.68 133.6 34.16 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.562 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.536 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -102.97 145.3 12.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.497 -178.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.925 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -146.02 -20.13 0.45 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 1.062 ' HB3' ' HA ' ' A' ' 84' ' ' VAL . . . -163.88 176.27 9.62 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.817 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -154.06 153.15 8.83 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 0.2 OUTLIER 77.95 -49.45 0.49 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.625 -1.625 . . . . 0.0 112.264 178.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' C ' ' CG1' ' A' ' 84' ' ' VAL . . . -154.78 32.61 0.68 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 1.062 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 1.4 p 48.46 73.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 126.781 2.033 . . . . 0.0 113.177 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.541 ' N ' ' CB ' ' A' ' 80' ' ' ALA . 14.9 p-10 -136.35 97.28 3.54 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 113.27 -1.787 . . . . 0.0 112.68 172.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.925 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 7.1 mt -116.71 88.28 2.87 Favored 'General case' 0 CA--C 1.469 -2.139 0 CA-C-N 124.273 3.215 . . . . 0.0 108.549 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.51 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -112.55 92.73 4.12 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 173.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.675 ' O ' ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -137.65 93.13 2.76 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.369 178.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.684 ' OG1' ' N ' ' A' ' 90' ' ' LYS . 1.0 OUTLIER 14.82 -124.89 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.684 ' N ' ' OG1' ' A' ' 89' ' ' THR . 3.5 mttp -75.29 168.56 19.76 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.743 ' NE2' ' HB ' ' B' ' 118' ' ' THR . 3.1 t-160 -44.61 -50.07 9.92 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -175.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.988 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 0.0 OUTLIER -60.77 -20.49 61.52 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.019 -176.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.66 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -65.86 -24.96 66.98 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.531 178.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.528 ' CB ' HD21 ' A' ' 86' ' ' LEU . . . -76.34 -38.61 55.68 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 92' ' ' LYS . 1.4 t -61.9 -44.94 99.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.588 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 93' ' ' GLU . 5.3 t -61.55 -36.32 80.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -68.98 -46.63 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.825 179.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.684 ' CG ' ' HA ' ' A' ' 95' ' ' VAL . 2.6 pp -74.88 -33.15 62.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.789 0.328 . . . . 0.0 111.522 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.6 t -57.41 -53.69 55.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.226 0.536 . . . . 0.0 110.719 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -69.9 -40.02 75.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.743 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.548 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -55.71 156.01 5.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.51 167.2 22.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.04 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.21 -130.65 10.32 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.463 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -98.2 128.76 44.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 122.169 0.985 . . . . 0.0 113.473 -178.236 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.607 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 30.8 mm -97.54 112.7 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.817 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -93.75 117.6 30.31 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 178.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 31.6 m-85 -99.25 118.61 36.32 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.616 -176.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.558 ' HG3' ' CB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -107.06 116.61 32.23 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 14.5 m -122.13 145.23 29.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.403 -0.919 . . . . 0.0 113.213 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.507 ' CG2' HD12 ' A' ' 79' ' ' LEU . 7.8 t -117.02 152.13 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.051 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -87.04 117.46 25.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.136 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.055 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . 0.48 ' HA ' ' CE1' ' A' ' 91' ' ' HIS . 14.6 m-20 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' THR . . . . . 0.988 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -169.02 157.33 7.82 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' ARG . . . . . 0.773 ' NH1' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -133.74 121.32 21.72 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.992 178.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 43' ' ' ILE . 2.4 mp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.814 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.31 134.64 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 C-N-CA 122.86 0.464 . . . . 0.0 111.239 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.459 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -142.45 122.22 13.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.177 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -106.11 119.46 39.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.149 0.976 . . . . 0.0 112.682 -178.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.578 HG13 HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -117.5 118.28 57.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.854 177.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -89.86 110.06 21.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.926 0.869 . . . . 0.0 112.739 -177.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -115.39 115.46 26.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.488 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.563 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -118.66 101.57 8.21 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.636 0.731 . . . . 0.0 110.672 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.28 161.31 13.69 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.435 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.65 119.44 26.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.966 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 51.91 -137.75 1.16 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.528 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.44 41.63 1.08 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.75 0.31 . . . . 0.0 110.926 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -56.37 -22.93 34.32 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.05 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.0 174.86 31.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.148 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.684 HD21 HG12 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -111.62 -26.78 8.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 110.684 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.471 ' HA2' ' CE1' ' A' ' 61' ' ' HIS . . . 65.29 33.1 85.82 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.684 HG12 HD21 ' A' ' 41' ' ' LEU . 1.8 pt -135.41 157.87 40.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.478 ' CB ' ' HB3' ' A' ' 59' ' ' GLU . 1.7 t -130.61 147.72 52.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.667 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.67 ' O ' ' HE1' ' A' ' 91' ' ' HIS . 2.9 pt -137.58 159.92 34.6 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.634 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.651 ' HA ' ' HD1' ' A' ' 91' ' ' HIS . 69.4 p -160.29 135.75 8.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.686 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 91' ' ' HIS . . . 165.42 170.16 30.0 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 119.807 -1.187 . . . . 0.0 112.944 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 148.63 -177.6 26.76 Favored Glycine 0 C--N 1.303 -1.255 0 CA-C-N 114.156 -1.022 . . . . 0.0 113.305 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -15.26 58.37 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 11.1 pt-20 -82.86 -35.73 26.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.991 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.59 ' CE1' ' OD1' ' B' ' 117' ' ' ASP . 30.9 m-70 -94.59 8.9 40.72 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.501 0.667 . . . . 0.0 109.562 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.29 55.31 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.828 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 54' ' ' PRO . 1.6 m -138.99 172.67 6.18 Favored Pre-proline 0 CA--C 1.513 -0.479 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.554 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 3.0 Cg_exo -86.55 166.98 8.9 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 124.761 3.641 . . . . 0.0 108.272 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.647 ' HB ' HG23 ' A' ' 78' ' ' ILE . 13.4 mm -72.46 99.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 117.756 -1.578 . . . . 0.0 107.122 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.87 137.1 44.32 Favored 'General case' 0 N--CA 1.405 -2.686 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.33 134.15 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.911 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -139.75 -12.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.535 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 1.0 OUTLIER -134.49 116.08 14.68 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.317 0.58 . . . . 0.0 110.994 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 66' ' ' ALA . 3.3 mm -123.18 112.15 32.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.788 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.814 ' CE1' ' CZ ' ' B' ' 119' ' ' ARG . 5.3 m170 -71.88 136.62 82.56 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.267 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -57.6 142.63 95.7 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.839 1.693 . . . . 0.0 112.561 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 46.36 19.84 0.49 Allowed Glycine 0 N--CA 1.432 -1.57 0 CA-C-N 115.216 -0.902 . . . . 0.0 114.23 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 1.095 ' O ' ' N ' ' A' ' 66' ' ' ALA . 8.6 mm100 -96.04 165.93 15.39 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.539 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 31.9 Cg_exo -28.31 2.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.421 2.081 . . . . 0.0 113.734 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 1.095 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.93 -36.32 19.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -102.19 -13.1 17.57 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.265 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.403 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -78.87 -26.46 43.95 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.911 -179.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.492 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 8.6 t -95.08 -1.53 51.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 48.94 10.07 0.12 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.464 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA3' ' CG1' ' A' ' 31' ' ' VAL . . . -133.47 7.42 4.97 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.063 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 5.5 mt -97.65 154.66 17.41 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 121.433 0.635 . . . . 0.0 110.844 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.97 126.65 0.06 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.253 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 75' ' ' GLY . 2.3 p -60.42 159.39 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.355 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.47 ' N ' ' CG2' ' A' ' 74' ' ' VAL . . . 108.9 -24.29 21.84 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.27 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.03 150.43 24.88 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.704 0.764 . . . . 0.0 109.226 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 110' ' ' VAL . . . -88.06 137.55 32.23 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.137 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.647 HG23 ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -100.47 149.19 6.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.884 -178.063 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.6 -50.89 0.62 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.363 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.7 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -147.81 175.93 10.53 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.006 1.114 . . . . 0.0 114.006 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.824 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -143.06 154.58 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.157 178.437 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.802 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.7 p30 63.13 5.14 1.8 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.987 -1.46 . . . . 0.0 112.462 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' N ' ' CD ' ' A' ' 106' ' ' GLU . . . 102.4 5.71 48.59 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.82 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.447 ' O ' ' CB ' ' A' ' 80' ' ' ALA . 21.1 t -123.8 136.53 59.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 117.004 0.402 . . . . 0.0 111.319 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.7 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 38.3 t-20 -61.39 133.29 55.64 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.56 ' CD1' ' H ' ' A' ' 81' ' ' VAL . 6.1 mp -103.22 86.43 2.68 Favored 'General case' 0 CA--C 1.465 -2.325 0 C-N-CA 118.278 -1.369 . . . . 0.0 108.98 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.534 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 5.3 tpp85 -100.6 94.4 6.09 Favored 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 173.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.652 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 20.7 m-20 -134.25 96.46 3.61 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.699 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.743 ' OG1' ' N ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER 29.28 -132.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.643 179.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.743 ' N ' ' OG1' ' A' ' 89' ' ' THR . 6.7 mttp -75.46 169.74 17.49 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.843 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.67 ' HE1' ' O ' ' A' ' 45' ' ' ILE . 4.9 t-160 -45.26 -49.97 12.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -175.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 1.029 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 0.3 OUTLIER -59.29 -20.04 51.1 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.847 -176.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.652 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -66.51 -25.02 66.49 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.429 ' HB3' HD22 ' A' ' 86' ' ' LEU . . . -82.59 -38.65 23.32 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.778 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.803 HG22 ' HA ' ' A' ' 92' ' ' LYS . 1.6 t -57.29 -43.48 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.035 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 93' ' ' GLU . 7.8 t -62.47 -36.24 81.84 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.561 ' O ' ' CG ' ' A' ' 101' ' ' GLN . 3.2 mm -69.49 -47.33 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.947 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.628 ' HG ' ' HA ' ' A' ' 95' ' ' VAL . 2.2 pp -73.0 -31.31 64.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.981 0.42 . . . . 0.0 111.561 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 80.6 p -52.41 -47.99 65.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.828 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -123.35 6.49 9.04 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.561 ' CG ' ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -51.98 -61.55 2.19 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.987 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.07 176.44 11.89 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.716 0.293 . . . . 0.0 110.671 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.94 -33.5 41.18 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 119.992 -1.099 . . . . 0.0 111.286 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 31.4 tt0 -103.42 118.65 37.23 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.756 -1.222 . . . . 0.0 110.062 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.526 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -98.16 121.67 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.613 0 CA-C-O 123.01 1.386 . . . . 0.0 108.99 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.824 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -94.04 123.04 37.16 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 111.959 -2.382 . . . . 0.0 107.628 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 17.7 m-85 -98.26 117.64 33.09 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.582 -177.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -109.72 116.83 32.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 175.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 11.2 m -121.15 149.81 24.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 122.013 0.911 . . . . 0.0 113.439 -176.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 77' ' ' ALA . 31.5 t -117.49 148.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 113.674 -1.603 . . . . 0.0 111.063 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -86.34 121.22 28.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.042 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.127 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . 0.59 ' OD1' ' CE1' ' A' ' 51' ' ' HIS . 10.8 m-20 . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' THR . . . . . 1.029 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -165.21 163.58 20.19 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 -178.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' ARG . . . . . 0.814 ' CZ ' ' CE1' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -137.05 111.62 8.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.94 178.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ILE . 2.4 mp . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.704 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.92 138.68 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-O 122.067 0.937 . . . . 0.0 111.962 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 7.0 mtt-85 -138.04 118.54 13.86 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.391 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 5.7 mtpt -97.28 119.55 36.01 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 122.316 1.055 . . . . 0.0 112.167 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.514 ' CG1' ' HA3' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.95 117.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.897 177.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.83 110.39 22.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.419 0.628 . . . . 0.0 112.135 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.636 ' HB3' HG21 ' A' ' 105' ' ' ILE . 0.7 OUTLIER -113.33 115.68 28.51 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.101 178.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -118.1 105.46 11.86 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.315 -177.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -99.13 161.41 13.63 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.855 -1.521 . . . . 0.0 110.573 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -86.91 126.0 34.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.266 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 57.72 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.335 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . 9.3 p80 -177.3 40.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.019 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -65.91 62.71 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.283 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.39 164.24 0.04 OUTLIER Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.597 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.456 ' CB ' ' HB3' ' B' ' 120' ' ' LEU . 0.3 OUTLIER -101.65 -66.09 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.527 0.664 . . . . 0.0 111.182 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 64' ' ' GLN . . . 110.61 16.82 9.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.925 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 65' ' ' PRO . 18.0 mm -135.75 156.98 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.532 ' HB2' ' CZ ' ' B' ' 119' ' ' ARG . 32.8 t -130.11 148.64 51.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.759 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.565 ' HB ' HG21 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -134.21 158.76 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.929 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.466 ' N ' ' HE1' ' A' ' 91' ' ' HIS . 17.3 p -155.2 137.81 15.14 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.807 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 54' ' ' PRO . . . 144.57 176.52 18.66 Favored Glycine 0 N--CA 1.422 -2.26 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.301 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 142.96 -168.2 26.08 Favored Glycine 0 C--N 1.3 -1.431 0 CA-C-N 114.886 -0.657 . . . . 0.0 112.586 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -78.15 -2.15 36.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.465 0.174 . . . . 0.0 111.238 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 1.3 pt-20 -98.85 -33.45 10.87 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.481 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.778 ' NE2' ' OD1' ' B' ' 117' ' ' ASP . 29.6 m-70 -96.33 10.64 37.4 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.409 0.623 . . . . 0.0 110.02 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.58 24.66 53.5 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.356 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.9 OUTLIER -136.34 172.83 6.38 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-O 121.898 0.856 . . . . 0.0 113.029 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.521 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 3.0 Cg_exo -85.36 170.78 9.16 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 124.691 3.594 . . . . 0.0 108.543 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.565 HG21 ' HB ' ' A' ' 45' ' ' ILE . 33.5 mm -72.65 105.57 2.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 118.744 -1.182 . . . . 0.0 108.59 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.485 HD23 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -109.75 146.42 34.97 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.44 ' CG2' ' HA ' ' A' ' 74' ' ' VAL . 3.1 mp -72.45 134.87 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.418 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.2 p -137.78 -19.14 1.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.611 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 3.6 tt0 -136.27 115.61 12.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.0 110.07 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.415 HD11 ' CD1' ' A' ' 43' ' ' ILE . 1.9 mm -128.51 104.98 12.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.705 0.764 . . . . 0.0 111.623 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 1.028 ' NE2' ' NH2' ' B' ' 119' ' ' ARG . 74.8 m-70 -70.24 137.12 86.66 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.516 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.43 145.01 81.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.186 1.924 . . . . 0.0 111.182 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.01 6.25 9.37 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.967 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 1.136 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -96.59 166.81 13.35 Favored Pre-proline 0 N--CA 1.431 -1.411 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 29.8 Cg_exo -17.36 -4.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.053 3.169 . . . . 0.0 115.386 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 1.136 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -84.9 -35.76 21.92 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.32 -7.23 19.0 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.926 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -92.32 -26.28 18.18 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.688 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.575 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . 35.3 t -107.0 7.4 29.84 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 43.18 14.28 0.02 OUTLIER Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.421 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' HA3' ' CG1' ' A' ' 31' ' ' VAL . . . -144.32 9.62 1.95 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 119.542 -1.313 . . . . 0.0 114.714 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.907 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 7.5 mt -98.71 153.71 18.51 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 117.948 0.874 . . . . 0.0 109.976 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.97 130.9 0.1 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.19 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 75' ' ' GLY . 2.7 p -61.4 159.4 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.792 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.46 ' N ' ' CG2' ' A' ' 74' ' ' VAL . . . 100.24 -21.76 43.02 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.145 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.8 150.71 23.39 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.52 0.676 . . . . 0.0 109.633 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 109' ' ' VAL . . . -88.49 144.02 26.61 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.709 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.53 HG21 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -106.34 125.96 62.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.429 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.37 -51.9 4.0 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.196 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.717 ' HB1' ' HA ' ' A' ' 85' ' ' ASN . . . -162.37 176.7 10.25 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 52.6 t -131.89 152.15 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.589 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.674 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 1.2 p30 58.73 6.33 0.6 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.492 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.54 12.02 49.22 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.461 -0.875 . . . . 0.0 114.024 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.602 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 25.7 t -123.28 123.26 67.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 117.108 0.454 . . . . 0.0 111.202 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.717 ' HA ' ' HB1' ' A' ' 80' ' ' ALA . 7.5 p-10 -60.89 127.21 30.46 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.507 ' CD1' ' HA ' ' A' ' 80' ' ' ALA . 4.9 mp -106.64 86.16 2.29 Favored 'General case' 0 N--CA 1.416 -2.155 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 mmt-85 -98.63 94.84 6.88 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 89' ' ' THR . 4.8 m-20 -133.91 95.57 3.48 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.063 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.589 ' C ' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -2.56 -67.61 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.179 0.99 . . . . 0.0 111.803 178.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -75.13 134.4 41.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 113.482 -1.69 . . . . 0.0 111.626 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.69 ' CD2' ' HB ' ' B' ' 118' ' ' THR . 6.7 t60 -64.11 -39.59 94.37 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.411 -1.722 . . . . 0.0 108.182 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.861 ' HA ' HG21 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -62.32 -22.01 65.72 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.189 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.534 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -64.64 -23.72 67.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.562 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -79.12 -45.77 19.35 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.816 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.861 HG21 ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -57.56 -45.6 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.874 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.6 t -60.3 -37.74 81.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.44 HG21 HD22 ' A' ' 86' ' ' LEU . 2.7 mt -69.85 -46.61 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.462 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.731 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 1.4 pp -76.12 -31.07 58.47 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.006 0.431 . . . . 0.0 111.642 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.8 t -53.68 -50.14 66.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -114.08 14.19 18.26 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.731 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -49.27 -86.49 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.87 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.442 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 4.7 ttt180 -151.63 176.55 11.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.6 -23.49 68.82 Favored Glycine 0 CA--C 1.504 -0.635 0 C-N-CA 119.528 -1.32 . . . . 0.0 112.428 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 20.7 mt-10 -104.09 117.52 34.47 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.267 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.636 HG21 ' HB3' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -98.43 116.72 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.926 0 CA-C-O 122.802 1.287 . . . . 0.0 107.565 178.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.678 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -96.09 140.11 31.28 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 112.813 -1.994 . . . . 0.0 108.739 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 12.2 m-85 -124.71 118.03 25.53 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.603 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.439 ' HG3' ' CA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -105.11 116.71 32.4 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 176.499 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 6.1 m -121.94 156.36 26.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -176.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 18.8 t -117.9 116.15 50.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.941 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -81.76 125.66 30.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.077 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' ASP . . . . . 0.778 ' OD1' ' NE2' ' A' ' 51' ' ' HIS . 80.4 m-20 . . . . . 0 N--CA 1.472 0.657 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' THR . . . . . 0.69 ' HB ' ' CD2' ' A' ' 91' ' ' HIS . 7.1 m -155.65 156.51 35.12 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' ARG . . . . . 1.028 ' NH2' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -136.74 125.62 24.16 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.892 178.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.524 ' N ' HD13 ' B' ' 120' ' ' LEU . 3.7 mp . . . . . 0 C--O 1.255 1.392 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.965 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.92 138.8 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-O 122.098 0.951 . . . . 0.0 111.903 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 13.6 mtt-85 -138.34 116.64 11.91 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.319 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.6 OUTLIER -96.65 119.86 35.91 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.567 1.175 . . . . 0.0 113.171 -178.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.542 ' CG1' ' HA3' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.64 117.95 56.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 112.533 -2.121 . . . . 0.0 108.303 177.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mp -95.3 110.21 22.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.106 0.479 . . . . 0.0 111.483 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 69' ' ' CYS . 1.2 tt -113.52 112.29 23.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.641 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.429 ' HG ' ' CB ' ' A' ' 104' ' ' GLU . 3.9 mp -117.13 101.58 8.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.727 0.775 . . . . 0.0 111.614 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.38 130.86 45.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.538 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 38' ' ' HIS . 55.3 mt-10 -137.97 160.27 39.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.803 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 38' ' ' HIS . 0.8 OUTLIER 59.59 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.531 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 58.2 m-70 -34.47 -55.63 0.53 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.643 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 4.9 tp10 94.54 172.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.92 163.83 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.1 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD21 HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -105.7 -82.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.749 0.309 . . . . 0.0 111.364 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.44 22.86 1.04 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.47 HG23 HD21 ' A' ' 41' ' ' LEU . 13.5 tt -135.18 158.27 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 C-N-CA 122.79 0.436 . . . . 0.0 109.849 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.49 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 41.1 t -130.74 146.19 52.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.988 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.574 ' O ' ' CE1' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -139.88 159.09 26.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 CA-C-O 122.189 0.995 . . . . 0.0 112.634 -179.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.75 ' HA ' ' HD1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -161.74 137.27 7.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.748 178.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' HG21 ' A' ' 53' ' ' VAL . . . 151.4 168.96 16.48 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.492 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 141.03 -164.62 26.44 Favored Glycine 0 C--N 1.304 -1.238 0 CA-C-N 114.367 -0.917 . . . . 0.0 112.125 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -76.89 -17.44 58.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 0.0 110.041 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HB2' ' HD3' ' A' ' 90' ' ' LYS . 2.7 tt0 -71.94 -42.7 66.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.947 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.749 ' NE2' ' OD1' ' B' ' 117' ' ' ASP . 21.3 m-70 -99.62 12.01 37.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.41 0.624 . . . . 0.0 110.178 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.93 23.9 40.12 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.75 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.8 OUTLIER -131.83 173.63 5.65 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 121.923 0.868 . . . . 0.0 113.079 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.552 ' O ' HG23 ' A' ' 53' ' ' VAL . 4.4 Cg_exo -87.2 160.45 8.47 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.644 3.563 . . . . 0.0 108.256 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.889 ' CD1' ' HA ' ' A' ' 91' ' ' HIS . 25.2 mm -73.2 99.87 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.188 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.506 ' CD1' ' HB2' ' A' ' 54' ' ' PRO . 6.9 mp -104.38 141.4 36.4 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.486 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.6 mp -71.12 129.3 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.198 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.63 -18.71 3.86 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.509 ' OE2' ' NH2' ' B' ' 119' ' ' ARG . 1.3 tt0 -137.27 115.88 12.07 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.737 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CG2' ' HB3' ' A' ' 66' ' ' ALA . 2.8 mm -129.03 108.78 17.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.143 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.924 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 65.3 m-70 -70.0 137.15 87.23 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.089 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.44 145.15 80.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.212 1.941 . . . . 0.0 111.307 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.66 6.27 4.71 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.745 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 1.136 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -96.85 167.1 12.67 Favored Pre-proline 0 N--CA 1.429 -1.495 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 10.8 Cg_exo -11.7 -9.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 124.745 3.63 . . . . 0.0 116.079 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 1.136 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.4 -35.69 21.17 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.44 -5.47 20.31 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.082 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HG2' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -93.05 -26.48 17.47 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.339 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.587 ' HB2' HD13 ' A' ' 33' ' ' LEU . 41.6 t -106.79 6.13 29.24 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 45.05 14.22 0.04 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.075 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.542 ' HA3' ' CG1' ' A' ' 31' ' ' VAL . . . -144.9 7.03 1.64 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 119.605 -1.283 . . . . 0.0 114.86 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.863 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 8.2 mt -97.18 151.09 20.16 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 118.216 1.008 . . . . 0.0 109.428 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.92 130.76 0.06 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.268 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 57' ' ' ILE . 2.1 p -58.92 159.12 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.638 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.478 ' N ' ' CG2' ' A' ' 74' ' ' VAL . . . 106.91 -23.98 26.34 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.724 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.88 149.65 22.54 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.676 0.75 . . . . 0.0 110.022 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 110' ' ' VAL . . . -89.3 131.84 35.2 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.52 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.714 HG23 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -104.3 138.35 29.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.276 -178.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.635 ' N ' HD21 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -148.22 -2.96 0.51 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.818 -177.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 1.028 ' CB ' ' HA ' ' A' ' 84' ' ' VAL . . . -157.2 138.05 13.32 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.872 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 21.5 t -140.28 143.85 28.78 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.11 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.533 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 5.6 p30 46.09 26.21 0.4 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.372 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.401 ' C ' ' CG1' ' A' ' 84' ' ' VAL . . . 128.05 44.86 0.21 Allowed Glycine 0 N--CA 1.464 0.525 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.38 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 1.028 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 1.5 p 43.37 77.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.452 1.101 . . . . 0.0 112.242 -177.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.621 ' H ' ' H ' ' A' ' 81' ' ' VAL . 19.8 m120 -130.98 92.76 3.27 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.613 ' CD1' ' HA ' ' A' ' 79' ' ' LEU . 2.0 mt -123.16 92.19 3.64 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 171.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.517 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -65.07 141.17 58.83 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.531 -176.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.16 96.33 10.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.084 -1.416 . . . . 0.0 114.475 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.025 ' CG2' ' OE1' ' B' ' 116' ' ' GLN . 0.9 OUTLIER -157.6 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 112.601 -2.09 . . . . 0.0 105.828 174.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.837 ' HG3' HG22 ' A' ' 89' ' ' THR . 25.2 mttm -132.48 168.28 18.47 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.889 ' HA ' ' CD1' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -47.36 -34.7 7.24 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.358 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.819 ' HB2' ' CG ' ' B' ' 116' ' ' GLN . 0.0 OUTLIER -58.43 -15.49 11.02 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.577 -177.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.719 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 9.6 mm-40 -64.16 -23.29 67.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.492 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -86.89 -39.42 15.81 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 92' ' ' LYS . 4.4 t -58.01 -46.02 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -61.95 -37.0 83.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.429 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 101' ' ' GLN . 1.0 OUTLIER -69.85 -47.15 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.746 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.667 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 2.7 pp -76.74 -35.99 57.42 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.432 ' N ' HD12 ' A' ' 98' ' ' LEU . 17.3 t -61.03 -54.23 47.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 101' ' ' GLN . 7.1 mm100 -85.12 -16.98 38.7 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.667 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 1.1 pt20 -54.63 -112.23 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.576 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.413 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 1.0 OUTLIER -147.47 177.32 9.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.99 -4.42 7.47 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.449 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.429 ' CB ' ' HG ' ' A' ' 34' ' ' LEU . 32.1 tt0 -103.17 116.73 33.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.548 0.69 . . . . 0.0 111.306 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.701 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 26.1 mm -103.22 112.45 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.872 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -95.28 122.54 38.08 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.701 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 44.0 m-85 -109.99 117.81 34.76 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.702 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 29' ' ' ARG . 1.3 mt-10 -108.66 115.85 30.88 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 29' ' ' ARG . 10.4 m -121.68 147.89 25.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 114.562 -1.199 . . . . 0.0 114.192 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.53 ' CG2' HD23 ' A' ' 79' ' ' LEU . 27.6 m -117.4 152.1 19.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 113.649 -1.614 . . . . 0.0 111.342 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -82.19 126.75 32.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.096 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.781 0.324 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -100.33 -34.15 10.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -76.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.583 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLN . . . . . 1.025 ' OE1' ' CG2' ' A' ' 89' ' ' THR . 0.0 OUTLIER -175.92 -23.97 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . 0.749 ' OD1' ' NE2' ' A' ' 51' ' ' HIS . 8.4 m-20 -54.0 176.13 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 118.819 -0.61 . . . . 0.0 109.616 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' THR . . . . . 0.718 ' HB ' ' NE2' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -167.66 166.59 13.84 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -178.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ARG . . . . . 0.924 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -131.86 123.63 27.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.071 -1.877 . . . . 0.0 108.663 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.499 HD13 ' N ' ' B' ' 120' ' ' LEU . 1.1 mp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.92 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 tt -80.19 138.71 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 122.024 0.916 . . . . 0.0 112.047 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -136.33 121.74 19.38 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.688 -1.597 . . . . 0.0 109.948 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -104.49 119.4 38.89 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.273 1.035 . . . . 0.0 112.475 -178.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.507 ' CG1' ' HA3' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.53 117.84 55.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 113.311 -1.768 . . . . 0.0 108.38 177.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mp -96.24 113.8 25.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.099 0.476 . . . . 0.0 111.438 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.475 ' CD1' ' HA ' ' A' ' 65' ' ' PRO . 2.2 tt -113.07 109.22 18.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.441 ' HG ' ' CB ' ' A' ' 104' ' ' GLU . 3.1 mp -116.02 104.73 11.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.922 0.868 . . . . 0.0 110.961 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.76 161.32 13.71 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.704 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.97 136.17 33.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.626 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 47.7 25.3 0.67 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.516 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 2.4 m170 46.26 29.57 0.86 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.197 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.9 81.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.816 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' HIS . . . 55.61 170.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.382 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 HG21 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -108.59 -76.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.699 0.749 . . . . 0.0 111.38 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 121.64 23.88 2.47 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.467 HG21 HD23 ' A' ' 41' ' ' LEU . 14.9 tt -135.5 158.31 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -130.88 148.07 52.6 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.498 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.572 ' HB ' HG21 ' A' ' 55' ' ' ILE . 0.8 OUTLIER -135.0 159.01 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.265 -178.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.483 ' CA ' ' CE1' ' A' ' 91' ' ' HIS . 67.5 p -156.22 137.33 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.36 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 54' ' ' PRO . . . 151.85 169.1 16.96 Favored Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.314 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 144.73 -166.75 27.31 Favored Glycine 0 C--N 1.303 -1.297 0 CA-C-N 114.567 -0.816 . . . . 0.0 111.449 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.405 ' CB ' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -76.72 -14.76 59.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.983 0.392 . . . . 0.0 110.95 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' B' ' 116' ' ' GLN . 1.5 tp10 -75.53 -41.41 55.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 110.27 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.49 ' O ' ' CG1' ' A' ' 53' ' ' VAL . 13.9 m-70 -98.9 11.32 39.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.519 0.676 . . . . 0.0 110.161 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.18 23.24 32.18 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.565 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.563 ' CG2' ' O ' ' A' ' 54' ' ' PRO . 1.1 m -128.19 170.94 9.33 Favored Pre-proline 0 CA--C 1.512 -0.496 0 CA-C-O 121.959 0.885 . . . . 0.0 113.014 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.571 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 7.5 Cg_exo -83.09 173.72 9.82 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.579 3.519 . . . . 0.0 108.132 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.572 HG21 ' HB ' ' A' ' 45' ' ' ILE . 39.4 mm -72.76 107.71 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.524 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.475 HD21 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.86 145.83 34.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -177.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 74' ' ' VAL . 3.8 mp -71.87 130.73 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.8 t -132.18 -22.45 2.27 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 0.2 OUTLIER -137.4 115.84 11.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.252 0.548 . . . . 0.0 110.21 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 66' ' ' ALA . 3.4 mm -125.43 107.06 17.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.72 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.984 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 39.2 m-70 -71.41 137.04 83.72 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.39 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.43 141.36 89.77 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.157 1.905 . . . . 0.0 111.227 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.33 0.92 8.62 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.609 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 1.112 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -96.43 167.36 12.42 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 6.2 Cg_exo -10.92 -9.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 125.075 3.85 . . . . 0.0 116.216 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 1.112 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.02 -35.83 21.67 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -102.14 -8.7 21.14 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.494 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -92.69 -26.44 17.79 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.439 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.723 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . 42.9 t -107.6 6.14 27.62 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 44.58 13.68 0.03 OUTLIER Glycine 0 C--N 1.336 0.557 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.35 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.507 ' HA3' ' CG1' ' A' ' 31' ' ' VAL . . . -149.63 12.25 1.0 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 119.431 -1.366 . . . . 0.0 115.152 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.774 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 10.0 mt -99.04 150.53 21.9 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 118.223 1.012 . . . . 0.0 110.159 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.1 t60 174.52 145.36 0.06 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.997 0.903 . . . . 0.0 111.611 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.584 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 7.3 p -65.4 147.49 12.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.951 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.79 -17.77 24.98 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.024 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -92.52 149.46 21.36 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.588 0.709 . . . . 0.0 110.324 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 109' ' ' VAL . . . -89.68 134.39 34.18 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.501 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.568 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -105.82 119.99 55.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.628 0.728 . . . . 0.0 111.608 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.457 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -96.16 -41.57 8.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.297 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 85' ' ' ASN . . . -162.61 176.94 9.85 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.927 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -140.95 154.89 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.604 178.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.743 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.2 p30 59.33 7.55 0.95 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.69 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.11 10.1 49.81 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.698 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 21.3 t -120.71 125.5 74.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.855 0.327 . . . . 0.0 110.769 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.649 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 14.6 p-10 -61.79 125.3 23.34 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.042 0.449 . . . . 0.0 109.945 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' CD1' ' H ' ' A' ' 81' ' ' VAL . 4.0 mp -106.8 86.34 2.31 Favored 'General case' 0 N--CA 1.413 -2.278 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.004 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -83.58 96.67 8.71 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.417 ' HB3' ' CB ' ' A' ' 93' ' ' GLU . 65.7 m-20 -132.61 99.31 4.6 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.675 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.826 ' O ' ' HG2' ' B' ' 116' ' ' GLN . 0.1 OUTLIER -56.42 -45.38 80.75 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.712 ' HA ' ' CG ' ' B' ' 116' ' ' GLN . 0.0 OUTLIER -73.91 128.75 36.35 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.841 ' CD2' ' HB ' ' B' ' 118' ' ' THR . 5.5 t60 -65.44 -40.32 93.14 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.063 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 1.06 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 1.3 mmtm -62.71 -22.35 66.45 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.856 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.417 ' CB ' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -65.27 -24.18 67.24 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.986 -0.685 . . . . 0.0 109.55 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -81.92 -45.09 15.92 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.262 0.553 . . . . 0.0 110.068 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.829 HG21 ' HA ' ' A' ' 92' ' ' LYS . 2.0 t -57.31 -41.71 78.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.328 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -62.88 -38.6 91.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.003 0.906 . . . . 0.0 108.567 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.435 ' CG2' ' CD2' ' A' ' 86' ' ' LEU . 2.1 mm -69.87 -46.75 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.534 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.819 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 2.0 pp -75.21 -31.42 60.9 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.935 0.398 . . . . 0.0 111.756 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.1 t -57.13 -53.72 54.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.79 2.85 30.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.819 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -50.64 -93.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.812 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.453 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -151.31 173.66 14.23 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 38' ' ' HIS . . . -66.78 -12.14 58.98 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 119.594 -1.288 . . . . 0.0 112.881 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.441 ' CB ' ' HG ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -103.62 117.86 35.39 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.341 0.591 . . . . 0.0 111.777 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.631 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 20.2 mm -100.14 111.88 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.927 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -95.27 118.6 32.32 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.631 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 38.8 m-85 -102.49 117.57 34.98 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.532 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -103.0 115.45 30.63 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 175.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 6.9 m -124.34 156.99 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -175.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 1.8 m -128.37 152.24 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.247 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -89.0 118.53 28.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.112 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.767 0.318 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . 0.412 ' O ' ' CG1' ' B' ' 115' ' ' VAL . 0.4 OUTLIER -179.58 -47.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.759 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.473 ' O ' ' NE2' ' A' ' 51' ' ' HIS . 13.1 p 45.12 27.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.843 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLN . . . . . 0.826 ' HG2' ' O ' ' A' ' 89' ' ' THR . 0.0 OUTLIER 22.57 89.55 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 178.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . 0.423 ' OD2' ' CE1' ' A' ' 51' ' ' HIS . 69.5 m-20 -165.29 160.72 18.59 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.342 0.657 . . . . 0.0 109.677 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' THR . . . . . 1.06 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 2.9 m -166.02 162.1 17.74 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ARG . . . . . 0.984 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -135.1 129.25 33.65 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.102 178.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 45' ' ' ILE . 2.8 mp . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.705 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.78 138.6 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 122.027 0.918 . . . . 0.0 112.019 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.509 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -139.59 118.72 12.68 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 113.652 -1.613 . . . . 0.0 110.35 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -100.34 119.49 38.51 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 122.307 1.051 . . . . 0.0 112.941 -178.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.647 HG11 HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -115.62 118.05 57.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 113.308 -1.769 . . . . 0.0 107.924 176.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.24 115.82 28.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -113.72 124.33 52.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.861 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 4.8 mp -117.22 102.02 8.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.746 0.784 . . . . 0.0 111.742 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.19 161.2 13.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.3 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -137.96 148.19 45.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.027 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.432 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 13.1 t0 59.07 27.21 16.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.096 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.432 ' CG ' ' O ' ' A' ' 37' ' ' ASP . 21.0 p80 43.18 39.13 1.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.415 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.25 -21.27 47.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.92 178.81 16.41 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.532 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 65' ' ' PRO . 1.2 tp -117.81 -19.07 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.116 0.458 . . . . 0.0 111.361 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' HA2' ' ND1' ' A' ' 61' ' ' HIS . . . 57.68 32.53 65.49 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.089 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' B' ' 120' ' ' LEU . 0.4 OUTLIER -135.14 157.52 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.445 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 5.4 t -130.87 147.87 52.57 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.465 0.65 . . . . 0.0 110.657 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.768 HG13 ' HB ' ' B' ' 118' ' ' THR . 0.5 OUTLIER -137.86 157.75 32.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.934 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.611 ' N ' ' CE1' ' A' ' 91' ' ' HIS . 21.9 p -160.94 152.36 19.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.482 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 91' ' ' HIS . . . 139.16 -168.82 24.72 Favored Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.721 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 130.65 -169.03 21.54 Favored Glycine 0 C--N 1.3 -1.442 0 CA-C-N 114.098 -1.051 . . . . 0.0 113.199 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.42 -16.92 58.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.542 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 12.5 pt-20 -84.46 -34.42 23.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.973 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.568 ' CE1' ' OD2' ' B' ' 117' ' ' ASP . 27.1 m-70 -95.71 9.72 39.39 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.492 0.663 . . . . 0.0 109.726 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.2 23.48 52.88 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.897 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.7 OUTLIER -139.58 177.44 2.03 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-O 121.663 0.745 . . . . 0.0 112.862 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 53' ' ' VAL . 3.8 Cg_exo -88.21 173.21 4.86 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 124.561 3.507 . . . . 0.0 109.012 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.691 HD12 ' CG ' ' A' ' 91' ' ' HIS . 32.5 mm -72.44 99.15 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.95 139.1 41.02 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.3 mp -71.82 129.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.431 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 p -137.02 -13.85 1.6 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.781 ' OE1' ' NH1' ' B' ' 119' ' ' ARG . 0.4 OUTLIER -137.13 116.1 12.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.371 0.605 . . . . 0.0 110.532 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.461 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 3.0 mm -117.76 109.72 28.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.308 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.99 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 7.4 m170 -71.53 136.56 83.52 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.829 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -53.08 139.67 61.53 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.836 1.691 . . . . 0.0 113.071 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.76 25.14 0.19 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 114.635 -1.166 . . . . 0.0 114.308 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 1.065 ' O ' ' N ' ' A' ' 66' ' ' ALA . 7.6 mm100 -94.97 165.41 17.08 Favored Pre-proline 0 N--CA 1.419 -1.977 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.523 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 37.2 Cg_exo -30.54 2.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.273 1.982 . . . . 0.0 113.593 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 1.065 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.29 -36.41 19.35 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -101.8 -12.92 17.94 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.37 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -26.13 36.94 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.006 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.507 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -90.63 -5.03 56.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.68 8.77 0.39 Allowed Glycine 0 CA--C 1.519 0.33 0 CA-C-N 114.945 -1.025 . . . . 0.0 113.128 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.458 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -129.9 -1.66 5.37 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.691 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.647 HD22 HG11 ' A' ' 31' ' ' VAL . 4.1 mt -94.81 151.37 19.3 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 121.785 0.802 . . . . 0.0 111.518 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.4 t60 176.73 139.43 0.07 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.468 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.567 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 2.9 p -66.89 147.46 12.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 113.829 -1.532 . . . . 0.0 112.3 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.22 -21.1 10.25 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.539 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.17 150.67 22.58 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.577 0.703 . . . . 0.0 109.677 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 109' ' ' VAL . . . -88.59 130.76 35.19 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.179 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.581 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -106.62 122.77 60.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.703 0.763 . . . . 0.0 110.939 -178.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 tt -101.39 -50.63 3.7 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.217 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -148.67 176.77 10.07 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.905 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -138.88 153.22 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.691 177.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.59 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 0.0 OUTLIER 73.99 -18.1 0.42 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.532 -179.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 81' ' ' VAL . . . 118.98 9.59 8.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.752 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.602 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 20.4 t -127.96 133.03 68.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.75 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 8.2 p30 -61.09 131.87 51.96 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.527 ' CD1' ' HA ' ' A' ' 80' ' ' ALA . 5.4 mp -102.92 85.95 2.63 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 118.161 -1.415 . . . . 0.0 111.411 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.13 94.87 7.78 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 172.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.617 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 19.6 m-20 -134.3 97.52 3.86 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.511 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.783 ' OG1' ' OE1' ' B' ' 116' ' ' GLN . 0.3 OUTLIER 46.19 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.087 0.946 . . . . 0.0 109.515 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.734 ' HB2' ' CB ' ' B' ' 116' ' ' GLN . 0.5 OUTLIER -126.97 168.04 15.07 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.132 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.714 ' CD2' ' OG1' ' B' ' 118' ' ' THR . 2.6 t-160 -46.06 -36.74 6.0 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 113.339 -1.755 . . . . 0.0 113.353 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.731 ' CB ' ' CG ' ' B' ' 116' ' ' GLN . 0.0 OUTLIER -61.0 -23.89 65.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.617 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -64.3 -22.34 66.92 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.632 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -71.17 -46.81 60.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.001 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.85 HG23 ' OG1' ' B' ' 118' ' ' THR . 0.0 OUTLIER -59.84 -47.32 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.668 0.747 . . . . 0.0 109.68 178.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 93' ' ' GLU . 1.2 t -62.74 -36.12 81.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.898 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.417 HG22 HD21 ' A' ' 86' ' ' LEU . 1.4 mt -65.07 -47.23 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.764 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -76.35 -40.53 50.97 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.776 0.322 . . . . 0.0 110.869 179.154 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 75.3 m -55.75 -28.34 55.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.202 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -91.54 30.94 1.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER 178.1 151.62 0.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.875 0.369 . . . . 0.0 111.293 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.2 ptt-85 -126.04 160.91 28.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.41 -151.54 21.18 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.156 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 9.3 pt-20 -85.15 117.94 24.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.79 0.805 . . . . 0.0 111.901 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -98.56 121.7 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.516 0 CA-C-O 122.734 1.254 . . . . 0.0 107.814 177.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.905 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -93.5 127.71 39.27 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.3 -2.227 . . . . 0.0 108.645 -178.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 17.7 m-85 -104.32 117.62 34.64 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.024 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.67 116.26 31.63 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 7.6 m -122.13 154.77 26.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 15.7 t -118.42 132.36 68.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.918 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -81.68 107.81 14.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.105 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.814 0.34 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 60.22 -176.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -167.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.613 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLN . . . . . 0.783 ' OE1' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -155.71 121.01 4.86 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.005 0.431 . . . . 0.0 111.727 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . 0.568 ' O ' HG21 ' A' ' 95' ' ' VAL . 6.4 m-20 -158.9 -173.19 4.13 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.446 0.698 . . . . 0.0 109.278 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' THR . . . . . 0.85 ' OG1' HG23 ' A' ' 95' ' ' VAL . 91.5 m -147.2 146.6 29.89 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ARG . . . . . 0.99 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -142.87 109.35 5.36 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.523 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 43' ' ' ILE . 1.2 mp . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.852 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 tp -82.19 138.37 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 122.124 0.964 . . . . 0.0 112.105 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 5.8 mtt180 -140.22 116.9 10.88 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.928 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.47 119.42 37.98 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 122.332 1.063 . . . . 0.0 112.75 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.507 HG13 HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.96 116.89 53.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 112.966 -1.924 . . . . 0.0 107.05 176.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.14 114.36 27.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.285 0.564 . . . . 0.0 111.816 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.702 ' O ' ' HA ' ' A' ' 104' ' ' GLU . 0.7 OUTLIER -113.16 119.04 36.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.316 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 4.4 mp -110.96 101.66 10.2 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.804 0.811 . . . . 0.0 110.848 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.57 134.43 42.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.812 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 38' ' ' HIS . 15.2 mt-10 -138.84 138.08 37.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.995 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 38' ' ' HIS . 3.6 m-20 60.93 -79.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.258 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.558 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 60.0 m80 -15.47 -63.97 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.952 0.501 . . . . 0.0 112.34 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.558 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 6.0 tt0 96.82 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.656 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 48.79 -174.09 0.04 OUTLIER Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.608 -0.805 . . . . 0.0 111.935 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -125.37 -67.26 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.27 0.535 . . . . 0.0 111.416 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 64' ' ' GLN . . . 112.51 20.07 6.73 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.562 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 20.2 tt -125.18 160.52 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.149 0 CA-C-O 121.144 0.497 . . . . 0.0 110.458 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.418 ' N ' ' CG1' ' A' ' 43' ' ' ILE . 3.2 t -128.26 146.92 50.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.693 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.805 HG13 HG22 ' B' ' 118' ' ' THR . 0.6 OUTLIER -138.69 160.37 30.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.098 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.453 ' N ' ' CE1' ' A' ' 91' ' ' HIS . 66.7 p -158.75 138.77 12.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.27 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.503 ' N ' ' HD1' ' A' ' 91' ' ' HIS . . . 163.26 -141.0 6.83 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 140.96 160.98 8.51 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.15 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -80.35 -16.75 53.83 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.402 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 1.3 pt-20 -70.06 -35.81 74.53 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.394 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 1.05 ' NE2' ' OE1' ' B' ' 116' ' ' GLN . 21.3 m-70 -97.37 15.1 23.99 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.533 0.682 . . . . 0.0 109.833 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.73 18.34 31.34 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.554 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 54' ' ' PRO . 1.9 m -103.58 154.05 38.16 Favored Pre-proline 0 CA--C 1.513 -0.456 0 CA-C-O 122.02 0.914 . . . . 0.0 113.249 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.735 ' O ' HG22 ' A' ' 53' ' ' VAL . 22.4 Cg_exo -77.41 -172.49 1.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 124.551 3.5 . . . . 0.0 109.424 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.81 ' O ' HG23 ' A' ' 78' ' ' ILE . 50.4 mm -84.64 120.38 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.539 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -105.73 126.53 52.26 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.71 HG13 HG22 ' A' ' 78' ' ' ILE . 3.2 mt -70.34 131.44 34.26 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.17 -15.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.896 ' OE1' ' NH1' ' B' ' 119' ' ' ARG . 1.7 tt0 -137.57 116.14 12.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.092 0.472 . . . . 0.0 111.087 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.73 HG22 ' CG ' ' A' ' 64' ' ' GLN . 3.2 mm -116.19 106.09 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.708 0.766 . . . . 0.0 111.118 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.909 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 2.9 m170 -73.28 118.75 71.37 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.974 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -45.77 114.0 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.748 1.632 . . . . 0.0 110.836 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' HA2' ' CB ' ' A' ' 67' ' ' ASP . . . 105.97 1.43 39.15 Favored Glycine 0 N--CA 1.422 -2.266 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.804 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 1.154 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -94.41 166.55 15.14 Favored Pre-proline 0 CA--C 1.492 -1.266 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.826 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 69.4 Cg_exo -12.46 -9.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 124.969 3.779 . . . . 0.0 115.739 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 1.154 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.35 -35.98 19.51 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.47 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . 4.7 t70 -91.2 -12.5 35.17 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.505 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.826 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 3.7 mtt-85 -77.48 1.05 20.47 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.305 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 4.0 t 77.76 -17.28 0.58 Allowed 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 68' ' ' ARG . . . -43.79 -31.78 1.97 Allowed Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.029 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.472 ' C ' HG13 ' A' ' 31' ' ' VAL . . . 86.34 29.89 23.64 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.176 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.529 HD12 ' HB3' ' A' ' 65' ' ' PRO . 1.6 mt -90.82 151.76 21.04 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 122.255 1.026 . . . . 0.0 112.142 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.647 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.9 t60 179.85 146.96 0.24 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.33 -1.759 . . . . 0.0 111.319 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.647 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 12.0 p -67.43 158.97 5.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.607 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.418 ' N ' ' CG2' ' A' ' 74' ' ' VAL . . . 102.95 -19.18 47.57 Favored Glycine 0 C--N 1.316 -0.552 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.546 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.16 149.64 21.77 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.385 0.612 . . . . 0.0 109.989 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 109' ' ' VAL . . . -89.15 129.37 35.76 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.684 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.81 HG23 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.15 113.82 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.527 0.679 . . . . 0.0 112.279 -177.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 108' ' ' GLU . 0.2 OUTLIER -89.64 -41.35 12.01 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.991 -178.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.72 ' HB1' ' HA ' ' A' ' 85' ' ' ASN . . . -162.67 177.53 9.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -175.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 1.063 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -133.71 154.49 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.367 178.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.685 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.6 p30 57.56 7.41 0.52 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.537 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.06 13.36 39.81 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.829 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.469 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 20.7 t -123.86 118.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.976 0.388 . . . . 0.0 111.511 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.72 ' HA ' ' HB1' ' A' ' 80' ' ' ALA . 2.7 m120 -61.33 124.7 21.33 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.517 ' CD1' ' HA ' ' A' ' 80' ' ' ALA . 4.6 mp -106.41 86.36 2.34 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.439 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -102.74 94.66 5.73 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 90' ' ' LYS . 1.1 m-20 -134.04 94.39 3.24 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.686 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.083 ' OG1' ' CG2' ' B' ' 115' ' ' VAL . 0.1 OUTLIER 14.72 -80.35 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 124.444 1.09 . . . . 0.0 111.92 178.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.737 ' HB3' ' HA ' ' B' ' 115' ' ' VAL . 0.0 OUTLIER -75.09 136.39 41.15 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 113.611 -1.631 . . . . 0.0 112.038 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.927 ' CD2' ' HB ' ' B' ' 118' ' ' THR . 7.6 t60 -60.8 -36.31 78.7 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.657 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 1.008 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 1.7 mmtm -61.92 -22.6 65.73 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.267 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.485 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -64.97 -25.39 67.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.556 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -84.03 -44.16 14.4 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.637 ' HA ' ' CG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -57.2 -45.51 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.858 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.463 ' N ' ' CG1' ' A' ' 95' ' ' VAL . 14.6 t -61.42 -36.39 80.21 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.1 mt -69.49 -46.57 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.956 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.637 ' CG ' ' HA ' ' A' ' 95' ' ' VAL . 0.9 OUTLIER -75.22 -35.04 61.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.652 0.263 . . . . 0.0 111.161 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 93.5 p -57.31 -57.29 13.28 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.138 0.494 . . . . 0.0 110.439 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -66.26 -32.8 74.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.12 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -51.0 149.61 3.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.512 179.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.57 169.65 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.47 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.41 -132.13 12.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.453 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.702 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 1.1 pt-20 -84.73 126.46 33.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.598 HG22 ' CE1' ' A' ' 107' ' ' PHE . 20.7 mm -97.09 112.8 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 1.063 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -94.47 121.37 35.94 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.631 -179.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.598 ' CE1' HG22 ' A' ' 105' ' ' ILE . 34.5 m-85 -105.22 118.06 35.59 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.715 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.433 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -100.06 115.98 31.03 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 5.0 m -129.1 157.49 41.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.43 ' CG2' HD22 ' A' ' 79' ' ' LEU . 58.5 t -118.12 130.4 73.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.893 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -83.6 117.33 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.961 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.179 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.748 0.309 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 63.85 -77.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 1.083 ' CG2' ' OG1' ' A' ' 89' ' ' THR . 0.3 OUTLIER -156.94 28.17 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.906 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLN . . . . . 1.05 ' OE1' ' NE2' ' A' ' 51' ' ' HIS . 0.8 OUTLIER -167.97 164.6 13.8 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 6.6 t70 70.66 138.71 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.228 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' THR . . . . . 1.008 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -170.79 159.8 6.58 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ARG . . . . . 0.909 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -124.28 165.44 17.64 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.512 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.509 HD11 HG12 ' A' ' 45' ' ' ILE . 5.9 mp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.247 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 tp -79.41 138.77 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.044 0.926 . . . . 0.0 112.028 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.466 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.9 OUTLIER -140.13 120.37 13.86 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.958 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -102.31 119.82 39.45 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 122.192 0.996 . . . . 0.0 112.661 -178.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.57 HG12 HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -113.58 117.94 56.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 113.342 -1.754 . . . . 0.0 108.673 177.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.3 112.0 23.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.41 0.624 . . . . 0.0 111.659 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -114.42 115.42 27.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.02 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -116.69 100.59 7.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.004 0.907 . . . . 0.0 109.923 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -100.78 161.81 13.34 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.474 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -86.31 160.75 19.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.475 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -41.09 -26.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 1.3 t-160 -40.61 -57.1 1.95 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 1.0 OUTLIER 101.57 160.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.468 0.707 . . . . 0.0 111.111 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.73 129.15 4.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.403 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.613 ' HB3' HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -120.35 -9.67 9.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.787 0.327 . . . . 0.0 111.673 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' HA2' ' ND1' ' A' ' 61' ' ' HIS . . . 47.09 37.62 10.34 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.703 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.613 HG23 ' HB3' ' A' ' 41' ' ' LEU . 9.3 tt -135.05 158.59 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.489 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 6.8 t -130.03 147.88 51.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.768 0.794 . . . . 0.0 111.185 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.694 ' O ' ' HE1' ' A' ' 91' ' ' HIS . 1.2 pt -138.16 160.96 32.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.729 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.487 ' HA ' ' CE1' ' A' ' 91' ' ' HIS . 7.1 p -160.64 136.48 8.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.955 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' CA ' HG22 ' A' ' 53' ' ' VAL . . . 163.01 -141.4 7.13 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 53' ' ' VAL . . . 160.69 128.68 0.97 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.1 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -74.51 -10.79 59.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 109.942 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.478 ' HG3' ' CD2' ' A' ' 51' ' ' HIS . 0.5 OUTLIER -102.65 -24.87 13.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.235 179.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.964 ' NE2' ' OE1' ' B' ' 116' ' ' GLN . 54.5 m-70 -91.61 21.3 4.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.436 0.636 . . . . 0.0 110.457 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.23 14.34 56.36 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.405 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -129.75 137.21 30.41 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.525 ' O ' HG21 ' A' ' 53' ' ' VAL . 77.7 Cg_exo -63.65 156.48 56.96 Favored 'Trans proline' 0 C--N 1.331 -0.357 0 C-N-CA 124.001 3.134 . . . . 0.0 111.069 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.536 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 24.9 mm -74.26 108.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.647 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 54' ' ' PRO . 8.0 mp -103.86 139.28 39.27 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.2 mp -72.01 131.62 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.017 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 m -136.79 -17.47 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.489 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 0.5 OUTLIER -137.27 116.11 12.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.234 0.54 . . . . 0.0 110.844 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 66' ' ' ALA . 4.2 mm -116.53 111.69 36.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.245 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.773 ' CE1' ' NH1' ' B' ' 119' ' ' ARG . 7.6 m170 -70.89 136.73 85.15 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.873 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.37 138.99 81.34 Favored 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 122.246 1.964 . . . . 0.0 113.119 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 42.19 25.33 0.25 Allowed Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.704 -1.135 . . . . 0.0 113.975 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 1.085 ' O ' ' N ' ' A' ' 66' ' ' ALA . 9.1 mm100 -95.21 165.34 17.06 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.575 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 49.1 Cg_exo -31.25 2.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.036 1.824 . . . . 0.0 113.255 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 1.085 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.15 -36.44 19.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.01 -13.95 19.67 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.346 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 29.6 mtp180 -76.19 -26.24 55.97 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.817 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.519 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 28.0 t -93.3 -1.78 55.66 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 48.85 11.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.985 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.559 ' HA3' ' CG1' ' A' ' 31' ' ' VAL . . . -136.75 5.61 3.73 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.489 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.57 HD22 HG12 ' A' ' 31' ' ' VAL . 6.3 mt -94.72 150.61 20.04 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 117.925 0.862 . . . . 0.0 109.357 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 179.6 133.22 0.1 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.627 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 75' ' ' GLY . 3.2 p -60.67 159.5 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.98 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 74' ' ' VAL . . . 105.99 -24.5 26.47 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.709 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.33 149.88 23.52 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.755 0.788 . . . . 0.0 109.874 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 110' ' ' VAL . . . -88.68 133.6 34.16 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.562 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.536 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -102.97 145.3 12.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.497 -178.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.925 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -146.02 -20.13 0.45 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 1.062 ' HB3' ' HA ' ' A' ' 84' ' ' VAL . . . -163.88 176.27 9.62 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.817 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -154.06 153.15 8.83 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 0.2 OUTLIER 77.95 -49.45 0.49 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.625 -1.625 . . . . 0.0 112.264 178.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' C ' ' CG1' ' A' ' 84' ' ' VAL . . . -154.78 32.61 0.68 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 1.062 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 1.4 p 48.46 73.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 126.781 2.033 . . . . 0.0 113.177 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.541 ' N ' ' CB ' ' A' ' 80' ' ' ALA . 14.9 p-10 -136.35 97.28 3.54 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 113.27 -1.787 . . . . 0.0 112.68 172.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.925 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 7.1 mt -116.71 88.28 2.87 Favored 'General case' 0 CA--C 1.469 -2.139 0 CA-C-N 124.273 3.215 . . . . 0.0 108.549 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.51 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -112.55 92.73 4.12 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 173.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.675 ' O ' ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -137.65 93.13 2.76 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.369 178.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.03 ' OG1' ' CG1' ' B' ' 115' ' ' VAL . 1.0 OUTLIER 14.82 -124.89 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.684 ' N ' ' OG1' ' A' ' 89' ' ' THR . 3.5 mttp -75.29 168.56 19.76 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.743 ' NE2' ' HB ' ' B' ' 118' ' ' THR . 3.1 t-160 -44.61 -50.07 9.92 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -175.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.988 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 0.0 OUTLIER -60.77 -20.49 61.52 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.019 -176.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.66 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -65.86 -24.96 66.98 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.531 178.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.528 ' CB ' HD21 ' A' ' 86' ' ' LEU . . . -76.34 -38.61 55.68 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 92' ' ' LYS . 1.4 t -61.9 -44.94 99.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.588 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 93' ' ' GLU . 5.3 t -61.55 -36.32 80.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -68.98 -46.63 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.825 179.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.684 ' CG ' ' HA ' ' A' ' 95' ' ' VAL . 2.6 pp -74.88 -33.15 62.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.789 0.328 . . . . 0.0 111.522 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.6 t -57.41 -53.69 55.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.226 0.536 . . . . 0.0 110.719 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -69.9 -40.02 75.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.743 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.548 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -55.71 156.01 5.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.51 167.2 22.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.04 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.21 -130.65 10.32 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.463 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -98.2 128.76 44.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 122.169 0.985 . . . . 0.0 113.473 -178.236 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.607 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 30.8 mm -97.54 112.7 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.817 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -93.75 117.6 30.31 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 178.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 31.6 m-85 -99.25 118.61 36.32 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.616 -176.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.558 ' HG3' ' CB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -107.06 116.61 32.23 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 14.5 m -122.13 145.23 29.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.403 -0.919 . . . . 0.0 113.213 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.507 ' CG2' HD12 ' A' ' 79' ' ' LEU . 7.8 t -117.02 152.13 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.051 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -87.04 117.46 25.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.136 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.055 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.826 0.346 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . 0.416 ' C ' ' CB ' ' A' ' 92' ' ' LYS . 21.1 tt0 -101.85 12.36 37.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.403 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 1.03 ' CG1' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -145.91 67.21 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.499 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLN . . . . . 0.964 ' OE1' ' NE2' ' A' ' 51' ' ' HIS . 0.0 OUTLIER 168.29 124.06 0.01 OUTLIER 'General case' 0 C--N 1.359 0.979 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . 0.48 ' HA ' ' CE1' ' A' ' 91' ' ' HIS . 14.6 m-20 52.6 150.68 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' THR . . . . . 0.988 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -169.02 157.33 7.82 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ARG . . . . . 0.773 ' NH1' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -133.74 121.32 21.72 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.992 178.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 43' ' ' ILE . 2.4 mp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.814 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.31 134.64 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 C-N-CA 122.86 0.464 . . . . 0.0 111.239 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.459 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -142.45 122.22 13.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.177 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -106.11 119.46 39.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.149 0.976 . . . . 0.0 112.682 -178.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.578 HG13 HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -117.5 118.28 57.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.854 177.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -89.86 110.06 21.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.926 0.869 . . . . 0.0 112.739 -177.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -115.39 115.46 26.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.488 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.563 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -118.66 101.57 8.21 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.636 0.731 . . . . 0.0 110.672 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.28 161.31 13.69 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.435 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.65 119.44 26.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.966 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 51.91 -137.75 1.16 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.528 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.44 41.63 1.08 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.75 0.31 . . . . 0.0 110.926 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -56.37 -22.93 34.32 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.05 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.0 174.86 31.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.148 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.684 HD21 HG12 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -111.62 -26.78 8.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 110.684 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.471 ' HA2' ' CE1' ' A' ' 61' ' ' HIS . . . 65.29 33.1 85.82 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.684 HG12 HD21 ' A' ' 41' ' ' LEU . 1.8 pt -135.41 157.87 40.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.478 ' CB ' ' HB3' ' A' ' 59' ' ' GLU . 1.7 t -130.61 147.72 52.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.667 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.67 ' O ' ' HE1' ' A' ' 91' ' ' HIS . 2.9 pt -137.58 159.92 34.6 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.634 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.651 ' HA ' ' HD1' ' A' ' 91' ' ' HIS . 69.4 p -160.29 135.75 8.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.686 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 91' ' ' HIS . . . 165.42 170.16 30.0 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 119.807 -1.187 . . . . 0.0 112.944 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 148.63 -177.6 26.76 Favored Glycine 0 C--N 1.303 -1.255 0 CA-C-N 114.156 -1.022 . . . . 0.0 113.305 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -15.26 58.37 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 11.1 pt-20 -82.86 -35.73 26.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.991 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.59 ' CE1' ' OD1' ' B' ' 117' ' ' ASP . 30.9 m-70 -94.59 8.9 40.72 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.501 0.667 . . . . 0.0 109.562 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.29 55.31 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.828 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 54' ' ' PRO . 1.6 m -138.99 172.67 6.18 Favored Pre-proline 0 CA--C 1.513 -0.479 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.554 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 3.0 Cg_exo -86.55 166.98 8.9 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 124.761 3.641 . . . . 0.0 108.272 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.647 ' HB ' HG23 ' A' ' 78' ' ' ILE . 13.4 mm -72.46 99.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 117.756 -1.578 . . . . 0.0 107.122 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.87 137.1 44.32 Favored 'General case' 0 N--CA 1.405 -2.686 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.33 134.15 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.911 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -139.75 -12.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.535 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 1.0 OUTLIER -134.49 116.08 14.68 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.317 0.58 . . . . 0.0 110.994 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 66' ' ' ALA . 3.3 mm -123.18 112.15 32.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.788 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.814 ' CE1' ' CZ ' ' B' ' 119' ' ' ARG . 5.3 m170 -71.88 136.62 82.56 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.267 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -57.6 142.63 95.7 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.839 1.693 . . . . 0.0 112.561 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 46.36 19.84 0.49 Allowed Glycine 0 N--CA 1.432 -1.57 0 CA-C-N 115.216 -0.902 . . . . 0.0 114.23 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 1.095 ' O ' ' N ' ' A' ' 66' ' ' ALA . 8.6 mm100 -96.04 165.93 15.39 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.539 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 31.9 Cg_exo -28.31 2.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.421 2.081 . . . . 0.0 113.734 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 1.095 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.93 -36.32 19.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -102.19 -13.1 17.57 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.265 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.403 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -78.87 -26.46 43.95 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.911 -179.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.492 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 8.6 t -95.08 -1.53 51.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 48.94 10.07 0.12 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.464 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA3' ' CG1' ' A' ' 31' ' ' VAL . . . -133.47 7.42 4.97 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.063 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 5.5 mt -97.65 154.66 17.41 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 121.433 0.635 . . . . 0.0 110.844 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.97 126.65 0.06 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.253 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 75' ' ' GLY . 2.3 p -60.42 159.39 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.355 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.47 ' N ' ' CG2' ' A' ' 74' ' ' VAL . . . 108.9 -24.29 21.84 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.27 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.03 150.43 24.88 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.704 0.764 . . . . 0.0 109.226 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 110' ' ' VAL . . . -88.06 137.55 32.23 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.137 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.647 HG23 ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -100.47 149.19 6.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.884 -178.063 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.6 -50.89 0.62 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.363 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.7 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -147.81 175.93 10.53 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.006 1.114 . . . . 0.0 114.006 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.824 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -143.06 154.58 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.157 178.437 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.802 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.7 p30 63.13 5.14 1.8 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.987 -1.46 . . . . 0.0 112.462 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' N ' ' CD ' ' A' ' 106' ' ' GLU . . . 102.4 5.71 48.59 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.82 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.447 ' O ' ' CB ' ' A' ' 80' ' ' ALA . 21.1 t -123.8 136.53 59.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 117.004 0.402 . . . . 0.0 111.319 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.7 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 38.3 t-20 -61.39 133.29 55.64 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.56 ' CD1' ' H ' ' A' ' 81' ' ' VAL . 6.1 mp -103.22 86.43 2.68 Favored 'General case' 0 CA--C 1.465 -2.325 0 C-N-CA 118.278 -1.369 . . . . 0.0 108.98 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.534 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 5.3 tpp85 -100.6 94.4 6.09 Favored 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 173.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.652 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 20.7 m-20 -134.25 96.46 3.61 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.699 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.815 ' OG1' ' OE1' ' B' ' 116' ' ' GLN . 0.1 OUTLIER 29.28 -132.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.643 179.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.873 ' HB2' ' CB ' ' B' ' 116' ' ' GLN . 6.7 mttp -75.46 169.74 17.49 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.843 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.67 ' HE1' ' O ' ' A' ' 45' ' ' ILE . 4.9 t-160 -45.26 -49.97 12.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -175.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 1.029 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 0.3 OUTLIER -59.29 -20.04 51.1 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.847 -176.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.652 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -66.51 -25.02 66.49 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.429 ' HB3' HD22 ' A' ' 86' ' ' LEU . . . -82.59 -38.65 23.32 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.778 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.803 HG22 ' HA ' ' A' ' 92' ' ' LYS . 1.6 t -57.29 -43.48 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.035 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 93' ' ' GLU . 7.8 t -62.47 -36.24 81.84 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.561 ' O ' ' CG ' ' A' ' 101' ' ' GLN . 3.2 mm -69.49 -47.33 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.947 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.628 ' HG ' ' HA ' ' A' ' 95' ' ' VAL . 2.2 pp -73.0 -31.31 64.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.981 0.42 . . . . 0.0 111.561 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 80.6 p -52.41 -47.99 65.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.828 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -123.35 6.49 9.04 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.561 ' CG ' ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -51.98 -61.55 2.19 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.987 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.07 176.44 11.89 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.716 0.293 . . . . 0.0 110.671 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.94 -33.5 41.18 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 119.992 -1.099 . . . . 0.0 111.286 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 31.4 tt0 -103.42 118.65 37.23 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.756 -1.222 . . . . 0.0 110.062 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.526 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -98.16 121.67 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.613 0 CA-C-O 123.01 1.386 . . . . 0.0 108.99 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.824 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -94.04 123.04 37.16 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 111.959 -2.382 . . . . 0.0 107.628 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 17.7 m-85 -98.26 117.64 33.09 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.582 -177.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -109.72 116.83 32.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 175.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 11.2 m -121.15 149.81 24.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 122.013 0.911 . . . . 0.0 113.439 -176.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 77' ' ' ALA . 31.5 t -117.49 148.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 113.674 -1.603 . . . . 0.0 111.063 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -86.34 121.22 28.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.042 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.127 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.905 0.383 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -58.81 -38.92 79.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 m -61.48 -150.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.119 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLN . . . . . 0.873 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -150.81 98.26 2.58 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.999 0.428 . . . . 0.0 111.599 -179.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . 0.59 ' OD1' ' CE1' ' A' ' 51' ' ' HIS . 10.8 m-20 -151.44 171.81 16.94 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' THR . . . . . 1.029 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -165.21 163.58 20.19 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 -178.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ARG . . . . . 0.814 ' CZ ' ' CE1' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -137.05 111.62 8.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.94 178.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ILE . 2.4 mp . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.704 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.92 138.68 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-O 122.067 0.937 . . . . 0.0 111.962 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 7.0 mtt-85 -138.04 118.54 13.86 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.391 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 5.7 mtpt -97.28 119.55 36.01 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 122.316 1.055 . . . . 0.0 112.167 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.514 ' CG1' ' HA3' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.95 117.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.897 177.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.83 110.39 22.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.419 0.628 . . . . 0.0 112.135 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.636 ' HB3' HG21 ' A' ' 105' ' ' ILE . 0.7 OUTLIER -113.33 115.68 28.51 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.101 178.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -118.1 105.46 11.86 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.315 -177.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -99.13 161.41 13.63 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.855 -1.521 . . . . 0.0 110.573 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -86.91 126.0 34.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.266 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 57.72 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.335 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . 9.3 p80 -177.3 40.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.019 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -65.91 62.71 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.283 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.39 164.24 0.04 OUTLIER Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.597 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.456 ' CB ' ' HB3' ' B' ' 120' ' ' LEU . 0.3 OUTLIER -101.65 -66.09 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.527 0.664 . . . . 0.0 111.182 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 64' ' ' GLN . . . 110.61 16.82 9.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.925 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 65' ' ' PRO . 18.0 mm -135.75 156.98 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.532 ' HB2' ' CZ ' ' B' ' 119' ' ' ARG . 32.8 t -130.11 148.64 51.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.759 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.565 ' HB ' HG21 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -134.21 158.76 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.929 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.466 ' N ' ' HE1' ' A' ' 91' ' ' HIS . 17.3 p -155.2 137.81 15.14 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.807 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 54' ' ' PRO . . . 144.57 176.52 18.66 Favored Glycine 0 N--CA 1.422 -2.26 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.301 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 142.96 -168.2 26.08 Favored Glycine 0 C--N 1.3 -1.431 0 CA-C-N 114.886 -0.657 . . . . 0.0 112.586 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -78.15 -2.15 36.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.465 0.174 . . . . 0.0 111.238 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 1.3 pt-20 -98.85 -33.45 10.87 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.481 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.778 ' NE2' ' OD1' ' B' ' 117' ' ' ASP . 29.6 m-70 -96.33 10.64 37.4 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.409 0.623 . . . . 0.0 110.02 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.58 24.66 53.5 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.356 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.9 OUTLIER -136.34 172.83 6.38 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-O 121.898 0.856 . . . . 0.0 113.029 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.521 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 3.0 Cg_exo -85.36 170.78 9.16 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 124.691 3.594 . . . . 0.0 108.543 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.565 HG21 ' HB ' ' A' ' 45' ' ' ILE . 33.5 mm -72.65 105.57 2.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 118.744 -1.182 . . . . 0.0 108.59 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.485 HD23 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -109.75 146.42 34.97 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.44 ' CG2' ' HA ' ' A' ' 74' ' ' VAL . 3.1 mp -72.45 134.87 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.418 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.2 p -137.78 -19.14 1.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.611 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 3.6 tt0 -136.27 115.61 12.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.0 110.07 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.415 HD11 ' CD1' ' A' ' 43' ' ' ILE . 1.9 mm -128.51 104.98 12.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.705 0.764 . . . . 0.0 111.623 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 1.028 ' NE2' ' NH2' ' B' ' 119' ' ' ARG . 74.8 m-70 -70.24 137.12 86.66 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.516 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.43 145.01 81.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.186 1.924 . . . . 0.0 111.182 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.01 6.25 9.37 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.967 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 1.136 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -96.59 166.81 13.35 Favored Pre-proline 0 N--CA 1.431 -1.411 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 29.8 Cg_exo -17.36 -4.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.053 3.169 . . . . 0.0 115.386 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 1.136 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -84.9 -35.76 21.92 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.32 -7.23 19.0 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.926 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -92.32 -26.28 18.18 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.688 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.575 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . 35.3 t -107.0 7.4 29.84 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 43.18 14.28 0.02 OUTLIER Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.421 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' HA3' ' CG1' ' A' ' 31' ' ' VAL . . . -144.32 9.62 1.95 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 119.542 -1.313 . . . . 0.0 114.714 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.907 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 7.5 mt -98.71 153.71 18.51 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 117.948 0.874 . . . . 0.0 109.976 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.97 130.9 0.1 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.19 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 75' ' ' GLY . 2.7 p -61.4 159.4 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.792 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.46 ' N ' ' CG2' ' A' ' 74' ' ' VAL . . . 100.24 -21.76 43.02 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.145 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.8 150.71 23.39 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.52 0.676 . . . . 0.0 109.633 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 109' ' ' VAL . . . -88.49 144.02 26.61 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.709 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.53 HG21 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -106.34 125.96 62.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.429 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.37 -51.9 4.0 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.196 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.717 ' HB1' ' HA ' ' A' ' 85' ' ' ASN . . . -162.37 176.7 10.25 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 52.6 t -131.89 152.15 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.589 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.674 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 1.2 p30 58.73 6.33 0.6 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.492 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.54 12.02 49.22 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.461 -0.875 . . . . 0.0 114.024 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.602 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 25.7 t -123.28 123.26 67.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 117.108 0.454 . . . . 0.0 111.202 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.717 ' HA ' ' HB1' ' A' ' 80' ' ' ALA . 7.5 p-10 -60.89 127.21 30.46 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.507 ' CD1' ' HA ' ' A' ' 80' ' ' ALA . 4.9 mp -106.64 86.16 2.29 Favored 'General case' 0 N--CA 1.416 -2.155 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 mmt-85 -98.63 94.84 6.88 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 89' ' ' THR . 4.8 m-20 -133.91 95.57 3.48 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.063 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.084 ' OG1' ' CG2' ' B' ' 115' ' ' VAL . 0.1 OUTLIER -2.56 -67.61 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.179 0.99 . . . . 0.0 111.803 178.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.656 ' HA ' ' HA ' ' B' ' 115' ' ' VAL . 0.0 OUTLIER -75.13 134.4 41.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 113.482 -1.69 . . . . 0.0 111.626 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.69 ' CD2' ' HB ' ' B' ' 118' ' ' THR . 6.7 t60 -64.11 -39.59 94.37 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.411 -1.722 . . . . 0.0 108.182 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.861 ' HA ' HG21 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -62.32 -22.01 65.72 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.189 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.534 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -64.64 -23.72 67.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.562 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -79.12 -45.77 19.35 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.816 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.861 HG21 ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -57.56 -45.6 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.874 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.6 t -60.3 -37.74 81.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.44 HG21 HD22 ' A' ' 86' ' ' LEU . 2.7 mt -69.85 -46.61 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.462 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.731 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 1.4 pp -76.12 -31.07 58.47 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.006 0.431 . . . . 0.0 111.642 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.8 t -53.68 -50.14 66.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -114.08 14.19 18.26 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.731 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -49.27 -86.49 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.87 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.442 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 4.7 ttt180 -151.63 176.55 11.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.6 -23.49 68.82 Favored Glycine 0 CA--C 1.504 -0.635 0 C-N-CA 119.528 -1.32 . . . . 0.0 112.428 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 20.7 mt-10 -104.09 117.52 34.47 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.267 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.636 HG21 ' HB3' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -98.43 116.72 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.926 0 CA-C-O 122.802 1.287 . . . . 0.0 107.565 178.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.678 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -96.09 140.11 31.28 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 112.813 -1.994 . . . . 0.0 108.739 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 12.2 m-85 -124.71 118.03 25.53 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.603 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.439 ' HG3' ' CA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -105.11 116.71 32.4 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 176.499 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 6.1 m -121.94 156.36 26.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -176.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 18.8 t -117.9 116.15 50.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.941 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -81.76 125.66 30.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.077 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.858 0.361 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . 0.432 ' O ' ' NE2' ' B' ' 116' ' ' GLN . 0.0 OUTLIER -163.78 123.93 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 1.084 ' CG2' ' OG1' ' A' ' 89' ' ' THR . 99.2 t -46.13 133.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.33 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLN . . . . . 0.838 ' OE1' ' NZ ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -149.91 -139.07 0.09 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ASP . . . . . 0.778 ' OD1' ' NE2' ' A' ' 51' ' ' HIS . 80.4 m-20 -124.53 -172.83 2.64 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.169 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' THR . . . . . 0.69 ' HB ' ' CD2' ' A' ' 91' ' ' HIS . 7.1 m -155.65 156.51 35.12 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ARG . . . . . 1.028 ' NH2' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -136.74 125.62 24.16 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.892 178.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.524 ' N ' HD13 ' B' ' 120' ' ' LEU . 3.7 mp . . . . . 0 C--O 1.255 1.392 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.965 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.421 ' CG1' ' HB3' ' A' ' 108' ' ' GLU . 0.6 OUTLIER -78.92 138.8 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-O 122.098 0.951 . . . . 0.0 111.903 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.663 ' HB2' HG22 ' A' ' 109' ' ' VAL . 13.6 mtt-85 -138.34 116.64 11.91 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.319 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.6 OUTLIER -96.65 119.86 35.91 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.567 1.175 . . . . 0.0 113.171 -178.135 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.776 HG12 ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -117.64 117.95 56.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 112.533 -2.121 . . . . 0.0 108.303 177.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mp -95.3 110.21 22.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.106 0.479 . . . . 0.0 111.483 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.834 HD12 ' HB2' ' A' ' 69' ' ' CYS . 1.2 tt -113.52 112.29 23.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.641 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 34' ' ' LEU . 3.9 mp -117.13 101.58 8.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.727 0.775 . . . . 0.0 111.614 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.38 130.86 45.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.538 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 38' ' ' HIS . 55.3 mt-10 -137.97 160.27 39.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.803 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 38' ' ' HIS . 0.8 OUTLIER 59.59 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.531 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 58.2 m-70 -34.47 -55.63 0.53 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.643 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 4.9 tp10 94.54 172.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.92 163.83 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.1 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.044 HD22 HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -105.7 -82.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.749 0.309 . . . . 0.0 111.364 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.44 22.86 1.04 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.044 HG22 HD22 ' A' ' 41' ' ' LEU . 13.5 tt -135.18 158.27 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 C-N-CA 122.79 0.436 . . . . 0.0 109.849 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.516 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 41.1 t -130.74 146.19 52.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.988 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.569 ' O ' ' CD2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -139.88 159.09 26.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 CA-C-O 122.189 0.995 . . . . 0.0 112.634 -179.346 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.855 ' HA ' ' HD2' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -161.74 137.27 7.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.748 178.106 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.836 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 151.4 168.96 16.48 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.492 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 141.03 -164.62 26.44 Favored Glycine 0 C--N 1.304 -1.238 0 CA-C-N 114.367 -0.917 . . . . 0.0 112.125 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -76.89 -17.44 58.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 0.0 110.041 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.444 ' HB2' ' HD3' ' A' ' 90' ' ' LYS . 2.7 tt0 -71.94 -42.7 66.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.947 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.749 ' NE2' ' OD1' ' B' ' 117' ' ' ASP . 21.3 m-70 -99.62 12.01 37.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.41 0.624 . . . . 0.0 110.178 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.93 23.9 40.12 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.75 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -131.83 173.63 5.65 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 121.923 0.868 . . . . 0.0 113.079 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.908 ' O ' HG23 ' A' ' 53' ' ' VAL . 4.4 Cg_exo -87.2 160.45 8.47 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.644 3.563 . . . . 0.0 108.256 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.011 HD11 ' HA ' ' A' ' 91' ' ' HIS . 25.2 mm -73.2 99.87 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.188 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 54' ' ' PRO . 6.9 mp -104.38 141.4 36.4 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.793 HD11 HG12 ' A' ' 78' ' ' ILE . 4.6 mp -71.12 129.3 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.198 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.63 -18.71 3.86 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 1.3 tt0 -137.27 115.88 12.07 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.737 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.749 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 2.8 mm -129.03 108.78 17.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.143 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.924 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 65.3 m-70 -70.0 137.15 87.23 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.089 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.44 145.15 80.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.212 1.941 . . . . 0.0 111.307 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.66 6.27 4.71 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.745 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 1.136 ' O ' ' N ' ' A' ' 66' ' ' ALA . 1.9 mp0 -96.85 167.1 12.67 Favored Pre-proline 0 N--CA 1.429 -1.495 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.94 ' CG ' HD23 ' A' ' 41' ' ' LEU . 10.8 Cg_exo -11.7 -9.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 124.745 3.63 . . . . 0.0 116.079 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.136 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.4 -35.69 21.17 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.44 -5.47 20.31 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.082 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.513 ' HG2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -93.05 -26.48 17.47 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.339 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.834 ' HB2' HD12 ' A' ' 33' ' ' LEU . 41.6 t -106.79 6.13 29.24 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 45.05 14.22 0.04 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.075 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.733 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -144.9 7.03 1.64 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 119.605 -1.283 . . . . 0.0 114.86 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.892 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 8.2 mt -97.18 151.09 20.16 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 118.216 1.008 . . . . 0.0 109.428 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.92 130.76 0.06 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.268 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 57' ' ' ILE . 2.1 p -58.92 159.12 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.638 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 106.91 -23.98 26.34 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.724 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.88 149.65 22.54 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.676 0.75 . . . . 0.0 110.022 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.86 ' HB3' HG23 ' A' ' 110' ' ' VAL . . . -89.3 131.84 35.2 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.52 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 1.03 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -104.3 138.35 29.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.276 -178.107 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.092 ' HA ' HD12 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -148.22 -2.96 0.51 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.818 -177.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.038 ' CB ' ' HA ' ' A' ' 84' ' ' VAL . . . -157.2 138.05 13.32 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.865 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 21.5 t -140.28 143.85 28.78 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.11 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.597 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 6.2 p-10 46.09 26.21 0.4 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.372 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.401 ' C ' ' CG1' ' A' ' 84' ' ' VAL . . . 128.05 44.86 0.21 Allowed Glycine 0 N--CA 1.464 0.525 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.38 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.038 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 1.5 p 43.37 77.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.452 1.101 . . . . 0.0 112.242 -177.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.66 ' H ' ' H ' ' A' ' 81' ' ' VAL . 19.8 m120 -130.98 92.76 3.27 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.092 HD12 ' HA ' ' A' ' 79' ' ' LEU . 2.0 mt -123.16 92.19 3.64 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 171.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.524 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -65.07 141.17 58.83 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.531 -176.589 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.16 96.33 10.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.084 -1.416 . . . . 0.0 114.475 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.869 HG22 ' H ' ' A' ' 90' ' ' LYS . 0.9 OUTLIER -157.6 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 112.601 -2.09 . . . . 0.0 105.828 174.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.869 ' H ' HG22 ' A' ' 89' ' ' THR . 25.2 mttm -132.48 168.28 18.47 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 1.011 ' HA ' HD11 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -47.36 -34.7 7.24 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.358 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.613 ' HA ' ' HB ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -58.43 -15.49 11.02 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.577 -177.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.778 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 9.6 mm-40 -64.16 -23.29 67.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.759 ' HB2' HD22 ' A' ' 86' ' ' LEU . . . -86.89 -39.42 15.81 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.895 HG22 HG21 ' B' ' 118' ' ' THR . 4.4 t -58.01 -46.02 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -61.95 -37.0 83.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.429 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -69.85 -47.15 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.746 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 1.078 HD22 HD21 ' B' ' 120' ' ' LEU . 2.7 pp -76.74 -35.99 57.42 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.463 ' N ' HD12 ' A' ' 98' ' ' LEU . 17.3 t -61.03 -54.23 47.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 101' ' ' GLN . 7.1 mm100 -85.12 -16.98 38.7 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.897 ' NE2' HD13 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -54.63 -112.23 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.576 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.436 ' O ' ' NE2' ' A' ' 101' ' ' GLN . 1.0 OUTLIER -147.47 177.32 9.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.99 -4.42 7.47 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.449 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.529 ' O ' ' NE2' ' A' ' 101' ' ' GLN . 32.1 tt0 -103.17 116.73 33.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.548 0.69 . . . . 0.0 111.306 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.897 HD13 ' NE2' ' A' ' 101' ' ' GLN . 26.1 mm -103.22 112.45 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.865 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -95.28 122.54 38.08 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.701 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 44.0 m-85 -109.99 117.81 34.76 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.702 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.633 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 1.3 mt-10 -108.66 115.85 30.88 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.663 HG22 ' HB2' ' A' ' 29' ' ' ARG . 10.4 m -121.68 147.89 25.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 114.562 -1.199 . . . . 0.0 114.192 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.975 HG22 HD21 ' A' ' 79' ' ' LEU . 27.6 m -117.4 152.1 19.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 113.649 -1.614 . . . . 0.0 111.342 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -82.19 126.75 32.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' A' ' 77' ' ' ALA . 21.9 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' ASP . . . . . 0.749 ' OD1' ' NE2' ' A' ' 51' ' ' HIS . 8.4 m-20 . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 118.819 -0.61 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.952 ' HB ' ' CE1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -167.66 166.59 13.84 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -178.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 119' ' ' ARG . . . . . 0.924 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -131.86 123.63 27.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.071 -1.877 . . . . 0.0 108.663 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 1.078 HD21 HD22 ' A' ' 98' ' ' LEU . 1.1 mp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.92 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 tt -80.19 138.71 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 122.024 0.916 . . . . 0.0 112.047 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.45 ' CB ' HG22 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -136.33 121.74 19.38 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.688 -1.597 . . . . 0.0 109.948 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -104.49 119.4 38.89 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.273 1.035 . . . . 0.0 112.475 -178.647 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.656 HG11 ' C ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.53 117.84 55.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 113.311 -1.768 . . . . 0.0 108.38 177.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mp -96.24 113.8 25.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.099 0.476 . . . . 0.0 111.438 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.755 HD12 ' HB2' ' A' ' 69' ' ' CYS . 2.2 tt -113.07 109.22 18.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HG ' ' CB ' ' A' ' 104' ' ' GLU . 3.1 mp -116.02 104.73 11.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.922 0.868 . . . . 0.0 110.961 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.76 161.32 13.71 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.704 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.97 136.17 33.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.626 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 47.7 25.3 0.67 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.516 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.42 ' O ' ' N ' ' A' ' 40' ' ' GLY . 1.3 m-70 46.26 29.57 0.86 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.197 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.9 81.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.816 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' HIS . . . 55.61 170.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.382 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.114 HD22 HG22 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -108.59 -76.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.699 0.749 . . . . 0.0 111.38 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 121.64 23.88 2.47 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.114 HG22 HD22 ' A' ' 41' ' ' LEU . 14.9 tt -135.5 158.31 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -130.88 148.07 52.6 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.498 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.622 HD11 HD11 ' B' ' 120' ' ' LEU . 0.8 OUTLIER -135.0 159.01 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.265 -178.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.501 ' N ' ' HE1' ' A' ' 91' ' ' HIS . 67.5 p -156.22 137.33 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.36 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.813 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 151.85 169.1 16.96 Favored Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.314 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 144.73 -166.75 27.31 Favored Glycine 0 C--N 1.303 -1.297 0 CA-C-N 114.567 -0.816 . . . . 0.0 111.449 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.405 ' CB ' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -76.72 -14.76 59.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.983 0.392 . . . . 0.0 110.95 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -75.53 -41.41 55.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 110.27 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.49 ' O ' ' CG1' ' A' ' 53' ' ' VAL . 13.9 m-70 -98.9 11.32 39.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.519 0.676 . . . . 0.0 110.161 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.18 23.24 32.18 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.565 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 54' ' ' PRO . 1.1 m -128.19 170.94 9.33 Favored Pre-proline 0 CA--C 1.512 -0.496 0 CA-C-O 121.959 0.885 . . . . 0.0 113.014 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.919 ' O ' HG23 ' A' ' 53' ' ' VAL . 7.5 Cg_exo -83.09 173.72 9.82 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.579 3.519 . . . . 0.0 108.132 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.013 HG23 ' CE1' ' A' ' 91' ' ' HIS . 39.4 mm -72.76 107.71 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.524 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.86 145.83 34.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -177.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.871 HD11 HG12 ' A' ' 78' ' ' ILE . 3.8 mp -71.87 130.73 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.532 ' HA ' HG23 ' A' ' 74' ' ' VAL . 11.8 t -132.18 -22.45 2.27 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 44' ' ' SER . 0.2 OUTLIER -137.4 115.84 11.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.252 0.548 . . . . 0.0 110.21 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.883 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 3.4 mm -125.43 107.06 17.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.72 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.984 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 39.2 m-70 -71.41 137.04 83.72 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.39 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.43 141.36 89.77 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.157 1.905 . . . . 0.0 111.227 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.33 0.92 8.62 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.609 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 1.112 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -96.43 167.36 12.42 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.896 ' HG3' HD23 ' A' ' 41' ' ' LEU . 6.2 Cg_exo -10.92 -9.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 125.075 3.85 . . . . 0.0 116.216 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.112 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.02 -35.83 21.67 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -102.14 -8.7 21.14 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.494 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 10.4 mmt180 -92.69 -26.44 17.79 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.439 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.755 ' HB2' HD12 ' A' ' 33' ' ' LEU . 42.9 t -107.6 6.14 27.62 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 44.58 13.68 0.03 OUTLIER Glycine 0 C--N 1.336 0.557 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.35 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.656 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -149.63 12.25 1.0 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 119.431 -1.366 . . . . 0.0 115.152 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.79 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 10.0 mt -99.04 150.53 21.9 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 118.223 1.012 . . . . 0.0 110.159 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.1 t60 174.52 145.36 0.06 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.997 0.903 . . . . 0.0 111.611 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.584 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 7.3 p -65.4 147.49 12.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.951 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.79 -17.77 24.98 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.024 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -92.52 149.46 21.36 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.588 0.709 . . . . 0.0 110.324 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.999 ' HB3' HG23 ' A' ' 110' ' ' VAL . . . -89.68 134.39 34.18 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.501 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.871 HG12 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -105.82 119.99 55.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.628 0.728 . . . . 0.0 111.608 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.007 HD21 HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -96.16 -41.57 8.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.297 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.864 ' HB1' ' O ' ' A' ' 84' ' ' VAL . . . -162.61 176.94 9.85 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.919 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -140.95 154.89 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.604 178.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.792 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.0 p-10 59.33 7.55 0.95 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.69 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.11 10.1 49.81 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.698 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.864 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 21.3 t -120.71 125.5 74.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.855 0.327 . . . . 0.0 110.769 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.743 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 14.6 p-10 -61.79 125.3 23.34 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.042 0.449 . . . . 0.0 109.945 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.032 HD21 HG21 ' A' ' 97' ' ' ILE . 4.0 mp -106.8 86.34 2.31 Favored 'General case' 0 N--CA 1.413 -2.278 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.004 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -83.58 96.67 8.71 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . 65.7 m-20 -132.61 99.31 4.6 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.675 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.405 ' OG1' ' CB ' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -56.42 -45.38 80.75 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.91 128.75 36.35 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 1.013 ' CE1' HG23 ' A' ' 55' ' ' ILE . 5.5 t60 -65.44 -40.32 93.14 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.063 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 1.06 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 1.3 mmtm -62.71 -22.35 66.45 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.856 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -65.27 -24.18 67.24 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.986 -0.685 . . . . 0.0 109.55 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.535 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -81.92 -45.09 15.92 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.262 0.553 . . . . 0.0 110.068 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.933 HG22 HG21 ' B' ' 118' ' ' THR . 2.0 t -57.31 -41.71 78.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.328 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -62.88 -38.6 91.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.003 0.906 . . . . 0.0 108.567 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.032 HG21 HD21 ' A' ' 86' ' ' LEU . 2.1 mm -69.87 -46.75 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.534 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.852 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 2.0 pp -75.21 -31.42 60.9 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.935 0.398 . . . . 0.0 111.756 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.418 ' N ' HD12 ' A' ' 98' ' ' LEU . 35.1 t -57.13 -53.72 54.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.79 2.85 30.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.852 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -50.64 -93.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.812 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.431 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -151.31 173.66 14.23 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.78 -12.14 58.98 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 119.594 -1.288 . . . . 0.0 112.881 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.452 ' CB ' ' HG ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -103.62 117.86 35.39 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.341 0.591 . . . . 0.0 111.777 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.745 HG13 HD11 ' A' ' 41' ' ' LEU . 20.2 mm -100.14 111.88 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.919 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -95.27 118.6 32.32 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.631 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 38.8 m-85 -102.49 117.57 34.98 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.532 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.643 ' CD ' ' HB3' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -103.0 115.45 30.63 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 175.291 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 6.9 m -124.34 156.99 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -175.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.007 HG22 HD21 ' A' ' 79' ' ' LEU . 1.8 m -128.37 152.24 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.247 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -89.0 118.53 28.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.112 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 117' ' ' ASP . . . . . 0.423 ' OD2' ' CE1' ' A' ' 51' ' ' HIS . 69.5 m-20 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' THR . . . . . 1.06 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 2.9 m -166.02 162.1 17.74 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' ARG . . . . . 0.984 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -135.1 129.25 33.65 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.102 178.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.801 HD21 HD22 ' A' ' 98' ' ' LEU . 2.8 mp . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.705 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.78 138.6 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 122.027 0.918 . . . . 0.0 112.019 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -139.59 118.72 12.68 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 113.652 -1.613 . . . . 0.0 110.35 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -100.34 119.49 38.51 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 122.307 1.051 . . . . 0.0 112.941 -178.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -115.62 118.05 57.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 113.308 -1.769 . . . . 0.0 107.924 176.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.24 115.82 28.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.975 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -113.72 124.33 52.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.861 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 4.8 mp -117.22 102.02 8.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.746 0.784 . . . . 0.0 111.742 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.19 161.2 13.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.3 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -137.96 148.19 45.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.027 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.432 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 13.1 t0 59.07 27.21 16.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.096 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.432 ' CG ' ' O ' ' A' ' 37' ' ' ASP . 21.0 p80 43.18 39.13 1.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.415 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.25 -21.27 47.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.92 178.81 16.41 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.532 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.779 HD22 HD22 ' B' ' 120' ' ' LEU . 1.2 tp -117.81 -19.07 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.116 0.458 . . . . 0.0 111.361 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.543 ' HA2' ' ND1' ' A' ' 61' ' ' HIS . . . 57.68 32.53 65.49 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.089 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.815 HG23 HD13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.14 157.52 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.474 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 5.4 t -130.87 147.87 52.57 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.465 0.65 . . . . 0.0 110.657 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.794 HG13 ' HB ' ' B' ' 118' ' ' THR . 0.5 OUTLIER -137.86 157.75 32.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.934 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.409 ' N ' ' NE2' ' A' ' 91' ' ' HIS . 21.9 p -160.94 152.36 19.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.482 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.767 ' CA ' HG22 ' A' ' 53' ' ' VAL . . . 139.16 -168.82 24.72 Favored Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.721 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 130.65 -169.03 21.54 Favored Glycine 0 C--N 1.3 -1.442 0 CA-C-N 114.098 -1.051 . . . . 0.0 113.199 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.42 -16.92 58.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.542 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 12.5 pt-20 -84.46 -34.42 23.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.973 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.675 ' O ' HG13 ' A' ' 53' ' ' VAL . 27.1 m-70 -95.71 9.72 39.39 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.492 0.663 . . . . 0.0 109.726 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.2 23.48 52.88 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.897 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -139.58 177.44 2.03 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-O 121.663 0.745 . . . . 0.0 112.862 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.834 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.8 Cg_exo -88.21 173.21 4.86 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 124.561 3.507 . . . . 0.0 109.012 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.914 HG23 ' NE2' ' A' ' 91' ' ' HIS . 32.5 mm -72.44 99.15 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.95 139.1 41.02 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.86 HD11 HG12 ' A' ' 78' ' ' ILE . 3.3 mp -71.82 129.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.431 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 p -137.02 -13.85 1.6 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.781 ' OE1' ' NH1' ' B' ' 119' ' ' ARG . 0.4 OUTLIER -137.13 116.1 12.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.371 0.605 . . . . 0.0 110.532 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.843 HG23 ' CB ' ' A' ' 66' ' ' ALA . 3.0 mm -117.76 109.72 28.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.308 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.99 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 7.4 m170 -71.53 136.56 83.52 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.829 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -53.08 139.67 61.53 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.836 1.691 . . . . 0.0 113.071 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.76 25.14 0.19 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 114.635 -1.166 . . . . 0.0 114.308 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 1.084 ' O ' ' N ' ' A' ' 66' ' ' ALA . 10.0 mm-40 -94.97 165.41 17.08 Favored Pre-proline 0 N--CA 1.419 -1.977 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.874 ' HB3' HD21 ' A' ' 33' ' ' LEU . 37.2 Cg_exo -30.54 2.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.273 1.982 . . . . 0.0 113.593 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.084 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.29 -36.41 19.35 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -101.8 -12.92 17.94 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.37 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -26.13 36.94 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.006 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.975 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -90.63 -5.03 56.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.68 8.77 0.39 Allowed Glycine 0 CA--C 1.519 0.33 0 CA-C-N 114.945 -1.025 . . . . 0.0 113.128 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.533 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -129.9 -1.66 5.37 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.691 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.907 HD11 HD13 ' A' ' 33' ' ' LEU . 4.1 mt -94.81 151.37 19.3 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 121.785 0.802 . . . . 0.0 111.518 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.4 t60 176.73 139.43 0.07 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.468 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 57' ' ' ILE . 2.9 p -66.89 147.46 12.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 113.829 -1.532 . . . . 0.0 112.3 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.22 -21.1 10.25 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.539 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.655 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -89.17 150.67 22.58 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.577 0.703 . . . . 0.0 109.677 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 110' ' ' VAL . . . -88.59 130.76 35.19 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.179 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.898 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -106.62 122.77 60.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.703 0.763 . . . . 0.0 110.939 -178.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 79' ' ' LEU . 5.2 tt -101.39 -50.63 3.7 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.217 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.949 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -148.67 176.77 10.07 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.891 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -138.88 153.22 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.691 177.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.627 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 0.0 OUTLIER 73.99 -18.1 0.42 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.532 -179.093 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 81' ' ' VAL . . . 118.98 9.59 8.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.752 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.913 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 20.4 t -127.96 133.03 68.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.949 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 8.2 p30 -61.09 131.87 51.96 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.775 HD23 HD13 ' A' ' 97' ' ' ILE . 5.4 mp -102.92 85.95 2.63 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 118.161 -1.415 . . . . 0.0 111.411 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.13 94.87 7.78 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 172.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.64 ' HB2' ' HB3' ' A' ' 93' ' ' GLU . 19.6 m-20 -134.3 97.52 3.86 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.511 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.701 ' OG1' ' N ' ' A' ' 90' ' ' LYS . 0.3 OUTLIER 46.19 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.087 0.946 . . . . 0.0 109.515 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.701 ' N ' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -126.97 168.04 15.07 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.132 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.935 ' HE1' ' HB ' ' B' ' 118' ' ' THR . 3.0 t-80 -46.06 -36.74 6.0 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 113.339 -1.755 . . . . 0.0 113.353 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.67 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -61.0 -23.89 65.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -64.3 -22.34 66.92 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.45 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -71.17 -46.81 60.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.001 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.084 HG22 ' OG1' ' B' ' 118' ' ' THR . 0.0 OUTLIER -59.84 -47.32 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.668 0.747 . . . . 0.0 109.68 178.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 93' ' ' GLU . 1.2 t -62.74 -36.12 81.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.898 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.775 HD13 HD23 ' A' ' 86' ' ' LEU . 1.4 mt -65.07 -47.23 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.764 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.948 HD22 HD21 ' B' ' 120' ' ' LEU . 0.9 OUTLIER -76.35 -40.53 50.97 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.776 0.322 . . . . 0.0 110.869 179.154 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.509 ' N ' HD12 ' A' ' 98' ' ' LEU . 75.3 m -55.75 -28.34 55.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.202 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -91.54 30.94 1.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER 178.1 151.62 0.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.875 0.369 . . . . 0.0 111.293 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.2 ptt-85 -126.04 160.91 28.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.41 -151.54 21.18 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.156 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 9.3 pt-20 -85.15 117.94 24.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.79 0.805 . . . . 0.0 111.901 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.635 HG12 HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.56 121.7 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.516 0 CA-C-O 122.734 1.254 . . . . 0.0 107.814 177.849 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.891 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -93.5 127.71 39.27 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.3 -2.227 . . . . 0.0 108.645 -178.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.582 ' HD2' HD11 ' A' ' 78' ' ' ILE . 17.7 m-85 -104.32 117.62 34.64 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.024 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.714 ' CD ' ' HB3' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -107.67 116.26 31.63 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 7.6 m -122.13 154.77 26.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.59 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 15.7 t -118.42 132.36 68.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.918 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -81.68 107.81 14.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.105 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 117' ' ' ASP . . . . . 0.568 ' OD2' ' CE1' ' A' ' 51' ' ' HIS . 6.4 m-20 . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' THR . . . . . 1.084 ' OG1' HG22 ' A' ' 95' ' ' VAL . 91.5 m -147.2 146.6 29.89 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' ARG . . . . . 0.99 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -142.87 109.35 5.36 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.523 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.948 HD21 HD22 ' A' ' 98' ' ' LEU . 1.2 mp . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.852 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 tp -82.19 138.37 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 122.124 0.964 . . . . 0.0 112.105 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.546 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 5.8 mtt180 -140.22 116.9 10.88 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.928 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.47 119.42 37.98 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 122.332 1.063 . . . . 0.0 112.75 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.978 HG12 ' O ' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -109.96 116.89 53.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 112.966 -1.924 . . . . 0.0 107.05 176.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.14 114.36 27.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.285 0.564 . . . . 0.0 111.816 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.885 HD13 ' HB3' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -113.16 119.04 36.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.316 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 34' ' ' LEU . 4.4 mp -110.96 101.66 10.2 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.804 0.811 . . . . 0.0 110.848 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.57 134.43 42.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.812 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 38' ' ' HIS . 15.2 mt-10 -138.84 138.08 37.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.995 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 38' ' ' HIS . 3.6 m-20 60.93 -79.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.258 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.558 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 60.0 m80 -15.47 -63.97 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.952 0.501 . . . . 0.0 112.34 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.558 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 6.0 tt0 96.82 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.656 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 48.79 -174.09 0.04 OUTLIER Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.608 -0.805 . . . . 0.0 111.935 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.666 HD11 HG13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -125.37 -67.26 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.27 0.535 . . . . 0.0 111.416 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 64' ' ' GLN . . . 112.51 20.07 6.73 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.647 HG22 HD23 ' A' ' 41' ' ' LEU . 20.2 tt -125.18 160.52 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.149 0 CA-C-O 121.144 0.497 . . . . 0.0 110.458 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.42 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 3.2 t -128.26 146.92 50.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.693 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.048 HD11 HD11 ' B' ' 120' ' ' LEU . 0.6 OUTLIER -138.69 160.37 30.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.098 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.453 ' N ' ' CE1' ' A' ' 91' ' ' HIS . 66.7 p -158.75 138.77 12.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.27 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.548 ' N ' ' HD1' ' A' ' 91' ' ' HIS . . . 163.26 -141.0 6.83 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 140.96 160.98 8.51 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.15 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.515 ' CB ' ' HA ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -80.35 -16.75 53.83 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.402 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.559 ' OE2' ' CE1' ' A' ' 51' ' ' HIS . 1.3 pt-20 -70.06 -35.81 74.53 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.394 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.681 ' HB2' HG13 ' A' ' 53' ' ' VAL . 17.2 m80 -97.37 15.1 23.99 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.533 0.682 . . . . 0.0 109.833 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.73 18.34 31.34 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.554 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 54' ' ' PRO . 1.9 m -103.58 154.05 38.16 Favored Pre-proline 0 CA--C 1.513 -0.456 0 CA-C-O 122.02 0.914 . . . . 0.0 113.249 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.825 ' O ' HG23 ' A' ' 53' ' ' VAL . 22.4 Cg_exo -77.41 -172.49 1.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 124.551 3.5 . . . . 0.0 109.424 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.04 HG23 ' CE1' ' A' ' 91' ' ' HIS . 50.4 mm -84.64 120.38 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.599 HD21 ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -105.73 126.53 52.26 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.231 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.844 HD12 HG22 ' A' ' 78' ' ' ILE . 3.2 mt -70.34 131.44 34.26 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.594 ' HA ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -140.17 -15.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.77 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.896 ' OE1' ' NH1' ' B' ' 119' ' ' ARG . 1.7 tt0 -137.57 116.14 12.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.092 0.472 . . . . 0.0 111.087 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.666 HG23 ' CD ' ' A' ' 64' ' ' GLN . 3.2 mm -116.19 106.09 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.708 0.766 . . . . 0.0 111.118 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.909 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 2.9 m170 -73.28 118.75 71.37 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.974 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 61' ' ' HIS . 3.2 Cg_endo -45.77 114.0 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.748 1.632 . . . . 0.0 110.836 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' HA2' ' CB ' ' A' ' 67' ' ' ASP . . . 105.97 1.43 39.15 Favored Glycine 0 N--CA 1.422 -2.266 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.804 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 1.154 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -94.41 166.55 15.14 Favored Pre-proline 0 CA--C 1.492 -1.266 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.969 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 69.4 Cg_exo -12.46 -9.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 124.969 3.779 . . . . 0.0 115.739 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.154 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.35 -35.98 19.51 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.491 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . 4.7 t70 -91.2 -12.5 35.17 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.505 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.969 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 3.7 mtt-85 -77.48 1.05 20.47 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.305 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 4.0 t 77.76 -17.28 0.58 Allowed 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.978 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -43.79 -31.78 1.97 Allowed Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.029 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.696 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 86.34 29.89 23.64 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.176 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.693 HD12 ' CB ' ' A' ' 65' ' ' PRO . 1.6 mt -90.82 151.76 21.04 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 122.255 1.026 . . . . 0.0 112.142 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.647 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.9 t60 179.85 146.96 0.24 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.33 -1.759 . . . . 0.0 111.319 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.647 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 12.0 p -67.43 158.97 5.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.607 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.547 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 102.95 -19.18 47.57 Favored Glycine 0 C--N 1.316 -0.552 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.546 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.16 149.64 21.77 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.385 0.612 . . . . 0.0 109.989 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.507 ' HA ' HD13 ' A' ' 56' ' ' LEU . . . -89.15 129.37 35.76 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.684 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.849 HG23 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.15 113.82 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.527 0.679 . . . . 0.0 112.279 -177.565 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.004 HD21 HG23 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -89.64 -41.35 12.01 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.991 -178.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.944 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -162.67 177.53 9.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -175.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.045 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -133.71 154.49 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.367 178.367 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.723 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.1 p-10 57.56 7.41 0.52 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.537 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.06 13.36 39.81 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.829 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.866 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 20.7 t -123.86 118.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.976 0.388 . . . . 0.0 111.511 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.944 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 2.7 m120 -61.33 124.7 21.33 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.884 HD21 HG21 ' A' ' 97' ' ' ILE . 4.6 mp -106.41 86.36 2.34 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.439 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -102.74 94.66 5.73 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 90' ' ' LYS . 1.1 m-20 -134.04 94.39 3.24 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.686 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.531 ' C ' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER 14.72 -80.35 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 124.444 1.09 . . . . 0.0 111.92 178.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -75.09 136.39 41.15 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 113.611 -1.631 . . . . 0.0 112.038 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 1.04 ' CE1' HG23 ' A' ' 55' ' ' ILE . 7.6 t60 -60.8 -36.31 78.7 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.657 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 1.008 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 1.7 mmtm -61.92 -22.6 65.73 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.267 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.492 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -64.97 -25.39 67.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.569 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -84.03 -44.16 14.4 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.746 HG23 ' CG2' ' B' ' 118' ' ' THR . 0.4 OUTLIER -57.2 -45.51 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.858 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.463 ' N ' ' CG1' ' A' ' 95' ' ' VAL . 14.6 t -61.42 -36.39 80.21 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.884 HG21 HD21 ' A' ' 86' ' ' LEU . 1.1 mt -69.49 -46.57 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.956 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.893 HD13 ' CD2' ' B' ' 120' ' ' LEU . 0.9 OUTLIER -75.22 -35.04 61.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.652 0.263 . . . . 0.0 111.161 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 93.5 p -57.31 -57.29 13.28 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.138 0.494 . . . . 0.0 110.439 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -66.26 -32.8 74.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.12 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 3.5 mm-40 -51.0 149.61 3.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.512 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.57 169.65 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.47 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.41 -132.13 12.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.453 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 1.1 pt-20 -84.73 126.46 33.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.666 HG13 HD11 ' A' ' 41' ' ' LEU . 20.7 mm -97.09 112.8 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 1.045 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -94.47 121.37 35.94 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.631 -179.324 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.565 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 34.5 m-85 -105.22 118.06 35.59 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.715 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.832 ' OE2' ' HB3' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -100.06 115.98 31.03 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.524 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 5.0 m -129.1 157.49 41.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.004 HG23 HD21 ' A' ' 79' ' ' LEU . 58.5 t -118.12 130.4 73.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.893 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -83.6 117.33 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.961 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.179 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 118' ' ' THR . . . . . 1.008 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -170.79 159.8 6.58 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 119' ' ' ARG . . . . . 0.909 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -124.28 165.44 17.64 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.512 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 1.048 HD11 HD11 ' A' ' 45' ' ' ILE . 5.9 mp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.247 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 tp -79.41 138.77 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.044 0.926 . . . . 0.0 112.028 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.487 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.9 OUTLIER -140.13 120.37 13.86 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.958 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -102.31 119.82 39.45 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 122.192 0.996 . . . . 0.0 112.661 -178.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.78 HG12 ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -113.58 117.94 56.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 113.342 -1.754 . . . . 0.0 108.673 177.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.3 112.0 23.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.41 0.624 . . . . 0.0 111.659 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.048 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.5 OUTLIER -114.42 115.42 27.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.02 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -116.69 100.59 7.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.004 0.907 . . . . 0.0 109.923 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -100.78 161.81 13.34 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.474 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -86.31 160.75 19.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.475 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -41.09 -26.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 1.3 t-160 -40.61 -57.1 1.95 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 1.0 OUTLIER 101.57 160.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.468 0.707 . . . . 0.0 111.111 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.73 129.15 4.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.403 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.776 HD22 ' CG2' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -120.35 -9.67 9.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.787 0.327 . . . . 0.0 111.673 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA2' ' ND1' ' A' ' 61' ' ' HIS . . . 47.09 37.62 10.34 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.703 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.776 ' CG2' HD22 ' A' ' 41' ' ' LEU . 9.3 tt -135.05 158.59 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.517 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 6.8 t -130.03 147.88 51.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.768 0.794 . . . . 0.0 111.185 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.592 HG13 HG22 ' B' ' 118' ' ' THR . 1.2 pt -138.16 160.96 32.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.729 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.632 ' HA ' ' CD2' ' A' ' 91' ' ' HIS . 7.1 p -160.64 136.48 8.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.955 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.556 ' CA ' HG22 ' A' ' 53' ' ' VAL . . . 163.01 -141.4 7.13 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 53' ' ' VAL . . . 160.69 128.68 0.97 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.1 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -74.51 -10.79 59.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 109.942 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.435 ' HG2' ' HD3' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -102.65 -24.87 13.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.235 179.021 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -91.61 21.3 4.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.436 0.636 . . . . 0.0 110.457 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.23 14.34 56.36 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.405 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -129.75 137.21 30.41 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.594 ' O ' HG23 ' A' ' 53' ' ' VAL . 77.7 Cg_exo -63.65 156.48 56.96 Favored 'Trans proline' 0 C--N 1.331 -0.357 0 C-N-CA 124.001 3.134 . . . . 0.0 111.069 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.945 ' HB ' HG22 ' A' ' 78' ' ' ILE . 24.9 mm -74.26 108.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.647 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 54' ' ' PRO . 8.0 mp -103.86 139.28 39.27 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.91 HD11 HG12 ' A' ' 78' ' ' ILE . 3.2 mp -72.01 131.62 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.017 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 m -136.79 -17.47 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.517 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 0.5 OUTLIER -137.27 116.11 12.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.234 0.54 . . . . 0.0 110.844 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.78 HG23 ' CB ' ' A' ' 66' ' ' ALA . 4.2 mm -116.53 111.69 36.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.245 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.773 ' CE1' ' NH1' ' B' ' 119' ' ' ARG . 7.6 m170 -70.89 136.73 85.15 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.873 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.37 138.99 81.34 Favored 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 122.246 1.964 . . . . 0.0 113.119 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 42.19 25.33 0.25 Allowed Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.704 -1.135 . . . . 0.0 113.975 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 1.085 ' O ' ' N ' ' A' ' 66' ' ' ALA . 14.5 mm-40 -95.21 165.34 17.06 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.626 ' HB2' HD23 ' A' ' 41' ' ' LEU . 49.1 Cg_exo -31.25 2.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.036 1.824 . . . . 0.0 113.255 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.085 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.15 -36.44 19.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -99.01 -13.95 19.67 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.346 177.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.541 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 29.6 mtp180 -76.19 -26.24 55.97 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.817 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 1.048 ' HB2' HD12 ' A' ' 33' ' ' LEU . 28.0 t -93.3 -1.78 55.66 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 48.85 11.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.985 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.73 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -136.75 5.61 3.73 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.489 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 6.3 mt -94.72 150.61 20.04 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 117.925 0.862 . . . . 0.0 109.357 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 179.6 133.22 0.1 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.627 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 75' ' ' GLY . 3.2 p -60.67 159.5 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.98 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.511 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 105.99 -24.5 26.47 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.709 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.542 ' O ' HD12 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -88.33 149.88 23.52 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.755 0.788 . . . . 0.0 109.874 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.852 ' HB2' HG13 ' A' ' 112' ' ' VAL . . . -88.68 133.6 34.16 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.562 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.945 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -102.97 145.3 12.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.497 -178.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.953 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -146.02 -20.13 0.45 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.168 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.012 ' HB1' ' N ' ' A' ' 85' ' ' ASN . . . -163.88 176.27 9.62 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.778 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -154.06 153.15 8.83 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.594 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 0.2 OUTLIER 77.95 -49.45 0.49 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.625 -1.625 . . . . 0.0 112.264 178.67 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' C ' ' CG1' ' A' ' 84' ' ' VAL . . . -154.78 32.61 0.68 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 84' ' ' VAL . 1.4 p 48.46 73.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 126.781 2.033 . . . . 0.0 113.177 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 1.012 ' N ' ' HB1' ' A' ' 80' ' ' ALA . 14.9 p-10 -136.35 97.28 3.54 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 113.27 -1.787 . . . . 0.0 112.68 172.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.953 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 7.1 mt -116.71 88.28 2.87 Favored 'General case' 0 CA--C 1.469 -2.139 0 CA-C-N 124.273 3.215 . . . . 0.0 108.549 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.51 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -112.55 92.73 4.12 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 173.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.682 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -137.65 93.13 2.76 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.369 178.094 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.684 ' OG1' ' N ' ' A' ' 90' ' ' LYS . 1.0 OUTLIER 14.82 -124.89 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.295 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.684 ' N ' ' OG1' ' A' ' 89' ' ' THR . 3.5 mttp -75.29 168.56 19.76 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.968 ' CE1' ' HB ' ' B' ' 118' ' ' THR . 0.1 OUTLIER -44.61 -50.07 9.92 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -175.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.988 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 0.0 OUTLIER -60.77 -20.49 61.52 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.019 -176.331 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.682 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -65.86 -24.96 66.98 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.531 178.508 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.495 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -76.34 -38.61 55.68 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.92 HG23 ' HA ' ' A' ' 92' ' ' LYS . 1.4 t -61.9 -44.94 99.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.588 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.668 HG22 ' O ' ' A' ' 93' ' ' GLU . 5.3 t -61.55 -36.32 80.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -68.98 -46.63 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.825 179.428 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.694 ' CG ' ' HA ' ' A' ' 95' ' ' VAL . 2.6 pp -74.88 -33.15 62.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.789 0.328 . . . . 0.0 111.522 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.538 ' N ' HD12 ' A' ' 98' ' ' LEU . 29.6 t -57.41 -53.69 55.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.226 0.536 . . . . 0.0 110.719 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -69.9 -40.02 75.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.743 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.588 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -55.71 156.01 5.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.42 ' HA ' ' NE ' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -141.51 167.2 22.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.04 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.21 -130.65 10.32 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.463 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -98.2 128.76 44.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 122.169 0.985 . . . . 0.0 113.473 -178.236 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.607 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 30.8 mm -97.54 112.7 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.778 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -93.75 117.6 30.31 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 178.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 31.6 m-85 -99.25 118.61 36.32 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.616 -176.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.994 ' HG3' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -107.06 116.61 32.23 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.487 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 14.5 m -122.13 145.23 29.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.403 -0.919 . . . . 0.0 113.213 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.689 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 7.8 t -117.02 152.13 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.051 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -87.04 117.46 25.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.136 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.852 HG13 ' HB2' ' A' ' 77' ' ' ALA . 4.9 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.055 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' ASP . . . . . 0.524 ' HA ' ' CD2' ' A' ' 91' ' ' HIS . 14.6 m-20 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.988 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -169.02 157.33 7.82 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 119' ' ' ARG . . . . . 0.773 ' NH1' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -133.74 121.32 21.72 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.992 178.485 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.673 HD21 HD22 ' A' ' 98' ' ' LEU . 2.4 mp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.814 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.31 134.64 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 C-N-CA 122.86 0.464 . . . . 0.0 111.239 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -142.45 122.22 13.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.177 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -106.11 119.46 39.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.149 0.976 . . . . 0.0 112.682 -178.529 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.734 HG11 ' C ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.5 118.28 57.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.854 177.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -89.86 110.06 21.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.926 0.869 . . . . 0.0 112.739 -177.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.002 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -115.39 115.46 26.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.488 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.554 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -118.66 101.57 8.21 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.636 0.731 . . . . 0.0 110.672 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.28 161.31 13.69 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.435 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.65 119.44 26.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.966 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 51.91 -137.75 1.16 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.528 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.44 41.63 1.08 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.75 0.31 . . . . 0.0 110.926 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -56.37 -22.93 34.32 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.05 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.0 174.86 31.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.148 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.784 HD22 HG12 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -111.62 -26.78 8.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 110.684 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 61' ' ' HIS . . . 65.29 33.1 85.82 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.784 HG12 HD22 ' A' ' 41' ' ' LEU . 1.8 pt -135.41 157.87 40.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 59' ' ' GLU . 1.7 t -130.61 147.72 52.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.667 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.732 HG13 HG22 ' B' ' 118' ' ' THR . 2.9 pt -137.58 159.92 34.6 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.634 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.722 ' HA ' ' HD2' ' A' ' 91' ' ' HIS . 69.4 p -160.29 135.75 8.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.686 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.873 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 165.42 170.16 30.0 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 119.807 -1.187 . . . . 0.0 112.944 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 148.63 -177.6 26.76 Favored Glycine 0 C--N 1.303 -1.255 0 CA-C-N 114.156 -1.022 . . . . 0.0 113.305 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -15.26 58.37 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 11.1 pt-20 -82.86 -35.73 26.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.991 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.59 ' CE1' ' OD1' ' B' ' 117' ' ' ASP . 30.9 m-70 -94.59 8.9 40.72 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.501 0.667 . . . . 0.0 109.562 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.29 55.31 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.828 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 54' ' ' PRO . 1.6 m -138.99 172.67 6.18 Favored Pre-proline 0 CA--C 1.513 -0.479 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.895 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.0 Cg_exo -86.55 166.98 8.9 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 124.761 3.641 . . . . 0.0 108.272 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.918 ' HB ' HG22 ' A' ' 78' ' ' ILE . 13.4 mm -72.46 99.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 117.756 -1.578 . . . . 0.0 107.122 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.87 137.1 44.32 Favored 'General case' 0 N--CA 1.405 -2.686 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.877 HD11 HG12 ' A' ' 78' ' ' ILE . 3.1 mp -72.33 134.15 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.911 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -139.75 -12.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.535 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 1.0 OUTLIER -134.49 116.08 14.68 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.317 0.58 . . . . 0.0 110.994 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.723 HG23 ' CB ' ' A' ' 66' ' ' ALA . 3.3 mm -123.18 112.15 32.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.788 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.814 ' CE1' ' CZ ' ' B' ' 119' ' ' ARG . 5.3 m170 -71.88 136.62 82.56 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.267 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -57.6 142.63 95.7 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.839 1.693 . . . . 0.0 112.561 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 46.36 19.84 0.49 Allowed Glycine 0 N--CA 1.432 -1.57 0 CA-C-N 115.216 -0.902 . . . . 0.0 114.23 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 1.11 ' O ' ' N ' ' A' ' 66' ' ' ALA . 12.7 mm-40 -96.04 165.93 15.39 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.729 ' HB3' HD21 ' A' ' 33' ' ' LEU . 31.9 Cg_exo -28.31 2.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.421 2.081 . . . . 0.0 113.734 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.11 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.93 -36.32 19.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 64' ' ' GLN . 4.6 t0 -102.19 -13.1 17.57 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.265 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -26.46 43.95 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.911 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 1.002 ' HB2' HD12 ' A' ' 33' ' ' LEU . 8.6 t -95.08 -1.53 51.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 48.94 10.07 0.12 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.464 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.734 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -133.47 7.42 4.97 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.063 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.668 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 5.5 mt -97.65 154.66 17.41 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 121.433 0.635 . . . . 0.0 110.844 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.97 126.65 0.06 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.253 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 75' ' ' GLY . 2.3 p -60.42 159.39 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.355 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 108.9 -24.29 21.84 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.27 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.568 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -85.03 150.43 24.88 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.704 0.764 . . . . 0.0 109.226 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 110' ' ' VAL . . . -88.06 137.55 32.23 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.137 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.918 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -100.47 149.19 6.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.884 -178.063 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.471 ' HA ' HD22 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -137.6 -50.89 0.62 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.363 -178.661 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.928 ' HB1' ' O ' ' A' ' 84' ' ' VAL . . . -147.81 175.93 10.53 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.006 1.114 . . . . 0.0 114.006 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -143.06 154.58 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.157 178.437 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.833 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 1.9 p-10 63.13 5.14 1.8 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.987 -1.46 . . . . 0.0 112.462 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' N ' ' CD ' ' A' ' 106' ' ' GLU . . . 102.4 5.71 48.59 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.82 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.928 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 21.1 t -123.8 136.53 59.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 117.004 0.402 . . . . 0.0 111.319 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.761 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 38.3 t-20 -61.39 133.29 55.64 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.8 HD13 ' HA ' ' A' ' 80' ' ' ALA . 6.1 mp -103.22 86.43 2.68 Favored 'General case' 0 CA--C 1.465 -2.325 0 C-N-CA 118.278 -1.369 . . . . 0.0 108.98 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 5.3 tpp85 -100.6 94.4 6.09 Favored 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 173.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.667 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 20.7 m-20 -134.25 96.46 3.61 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.699 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.958 HG23 ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER 29.28 -132.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.643 179.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.743 ' N ' ' OG1' ' A' ' 89' ' ' THR . 6.7 mttp -75.46 169.74 17.49 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.843 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.893 ' CE1' ' HB ' ' B' ' 118' ' ' THR . 0.1 OUTLIER -45.26 -49.97 12.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -175.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 1.029 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 0.3 OUTLIER -59.29 -20.04 51.1 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.847 -176.052 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.958 ' HG3' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER -66.51 -25.02 66.49 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.439 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 97' ' ' ILE . . . -82.59 -38.65 23.32 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.778 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.969 HG23 ' HA ' ' A' ' 92' ' ' LYS . 1.6 t -57.29 -43.48 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.035 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 93' ' ' GLU . 7.8 t -62.47 -36.24 81.84 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.561 ' O ' ' CG ' ' A' ' 101' ' ' GLN . 3.2 mm -69.49 -47.33 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.947 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.632 HD13 ' CD2' ' B' ' 120' ' ' LEU . 2.2 pp -73.0 -31.31 64.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.981 0.42 . . . . 0.0 111.561 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.43 ' N ' HD12 ' A' ' 98' ' ' LEU . 80.6 p -52.41 -47.99 65.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.828 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -123.35 6.49 9.04 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.561 ' CG ' ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -51.98 -61.55 2.19 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.987 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.07 176.44 11.89 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.716 0.293 . . . . 0.0 110.671 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.94 -33.5 41.18 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 119.992 -1.099 . . . . 0.0 111.286 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 31.4 tt0 -103.42 118.65 37.23 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.756 -1.222 . . . . 0.0 110.062 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.691 HG12 HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.16 121.67 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.613 0 CA-C-O 123.01 1.386 . . . . 0.0 108.99 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.833 ' HB3' ' HA ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -94.04 123.04 37.16 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 111.959 -2.382 . . . . 0.0 107.628 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 17.7 m-85 -98.26 117.64 33.09 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.582 -177.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -109.72 116.83 32.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 175.121 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 11.2 m -121.15 149.81 24.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 122.013 0.911 . . . . 0.0 113.439 -176.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.637 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 31.5 t -117.49 148.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 113.674 -1.603 . . . . 0.0 111.063 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -86.34 121.22 28.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.042 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 77' ' ' ALA . 4.7 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.127 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' ASP . . . . . 0.753 ' HA ' ' CD2' ' A' ' 91' ' ' HIS . 10.8 m-20 . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' THR . . . . . 1.029 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -165.21 163.58 20.19 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 -178.284 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 119' ' ' ARG . . . . . 0.814 ' CZ ' ' CE1' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -137.05 111.62 8.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.94 178.421 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.632 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.4 mp . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.704 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.92 138.68 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-O 122.067 0.937 . . . . 0.0 111.962 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.448 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 7.0 mtt-85 -138.04 118.54 13.86 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.391 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 5.7 mtpt -97.28 119.55 36.01 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 122.316 1.055 . . . . 0.0 112.167 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.689 HG11 ' C ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.95 117.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.897 177.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.83 110.39 22.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.419 0.628 . . . . 0.0 112.135 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.7 OUTLIER -113.33 115.68 28.51 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.101 178.27 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -118.1 105.46 11.86 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.315 -177.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -99.13 161.41 13.63 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.855 -1.521 . . . . 0.0 110.573 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -86.91 126.0 34.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.266 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 57.72 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.335 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.483 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . 9.3 p80 -177.3 40.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.019 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -65.91 62.71 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.283 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 38' ' ' HIS . . . 56.39 164.24 0.04 OUTLIER Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.597 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.897 HD13 HD23 ' B' ' 120' ' ' LEU . 0.3 OUTLIER -101.65 -66.09 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.527 0.664 . . . . 0.0 111.182 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.902 ' O ' HD13 ' A' ' 43' ' ' ILE . . . 110.61 16.82 9.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.925 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.953 HD12 HD13 ' A' ' 60' ' ' ILE . 18.0 mm -135.75 156.98 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.549 ' HB2' ' CZ ' ' B' ' 119' ' ' ARG . 32.8 t -130.11 148.64 51.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.759 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.604 HD11 HD11 ' B' ' 120' ' ' LEU . 0.9 OUTLIER -134.21 158.76 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.929 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.484 ' N ' ' HE1' ' A' ' 91' ' ' HIS . 17.3 p -155.2 137.81 15.14 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.807 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.777 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 144.57 176.52 18.66 Favored Glycine 0 N--CA 1.422 -2.26 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.301 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 142.96 -168.2 26.08 Favored Glycine 0 C--N 1.3 -1.431 0 CA-C-N 114.886 -0.657 . . . . 0.0 112.586 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -78.15 -2.15 36.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.465 0.174 . . . . 0.0 111.238 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 1.3 pt-20 -98.85 -33.45 10.87 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.481 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.778 ' NE2' ' OD1' ' B' ' 117' ' ' ASP . 29.6 m-70 -96.33 10.64 37.4 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.409 0.623 . . . . 0.0 110.02 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.58 24.66 53.5 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.356 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.9 OUTLIER -136.34 172.83 6.38 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-O 121.898 0.856 . . . . 0.0 113.029 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.903 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.0 Cg_exo -85.36 170.78 9.16 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 124.691 3.594 . . . . 0.0 108.543 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.083 HG23 ' CE1' ' A' ' 91' ' ' HIS . 33.5 mm -72.65 105.57 2.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 118.744 -1.182 . . . . 0.0 108.59 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.528 HD23 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -109.75 146.42 34.97 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.821 HD11 HG12 ' A' ' 78' ' ' ILE . 3.1 mp -72.45 134.87 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.418 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.2 p -137.78 -19.14 1.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.611 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 3.6 tt0 -136.27 115.61 12.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.0 110.07 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.953 HD13 HD12 ' A' ' 43' ' ' ILE . 1.9 mm -128.51 104.98 12.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.705 0.764 . . . . 0.0 111.623 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 1.028 ' NE2' ' NH2' ' B' ' 119' ' ' ARG . 74.8 m-70 -70.24 137.12 86.66 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.516 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.43 145.01 81.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.186 1.924 . . . . 0.0 111.182 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.01 6.25 9.37 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.967 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 1.136 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -96.59 166.81 13.35 Favored Pre-proline 0 N--CA 1.431 -1.411 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.758 ' HB2' HD11 ' A' ' 43' ' ' ILE . 29.8 Cg_exo -17.36 -4.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.053 3.169 . . . . 0.0 115.386 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.136 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -84.9 -35.76 21.92 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.32 -7.23 19.0 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.926 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.401 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 3.2 mmt180 -92.32 -26.28 18.18 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.688 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.787 ' HB2' HD12 ' A' ' 33' ' ' LEU . 35.3 t -107.0 7.4 29.84 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 43.18 14.28 0.02 OUTLIER Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.421 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.689 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -144.32 9.62 1.95 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 119.542 -1.313 . . . . 0.0 114.714 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.934 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 7.5 mt -98.71 153.71 18.51 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 117.948 0.874 . . . . 0.0 109.976 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.97 130.9 0.1 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.19 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 75' ' ' GLY . 2.7 p -61.4 159.4 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.792 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.515 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 100.24 -21.76 43.02 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.145 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -87.8 150.71 23.39 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.52 0.676 . . . . 0.0 109.633 178.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . . . -88.49 144.02 26.61 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.709 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.821 HG12 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -106.34 125.96 62.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.429 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.5 OUTLIER -97.37 -51.9 4.0 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.196 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.945 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -162.37 176.7 10.25 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 52.6 t -131.89 152.15 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.589 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.714 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 1.2 p-10 58.73 6.33 0.6 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.492 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.54 12.02 49.22 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.461 -0.875 . . . . 0.0 114.024 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.871 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 25.7 t -123.28 123.26 67.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 117.108 0.454 . . . . 0.0 111.202 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.945 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 7.5 p-10 -60.89 127.21 30.46 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.929 HD21 HG21 ' A' ' 97' ' ' ILE . 4.9 mp -106.64 86.16 2.29 Favored 'General case' 0 N--CA 1.416 -2.155 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 mmt-85 -98.63 94.84 6.88 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 89' ' ' THR . 4.8 m-20 -133.91 95.57 3.48 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.063 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.589 ' C ' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -2.56 -67.61 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.179 0.99 . . . . 0.0 111.803 178.482 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -75.13 134.4 41.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 113.482 -1.69 . . . . 0.0 111.626 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 1.083 ' CE1' HG23 ' A' ' 55' ' ' ILE . 6.7 t60 -64.11 -39.59 94.37 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.411 -1.722 . . . . 0.0 108.182 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.88 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -62.32 -22.01 65.72 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.189 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -64.64 -23.72 67.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.378 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.575 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -79.12 -45.77 19.35 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.816 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.88 HG23 ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -57.56 -45.6 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.874 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.6 t -60.3 -37.74 81.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.929 HG21 HD21 ' A' ' 86' ' ' LEU . 2.7 mt -69.85 -46.61 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.462 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.768 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 1.4 pp -76.12 -31.07 58.47 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.006 0.431 . . . . 0.0 111.642 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.8 t -53.68 -50.14 66.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -114.08 14.19 18.26 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.768 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -49.27 -86.49 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.87 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.411 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 4.7 ttt180 -151.63 176.55 11.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.6 -23.49 68.82 Favored Glycine 0 CA--C 1.504 -0.635 0 C-N-CA 119.528 -1.32 . . . . 0.0 112.428 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 20.7 mt-10 -104.09 117.52 34.47 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.267 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.677 HD12 ' OE1' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -98.43 116.72 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.926 0 CA-C-O 122.802 1.287 . . . . 0.0 107.565 178.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.714 ' HB3' ' HA ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -96.09 140.11 31.28 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 112.813 -1.994 . . . . 0.0 108.739 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 12.2 m-85 -124.71 118.03 25.53 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.603 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.799 ' OE2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -105.11 116.71 32.4 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 176.499 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 6.1 m -121.94 156.36 26.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -176.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.669 ' HB ' ' HB3' ' A' ' 77' ' ' ALA . 18.8 t -117.9 116.15 50.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.941 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -81.76 125.66 30.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.077 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 117' ' ' ASP . . . . . 0.778 ' OD1' ' NE2' ' A' ' 51' ' ' HIS . 80.4 m-20 . . . . . 0 N--CA 1.472 0.657 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.64 ' HB ' ' CD2' ' A' ' 91' ' ' HIS . 7.1 m -155.65 156.51 35.12 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' ARG . . . . . 1.028 ' NH2' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -136.74 125.62 24.16 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.892 178.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.897 HD23 HD13 ' A' ' 41' ' ' LEU . 3.7 mp . . . . . 0 C--O 1.255 1.392 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.965 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.421 ' CG1' ' HB3' ' A' ' 108' ' ' GLU . 0.6 OUTLIER -78.92 138.8 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-O 122.098 0.951 . . . . 0.0 111.903 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.663 ' HB2' HG22 ' A' ' 109' ' ' VAL . 13.6 mtt-85 -138.34 116.64 11.91 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.319 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.6 OUTLIER -96.65 119.86 35.91 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.567 1.175 . . . . 0.0 113.171 -178.135 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.776 HG12 ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -117.64 117.95 56.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 112.533 -2.121 . . . . 0.0 108.303 177.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mp -95.3 110.21 22.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.106 0.479 . . . . 0.0 111.483 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.834 HD12 ' HB2' ' A' ' 69' ' ' CYS . 1.2 tt -113.52 112.29 23.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.641 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 34' ' ' LEU . 3.9 mp -117.13 101.58 8.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.727 0.775 . . . . 0.0 111.614 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.38 130.86 45.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.538 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 38' ' ' HIS . 55.3 mt-10 -137.97 160.27 39.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.803 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 38' ' ' HIS . 0.8 OUTLIER 59.59 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.531 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 58.2 m-70 -34.47 -55.63 0.53 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.643 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 4.9 tp10 94.54 172.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.92 163.83 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.1 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.044 HD22 HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -105.7 -82.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.749 0.309 . . . . 0.0 111.364 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.44 22.86 1.04 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.044 HG22 HD22 ' A' ' 41' ' ' LEU . 13.5 tt -135.18 158.27 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 C-N-CA 122.79 0.436 . . . . 0.0 109.849 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.516 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 41.1 t -130.74 146.19 52.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.988 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.569 ' O ' ' CD2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -139.88 159.09 26.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 CA-C-O 122.189 0.995 . . . . 0.0 112.634 -179.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.855 ' HA ' ' HD2' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -161.74 137.27 7.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.748 178.106 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.836 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 151.4 168.96 16.48 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.492 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 141.03 -164.62 26.44 Favored Glycine 0 C--N 1.304 -1.238 0 CA-C-N 114.367 -0.917 . . . . 0.0 112.125 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -76.89 -17.44 58.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 0.0 110.041 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.447 ' OE2' HG11 ' B' ' 115' ' ' VAL . 2.7 tt0 -71.94 -42.7 66.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.947 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.749 ' NE2' ' OD1' ' B' ' 117' ' ' ASP . 21.3 m-70 -99.62 12.01 37.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.41 0.624 . . . . 0.0 110.178 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.93 23.9 40.12 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.75 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -131.83 173.63 5.65 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 121.923 0.868 . . . . 0.0 113.079 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.908 ' O ' HG23 ' A' ' 53' ' ' VAL . 4.4 Cg_exo -87.2 160.45 8.47 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.644 3.563 . . . . 0.0 108.256 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.011 HD11 ' HA ' ' A' ' 91' ' ' HIS . 25.2 mm -73.2 99.87 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.188 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 54' ' ' PRO . 6.9 mp -104.38 141.4 36.4 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.793 HD11 HG12 ' A' ' 78' ' ' ILE . 4.6 mp -71.12 129.3 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.198 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.63 -18.71 3.86 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 1.3 tt0 -137.27 115.88 12.07 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.737 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.749 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 2.8 mm -129.03 108.78 17.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.143 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.924 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 65.3 m-70 -70.0 137.15 87.23 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.089 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.44 145.15 80.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.212 1.941 . . . . 0.0 111.307 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.66 6.27 4.71 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.745 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 1.136 ' O ' ' N ' ' A' ' 66' ' ' ALA . 1.9 mp0 -96.85 167.1 12.67 Favored Pre-proline 0 N--CA 1.429 -1.495 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.94 ' CG ' HD23 ' A' ' 41' ' ' LEU . 10.8 Cg_exo -11.7 -9.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 124.745 3.63 . . . . 0.0 116.079 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.136 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.4 -35.69 21.17 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.44 -5.47 20.31 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.082 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.513 ' HG2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -93.05 -26.48 17.47 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.339 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.834 ' HB2' HD12 ' A' ' 33' ' ' LEU . 41.6 t -106.79 6.13 29.24 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 45.05 14.22 0.04 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.075 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.733 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -144.9 7.03 1.64 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 119.605 -1.283 . . . . 0.0 114.86 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.892 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 8.2 mt -97.18 151.09 20.16 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 118.216 1.008 . . . . 0.0 109.428 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.92 130.76 0.06 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.268 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 57' ' ' ILE . 2.1 p -58.92 159.12 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.638 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 106.91 -23.98 26.34 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.724 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.88 149.65 22.54 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.676 0.75 . . . . 0.0 110.022 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.86 ' HB3' HG23 ' A' ' 110' ' ' VAL . . . -89.3 131.84 35.2 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.52 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.03 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -104.3 138.35 29.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.276 -178.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.092 ' HA ' HD12 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -148.22 -2.96 0.51 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.818 -177.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.038 ' CB ' ' HA ' ' A' ' 84' ' ' VAL . . . -157.2 138.05 13.32 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.865 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 21.5 t -140.28 143.85 28.78 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.11 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.597 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 6.2 p-10 46.09 26.21 0.4 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.372 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.401 ' C ' ' CG1' ' A' ' 84' ' ' VAL . . . 128.05 44.86 0.21 Allowed Glycine 0 N--CA 1.464 0.525 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.38 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.038 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 1.5 p 43.37 77.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.452 1.101 . . . . 0.0 112.242 -177.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.66 ' H ' ' H ' ' A' ' 81' ' ' VAL . 19.8 m120 -130.98 92.76 3.27 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.092 HD12 ' HA ' ' A' ' 79' ' ' LEU . 2.0 mt -123.16 92.19 3.64 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 171.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.524 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -65.07 141.17 58.83 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.531 -176.589 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.16 96.33 10.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.084 -1.416 . . . . 0.0 114.475 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 1.025 ' CG2' ' OE1' ' B' ' 116' ' ' GLN . 0.9 OUTLIER -157.6 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 112.601 -2.09 . . . . 0.0 105.828 174.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.869 ' H ' HG22 ' A' ' 89' ' ' THR . 25.2 mttm -132.48 168.28 18.47 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 1.011 ' HA ' HD11 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -47.36 -34.7 7.24 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.358 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.865 ' HB2' ' CG ' ' B' ' 116' ' ' GLN . 0.0 OUTLIER -58.43 -15.49 11.02 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.577 -177.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.778 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 9.6 mm-40 -64.16 -23.29 67.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.759 ' HB2' HD22 ' A' ' 86' ' ' LEU . . . -86.89 -39.42 15.81 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.895 HG22 HG21 ' B' ' 118' ' ' THR . 4.4 t -58.01 -46.02 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -61.95 -37.0 83.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.429 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -69.85 -47.15 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.746 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 1.078 HD22 HD21 ' B' ' 120' ' ' LEU . 2.7 pp -76.74 -35.99 57.42 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.463 ' N ' HD12 ' A' ' 98' ' ' LEU . 17.3 t -61.03 -54.23 47.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 101' ' ' GLN . 7.1 mm100 -85.12 -16.98 38.7 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.897 ' NE2' HD13 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -54.63 -112.23 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.576 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.436 ' O ' ' NE2' ' A' ' 101' ' ' GLN . 1.0 OUTLIER -147.47 177.32 9.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.99 -4.42 7.47 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.449 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.529 ' O ' ' NE2' ' A' ' 101' ' ' GLN . 32.1 tt0 -103.17 116.73 33.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.548 0.69 . . . . 0.0 111.306 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.897 HD13 ' NE2' ' A' ' 101' ' ' GLN . 26.1 mm -103.22 112.45 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.865 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -95.28 122.54 38.08 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.701 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 44.0 m-85 -109.99 117.81 34.76 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.702 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.633 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 1.3 mt-10 -108.66 115.85 30.88 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.663 HG22 ' HB2' ' A' ' 29' ' ' ARG . 10.4 m -121.68 147.89 25.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 114.562 -1.199 . . . . 0.0 114.192 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.975 HG22 HD21 ' A' ' 79' ' ' LEU . 27.6 m -117.4 152.1 19.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 113.649 -1.614 . . . . 0.0 111.342 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -82.19 126.75 32.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' A' ' 77' ' ' ALA . 21.9 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.781 0.324 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -100.33 -34.15 10.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.447 HG11 ' OE2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -63.32 -76.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.583 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLN . . . . . 1.025 ' OE1' ' CG2' ' A' ' 89' ' ' THR . 0.0 OUTLIER -175.92 -23.97 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ASP . . . . . 0.749 ' OD1' ' NE2' ' A' ' 51' ' ' HIS . 8.4 m-20 -54.0 176.13 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 118.819 -0.61 . . . . 0.0 109.616 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.952 ' HB ' ' CE1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -167.66 166.59 13.84 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -178.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ARG . . . . . 0.924 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -131.86 123.63 27.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.071 -1.877 . . . . 0.0 108.663 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 1.078 HD21 HD22 ' A' ' 98' ' ' LEU . 1.1 mp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.92 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 tt -80.19 138.71 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 122.024 0.916 . . . . 0.0 112.047 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.45 ' CB ' HG22 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -136.33 121.74 19.38 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.688 -1.597 . . . . 0.0 109.948 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -104.49 119.4 38.89 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.273 1.035 . . . . 0.0 112.475 -178.647 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.656 HG11 ' C ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.53 117.84 55.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 113.311 -1.768 . . . . 0.0 108.38 177.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mp -96.24 113.8 25.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.099 0.476 . . . . 0.0 111.438 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.755 HD12 ' HB2' ' A' ' 69' ' ' CYS . 2.2 tt -113.07 109.22 18.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HG ' ' CB ' ' A' ' 104' ' ' GLU . 3.1 mp -116.02 104.73 11.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.922 0.868 . . . . 0.0 110.961 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.76 161.32 13.71 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.704 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.97 136.17 33.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.626 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 47.7 25.3 0.67 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.516 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.42 ' O ' ' N ' ' A' ' 40' ' ' GLY . 1.3 m-70 46.26 29.57 0.86 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.197 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.9 81.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.816 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' HIS . . . 55.61 170.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.382 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.114 HD22 HG22 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -108.59 -76.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.699 0.749 . . . . 0.0 111.38 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 121.64 23.88 2.47 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.114 HG22 HD22 ' A' ' 41' ' ' LEU . 14.9 tt -135.5 158.31 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -130.88 148.07 52.6 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.498 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.622 HD11 HD11 ' B' ' 120' ' ' LEU . 0.8 OUTLIER -135.0 159.01 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.265 -178.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.501 ' N ' ' HE1' ' A' ' 91' ' ' HIS . 67.5 p -156.22 137.33 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.36 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.813 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 151.85 169.1 16.96 Favored Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.314 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 144.73 -166.75 27.31 Favored Glycine 0 C--N 1.303 -1.297 0 CA-C-N 114.567 -0.816 . . . . 0.0 111.449 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.405 ' CB ' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -76.72 -14.76 59.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.983 0.392 . . . . 0.0 110.95 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.581 ' HB3' ' HB2' ' B' ' 116' ' ' GLN . 1.5 tp10 -75.53 -41.41 55.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 110.27 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.499 ' NE2' ' O ' ' B' ' 115' ' ' VAL . 13.9 m-70 -98.9 11.32 39.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.519 0.676 . . . . 0.0 110.161 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.18 23.24 32.18 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.565 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 54' ' ' PRO . 1.1 m -128.19 170.94 9.33 Favored Pre-proline 0 CA--C 1.512 -0.496 0 CA-C-O 121.959 0.885 . . . . 0.0 113.014 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.919 ' O ' HG23 ' A' ' 53' ' ' VAL . 7.5 Cg_exo -83.09 173.72 9.82 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.579 3.519 . . . . 0.0 108.132 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.013 HG23 ' CE1' ' A' ' 91' ' ' HIS . 39.4 mm -72.76 107.71 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.524 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.86 145.83 34.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -177.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.871 HD11 HG12 ' A' ' 78' ' ' ILE . 3.8 mp -71.87 130.73 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.532 ' HA ' HG23 ' A' ' 74' ' ' VAL . 11.8 t -132.18 -22.45 2.27 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 44' ' ' SER . 0.2 OUTLIER -137.4 115.84 11.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.252 0.548 . . . . 0.0 110.21 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.883 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 3.4 mm -125.43 107.06 17.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.72 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.984 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 39.2 m-70 -71.41 137.04 83.72 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.39 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.43 141.36 89.77 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.157 1.905 . . . . 0.0 111.227 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.33 0.92 8.62 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.609 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 1.112 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -96.43 167.36 12.42 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.896 ' HG3' HD23 ' A' ' 41' ' ' LEU . 6.2 Cg_exo -10.92 -9.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 125.075 3.85 . . . . 0.0 116.216 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.112 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.02 -35.83 21.67 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -102.14 -8.7 21.14 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.494 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 10.4 mmt180 -92.69 -26.44 17.79 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.439 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.755 ' HB2' HD12 ' A' ' 33' ' ' LEU . 42.9 t -107.6 6.14 27.62 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 44.58 13.68 0.03 OUTLIER Glycine 0 C--N 1.336 0.557 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.35 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.656 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -149.63 12.25 1.0 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 119.431 -1.366 . . . . 0.0 115.152 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.79 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 10.0 mt -99.04 150.53 21.9 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 118.223 1.012 . . . . 0.0 110.159 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.1 t60 174.52 145.36 0.06 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.997 0.903 . . . . 0.0 111.611 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.584 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 7.3 p -65.4 147.49 12.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.951 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.79 -17.77 24.98 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.024 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -92.52 149.46 21.36 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.588 0.709 . . . . 0.0 110.324 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.999 ' HB3' HG23 ' A' ' 110' ' ' VAL . . . -89.68 134.39 34.18 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.501 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.871 HG12 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -105.82 119.99 55.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.628 0.728 . . . . 0.0 111.608 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.007 HD21 HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -96.16 -41.57 8.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.297 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.864 ' HB1' ' O ' ' A' ' 84' ' ' VAL . . . -162.61 176.94 9.85 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.919 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -140.95 154.89 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.604 178.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.792 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.0 p-10 59.33 7.55 0.95 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.69 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.11 10.1 49.81 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.698 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.864 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 21.3 t -120.71 125.5 74.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.855 0.327 . . . . 0.0 110.769 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.743 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 14.6 p-10 -61.79 125.3 23.34 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.042 0.449 . . . . 0.0 109.945 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.032 HD21 HG21 ' A' ' 97' ' ' ILE . 4.0 mp -106.8 86.34 2.31 Favored 'General case' 0 N--CA 1.413 -2.278 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.004 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -83.58 96.67 8.71 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . 65.7 m-20 -132.61 99.31 4.6 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.675 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.835 ' O ' ' HG2' ' B' ' 116' ' ' GLN . 0.1 OUTLIER -56.42 -45.38 80.75 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' B' ' 116' ' ' GLN . 0.0 OUTLIER -73.91 128.75 36.35 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 1.013 ' CE1' HG23 ' A' ' 55' ' ' ILE . 5.5 t60 -65.44 -40.32 93.14 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.063 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 1.06 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 1.3 mmtm -62.71 -22.35 66.45 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.856 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -65.27 -24.18 67.24 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.986 -0.685 . . . . 0.0 109.55 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.535 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -81.92 -45.09 15.92 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.262 0.553 . . . . 0.0 110.068 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.933 HG22 HG21 ' B' ' 118' ' ' THR . 2.0 t -57.31 -41.71 78.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.328 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -62.88 -38.6 91.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.003 0.906 . . . . 0.0 108.567 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.032 HG21 HD21 ' A' ' 86' ' ' LEU . 2.1 mm -69.87 -46.75 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.534 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.852 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 2.0 pp -75.21 -31.42 60.9 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.935 0.398 . . . . 0.0 111.756 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.418 ' N ' HD12 ' A' ' 98' ' ' LEU . 35.1 t -57.13 -53.72 54.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.79 2.85 30.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.852 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -50.64 -93.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.812 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.431 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -151.31 173.66 14.23 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.78 -12.14 58.98 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 119.594 -1.288 . . . . 0.0 112.881 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.452 ' CB ' ' HG ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -103.62 117.86 35.39 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.341 0.591 . . . . 0.0 111.777 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.745 HG13 HD11 ' A' ' 41' ' ' LEU . 20.2 mm -100.14 111.88 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.919 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -95.27 118.6 32.32 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.631 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 38.8 m-85 -102.49 117.57 34.98 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.532 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.643 ' CD ' ' HB3' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -103.0 115.45 30.63 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 175.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 6.9 m -124.34 156.99 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -175.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.007 HG22 HD21 ' A' ' 79' ' ' LEU . 1.8 m -128.37 152.24 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.247 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -89.0 118.53 28.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.112 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.767 0.318 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.489 ' O ' HG12 ' B' ' 115' ' ' VAL . 0.4 OUTLIER -179.58 -47.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.759 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.629 HG22 ' O ' ' B' ' 115' ' ' VAL . 13.1 p 45.12 27.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.843 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLN . . . . . 0.835 ' HG2' ' O ' ' A' ' 89' ' ' THR . 0.0 OUTLIER 22.57 89.55 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 178.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ASP . . . . . 0.423 ' OD2' ' CE1' ' A' ' 51' ' ' HIS . 69.5 m-20 -165.29 160.72 18.59 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.342 0.657 . . . . 0.0 109.677 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' THR . . . . . 1.06 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 2.9 m -166.02 162.1 17.74 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ARG . . . . . 0.984 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -135.1 129.25 33.65 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.102 178.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.801 HD21 HD22 ' A' ' 98' ' ' LEU . 2.8 mp . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.705 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.78 138.6 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 122.027 0.918 . . . . 0.0 112.019 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -139.59 118.72 12.68 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 113.652 -1.613 . . . . 0.0 110.35 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -100.34 119.49 38.51 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 122.307 1.051 . . . . 0.0 112.941 -178.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -115.62 118.05 57.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 113.308 -1.769 . . . . 0.0 107.924 176.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.24 115.82 28.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.975 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -113.72 124.33 52.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.861 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 4.8 mp -117.22 102.02 8.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.746 0.784 . . . . 0.0 111.742 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.19 161.2 13.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.3 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -137.96 148.19 45.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.027 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.432 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 13.1 t0 59.07 27.21 16.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.096 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.432 ' CG ' ' O ' ' A' ' 37' ' ' ASP . 21.0 p80 43.18 39.13 1.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.415 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.25 -21.27 47.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.92 178.81 16.41 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.532 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.779 HD22 HD22 ' B' ' 120' ' ' LEU . 1.2 tp -117.81 -19.07 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.116 0.458 . . . . 0.0 111.361 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.543 ' HA2' ' ND1' ' A' ' 61' ' ' HIS . . . 57.68 32.53 65.49 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.089 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.815 HG23 HD13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.14 157.52 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.474 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 5.4 t -130.87 147.87 52.57 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.465 0.65 . . . . 0.0 110.657 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.794 HG13 ' HB ' ' B' ' 118' ' ' THR . 0.5 OUTLIER -137.86 157.75 32.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.934 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.409 ' N ' ' NE2' ' A' ' 91' ' ' HIS . 21.9 p -160.94 152.36 19.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.482 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.767 ' CA ' HG22 ' A' ' 53' ' ' VAL . . . 139.16 -168.82 24.72 Favored Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.721 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 130.65 -169.03 21.54 Favored Glycine 0 C--N 1.3 -1.442 0 CA-C-N 114.098 -1.051 . . . . 0.0 113.199 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.42 -16.92 58.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.758 ' OE2' HG12 ' B' ' 115' ' ' VAL . 12.5 pt-20 -84.46 -34.42 23.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.973 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.675 ' O ' HG13 ' A' ' 53' ' ' VAL . 27.1 m-70 -95.71 9.72 39.39 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.492 0.663 . . . . 0.0 109.726 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.2 23.48 52.88 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.897 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -139.58 177.44 2.03 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-O 121.663 0.745 . . . . 0.0 112.862 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.834 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.8 Cg_exo -88.21 173.21 4.86 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 124.561 3.507 . . . . 0.0 109.012 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.914 HG23 ' NE2' ' A' ' 91' ' ' HIS . 32.5 mm -72.44 99.15 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.95 139.1 41.02 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.86 HD11 HG12 ' A' ' 78' ' ' ILE . 3.3 mp -71.82 129.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.431 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 p -137.02 -13.85 1.6 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.781 ' OE1' ' NH1' ' B' ' 119' ' ' ARG . 0.4 OUTLIER -137.13 116.1 12.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.371 0.605 . . . . 0.0 110.532 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.843 HG23 ' CB ' ' A' ' 66' ' ' ALA . 3.0 mm -117.76 109.72 28.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.308 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.99 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 7.4 m170 -71.53 136.56 83.52 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.829 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -53.08 139.67 61.53 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.836 1.691 . . . . 0.0 113.071 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.76 25.14 0.19 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 114.635 -1.166 . . . . 0.0 114.308 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 1.084 ' O ' ' N ' ' A' ' 66' ' ' ALA . 10.0 mm-40 -94.97 165.41 17.08 Favored Pre-proline 0 N--CA 1.419 -1.977 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.874 ' HB3' HD21 ' A' ' 33' ' ' LEU . 37.2 Cg_exo -30.54 2.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.273 1.982 . . . . 0.0 113.593 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.084 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.29 -36.41 19.35 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -101.8 -12.92 17.94 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.37 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -26.13 36.94 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.006 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.975 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -90.63 -5.03 56.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.68 8.77 0.39 Allowed Glycine 0 CA--C 1.519 0.33 0 CA-C-N 114.945 -1.025 . . . . 0.0 113.128 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.533 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -129.9 -1.66 5.37 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.691 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.907 HD11 HD13 ' A' ' 33' ' ' LEU . 4.1 mt -94.81 151.37 19.3 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 121.785 0.802 . . . . 0.0 111.518 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.4 t60 176.73 139.43 0.07 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.468 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 57' ' ' ILE . 2.9 p -66.89 147.46 12.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 113.829 -1.532 . . . . 0.0 112.3 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.22 -21.1 10.25 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.539 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.655 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -89.17 150.67 22.58 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.577 0.703 . . . . 0.0 109.677 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 110' ' ' VAL . . . -88.59 130.76 35.19 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.179 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.898 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -106.62 122.77 60.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.703 0.763 . . . . 0.0 110.939 -178.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 79' ' ' LEU . 5.2 tt -101.39 -50.63 3.7 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.217 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.949 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -148.67 176.77 10.07 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.891 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -138.88 153.22 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.691 177.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.627 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 0.0 OUTLIER 73.99 -18.1 0.42 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.532 -179.093 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 81' ' ' VAL . . . 118.98 9.59 8.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.752 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.913 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 20.4 t -127.96 133.03 68.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.949 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 8.2 p30 -61.09 131.87 51.96 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.775 HD23 HD13 ' A' ' 97' ' ' ILE . 5.4 mp -102.92 85.95 2.63 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 118.161 -1.415 . . . . 0.0 111.411 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.13 94.87 7.78 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 172.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.64 ' HB2' ' HB3' ' A' ' 93' ' ' GLU . 19.6 m-20 -134.3 97.52 3.86 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.511 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.783 ' OG1' ' OE1' ' B' ' 116' ' ' GLN . 0.3 OUTLIER 46.19 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.087 0.946 . . . . 0.0 109.515 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.773 ' HB2' ' CB ' ' B' ' 116' ' ' GLN . 0.5 OUTLIER -126.97 168.04 15.07 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.132 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.935 ' HE1' ' HB ' ' B' ' 118' ' ' THR . 3.0 t-80 -46.06 -36.74 6.0 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 113.339 -1.755 . . . . 0.0 113.353 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.753 ' HB2' ' CG ' ' B' ' 116' ' ' GLN . 0.0 OUTLIER -61.0 -23.89 65.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -64.3 -22.34 66.92 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.45 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -71.17 -46.81 60.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.001 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.084 HG22 ' OG1' ' B' ' 118' ' ' THR . 0.0 OUTLIER -59.84 -47.32 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.668 0.747 . . . . 0.0 109.68 178.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 93' ' ' GLU . 1.2 t -62.74 -36.12 81.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.898 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.775 HD13 HD23 ' A' ' 86' ' ' LEU . 1.4 mt -65.07 -47.23 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.764 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.948 HD22 HD21 ' B' ' 120' ' ' LEU . 0.9 OUTLIER -76.35 -40.53 50.97 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.776 0.322 . . . . 0.0 110.869 179.154 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.509 ' N ' HD12 ' A' ' 98' ' ' LEU . 75.3 m -55.75 -28.34 55.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.202 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -91.54 30.94 1.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER 178.1 151.62 0.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.875 0.369 . . . . 0.0 111.293 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.2 ptt-85 -126.04 160.91 28.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.41 -151.54 21.18 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.156 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 9.3 pt-20 -85.15 117.94 24.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.79 0.805 . . . . 0.0 111.901 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.635 HG12 HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.56 121.7 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.516 0 CA-C-O 122.734 1.254 . . . . 0.0 107.814 177.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.891 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -93.5 127.71 39.27 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.3 -2.227 . . . . 0.0 108.645 -178.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.582 ' HD2' HD11 ' A' ' 78' ' ' ILE . 17.7 m-85 -104.32 117.62 34.64 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.024 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.714 ' CD ' ' HB3' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -107.67 116.26 31.63 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 7.6 m -122.13 154.77 26.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.59 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 15.7 t -118.42 132.36 68.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.918 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -81.68 107.81 14.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.105 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.814 0.34 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 60.22 -176.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.758 HG12 ' OE2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -74.0 -167.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.613 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLN . . . . . 0.783 ' OE1' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -155.71 121.01 4.86 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.005 0.431 . . . . 0.0 111.727 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ASP . . . . . 0.568 ' OD2' ' CE1' ' A' ' 51' ' ' HIS . 6.4 m-20 -158.9 -173.19 4.13 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.446 0.698 . . . . 0.0 109.278 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' THR . . . . . 1.084 ' OG1' HG22 ' A' ' 95' ' ' VAL . 91.5 m -147.2 146.6 29.89 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ARG . . . . . 0.99 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -142.87 109.35 5.36 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.523 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.948 HD21 HD22 ' A' ' 98' ' ' LEU . 1.2 mp . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.852 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 tp -82.19 138.37 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 122.124 0.964 . . . . 0.0 112.105 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.546 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 5.8 mtt180 -140.22 116.9 10.88 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.928 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.47 119.42 37.98 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 122.332 1.063 . . . . 0.0 112.75 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.978 HG12 ' O ' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -109.96 116.89 53.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 112.966 -1.924 . . . . 0.0 107.05 176.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.14 114.36 27.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.285 0.564 . . . . 0.0 111.816 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.885 HD13 ' HB3' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -113.16 119.04 36.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.316 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 34' ' ' LEU . 4.4 mp -110.96 101.66 10.2 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.804 0.811 . . . . 0.0 110.848 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.57 134.43 42.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.812 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 38' ' ' HIS . 15.2 mt-10 -138.84 138.08 37.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.995 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 38' ' ' HIS . 3.6 m-20 60.93 -79.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.258 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.558 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 60.0 m80 -15.47 -63.97 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.952 0.501 . . . . 0.0 112.34 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.558 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 6.0 tt0 96.82 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.656 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 48.79 -174.09 0.04 OUTLIER Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.608 -0.805 . . . . 0.0 111.935 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.666 HD11 HG13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -125.37 -67.26 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.27 0.535 . . . . 0.0 111.416 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 64' ' ' GLN . . . 112.51 20.07 6.73 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.647 HG22 HD23 ' A' ' 41' ' ' LEU . 20.2 tt -125.18 160.52 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.149 0 CA-C-O 121.144 0.497 . . . . 0.0 110.458 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.42 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 3.2 t -128.26 146.92 50.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.693 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.048 HD11 HD11 ' B' ' 120' ' ' LEU . 0.6 OUTLIER -138.69 160.37 30.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.098 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.453 ' N ' ' CE1' ' A' ' 91' ' ' HIS . 66.7 p -158.75 138.77 12.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.27 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.548 ' N ' ' HD1' ' A' ' 91' ' ' HIS . . . 163.26 -141.0 6.83 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 140.96 160.98 8.51 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.15 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.515 ' CB ' ' HA ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -80.35 -16.75 53.83 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.402 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.643 ' HB3' HG11 ' B' ' 115' ' ' VAL . 1.3 pt-20 -70.06 -35.81 74.53 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.394 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 1.043 ' NE2' ' OE1' ' B' ' 116' ' ' GLN . 21.3 m-70 -97.37 15.1 23.99 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.533 0.682 . . . . 0.0 109.833 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.73 18.34 31.34 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.554 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 54' ' ' PRO . 1.9 m -103.58 154.05 38.16 Favored Pre-proline 0 CA--C 1.513 -0.456 0 CA-C-O 122.02 0.914 . . . . 0.0 113.249 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.825 ' O ' HG23 ' A' ' 53' ' ' VAL . 22.4 Cg_exo -77.41 -172.49 1.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 124.551 3.5 . . . . 0.0 109.424 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.04 HG23 ' CE1' ' A' ' 91' ' ' HIS . 50.4 mm -84.64 120.38 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.599 HD21 ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -105.73 126.53 52.26 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.231 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.844 HD12 HG22 ' A' ' 78' ' ' ILE . 3.2 mt -70.34 131.44 34.26 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.594 ' HA ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -140.17 -15.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.77 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.896 ' OE1' ' NH1' ' B' ' 119' ' ' ARG . 1.7 tt0 -137.57 116.14 12.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.092 0.472 . . . . 0.0 111.087 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.666 HG23 ' CD ' ' A' ' 64' ' ' GLN . 3.2 mm -116.19 106.09 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.708 0.766 . . . . 0.0 111.118 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.909 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 2.9 m170 -73.28 118.75 71.37 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.974 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 61' ' ' HIS . 3.2 Cg_endo -45.77 114.0 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.748 1.632 . . . . 0.0 110.836 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' HA2' ' CB ' ' A' ' 67' ' ' ASP . . . 105.97 1.43 39.15 Favored Glycine 0 N--CA 1.422 -2.266 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.804 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 1.154 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -94.41 166.55 15.14 Favored Pre-proline 0 CA--C 1.492 -1.266 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.969 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 69.4 Cg_exo -12.46 -9.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 124.969 3.779 . . . . 0.0 115.739 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.154 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.35 -35.98 19.51 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.491 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . 4.7 t70 -91.2 -12.5 35.17 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.505 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.969 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 3.7 mtt-85 -77.48 1.05 20.47 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.305 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 4.0 t 77.76 -17.28 0.58 Allowed 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.978 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -43.79 -31.78 1.97 Allowed Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.029 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.696 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 86.34 29.89 23.64 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.176 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.693 HD12 ' CB ' ' A' ' 65' ' ' PRO . 1.6 mt -90.82 151.76 21.04 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 122.255 1.026 . . . . 0.0 112.142 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.647 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.9 t60 179.85 146.96 0.24 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.33 -1.759 . . . . 0.0 111.319 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.647 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 12.0 p -67.43 158.97 5.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.607 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.547 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 102.95 -19.18 47.57 Favored Glycine 0 C--N 1.316 -0.552 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.546 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.16 149.64 21.77 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.385 0.612 . . . . 0.0 109.989 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.507 ' HA ' HD13 ' A' ' 56' ' ' LEU . . . -89.15 129.37 35.76 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.684 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.849 HG23 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.15 113.82 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.527 0.679 . . . . 0.0 112.279 -177.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.004 HD21 HG23 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -89.64 -41.35 12.01 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.991 -178.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.944 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -162.67 177.53 9.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -175.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.045 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -133.71 154.49 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.367 178.367 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.723 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.1 p-10 57.56 7.41 0.52 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.537 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.06 13.36 39.81 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.829 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.866 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 20.7 t -123.86 118.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.976 0.388 . . . . 0.0 111.511 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.944 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 2.7 m120 -61.33 124.7 21.33 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.884 HD21 HG21 ' A' ' 97' ' ' ILE . 4.6 mp -106.41 86.36 2.34 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.439 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -102.74 94.66 5.73 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 90' ' ' LYS . 1.1 m-20 -134.04 94.39 3.24 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.686 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 1.083 ' OG1' ' CG2' ' B' ' 115' ' ' VAL . 0.1 OUTLIER 14.72 -80.35 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 124.444 1.09 . . . . 0.0 111.92 178.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.756 ' HB3' ' HA ' ' B' ' 115' ' ' VAL . 0.0 OUTLIER -75.09 136.39 41.15 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 113.611 -1.631 . . . . 0.0 112.038 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 1.04 ' CE1' HG23 ' A' ' 55' ' ' ILE . 7.6 t60 -60.8 -36.31 78.7 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.657 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 1.008 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 1.7 mmtm -61.92 -22.6 65.73 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.267 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.492 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -64.97 -25.39 67.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.569 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -84.03 -44.16 14.4 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.746 HG23 ' CG2' ' B' ' 118' ' ' THR . 0.4 OUTLIER -57.2 -45.51 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.858 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.463 ' N ' ' CG1' ' A' ' 95' ' ' VAL . 14.6 t -61.42 -36.39 80.21 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.884 HG21 HD21 ' A' ' 86' ' ' LEU . 1.1 mt -69.49 -46.57 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.956 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.893 HD13 ' CD2' ' B' ' 120' ' ' LEU . 0.9 OUTLIER -75.22 -35.04 61.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.652 0.263 . . . . 0.0 111.161 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 93.5 p -57.31 -57.29 13.28 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.138 0.494 . . . . 0.0 110.439 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -66.26 -32.8 74.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.12 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 3.5 mm-40 -51.0 149.61 3.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.512 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.57 169.65 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.47 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.41 -132.13 12.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.453 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 1.1 pt-20 -84.73 126.46 33.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.666 HG13 HD11 ' A' ' 41' ' ' LEU . 20.7 mm -97.09 112.8 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 1.045 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -94.47 121.37 35.94 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.631 -179.324 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.565 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 34.5 m-85 -105.22 118.06 35.59 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.715 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.832 ' OE2' ' HB3' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -100.06 115.98 31.03 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 5.0 m -129.1 157.49 41.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.004 HG23 HD21 ' A' ' 79' ' ' LEU . 58.5 t -118.12 130.4 73.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.893 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -83.6 117.33 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.961 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.179 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.748 0.309 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 63.85 -77.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 1.083 ' CG2' ' OG1' ' A' ' 89' ' ' THR . 0.3 OUTLIER -156.94 28.17 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.906 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLN . . . . . 1.043 ' OE1' ' NE2' ' A' ' 51' ' ' HIS . 0.8 OUTLIER -167.97 164.6 13.8 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 6.6 t70 70.66 138.71 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.228 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' THR . . . . . 1.008 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -170.79 159.8 6.58 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ARG . . . . . 0.909 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -124.28 165.44 17.64 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.512 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 1.048 HD11 HD11 ' A' ' 45' ' ' ILE . 5.9 mp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.247 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 tp -79.41 138.77 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.044 0.926 . . . . 0.0 112.028 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.487 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.9 OUTLIER -140.13 120.37 13.86 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.958 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -102.31 119.82 39.45 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 122.192 0.996 . . . . 0.0 112.661 -178.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.78 HG12 ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -113.58 117.94 56.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 113.342 -1.754 . . . . 0.0 108.673 177.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.3 112.0 23.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.41 0.624 . . . . 0.0 111.659 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.048 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.5 OUTLIER -114.42 115.42 27.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.02 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -116.69 100.59 7.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.004 0.907 . . . . 0.0 109.923 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -100.78 161.81 13.34 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.474 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -86.31 160.75 19.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.475 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -41.09 -26.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 1.3 t-160 -40.61 -57.1 1.95 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 1.0 OUTLIER 101.57 160.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.468 0.707 . . . . 0.0 111.111 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.73 129.15 4.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.403 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.776 HD22 ' CG2' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -120.35 -9.67 9.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.787 0.327 . . . . 0.0 111.673 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA2' ' ND1' ' A' ' 61' ' ' HIS . . . 47.09 37.62 10.34 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.703 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.776 ' CG2' HD22 ' A' ' 41' ' ' LEU . 9.3 tt -135.05 158.59 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.517 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 6.8 t -130.03 147.88 51.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.768 0.794 . . . . 0.0 111.185 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.592 HG13 HG22 ' B' ' 118' ' ' THR . 1.2 pt -138.16 160.96 32.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.729 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.632 ' HA ' ' CD2' ' A' ' 91' ' ' HIS . 7.1 p -160.64 136.48 8.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.955 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.556 ' CA ' HG22 ' A' ' 53' ' ' VAL . . . 163.01 -141.4 7.13 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 53' ' ' VAL . . . 160.69 128.68 0.97 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.1 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -74.51 -10.79 59.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 109.942 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HG3' ' CD2' ' A' ' 51' ' ' HIS . 0.5 OUTLIER -102.65 -24.87 13.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.235 179.021 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 1.114 ' NE2' ' NE2' ' B' ' 116' ' ' GLN . 54.5 m-70 -91.61 21.3 4.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.436 0.636 . . . . 0.0 110.457 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.23 14.34 56.36 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.405 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -129.75 137.21 30.41 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.594 ' O ' HG23 ' A' ' 53' ' ' VAL . 77.7 Cg_exo -63.65 156.48 56.96 Favored 'Trans proline' 0 C--N 1.331 -0.357 0 C-N-CA 124.001 3.134 . . . . 0.0 111.069 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.945 ' HB ' HG22 ' A' ' 78' ' ' ILE . 24.9 mm -74.26 108.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.647 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 54' ' ' PRO . 8.0 mp -103.86 139.28 39.27 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.91 HD11 HG12 ' A' ' 78' ' ' ILE . 3.2 mp -72.01 131.62 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.017 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 m -136.79 -17.47 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.517 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 0.5 OUTLIER -137.27 116.11 12.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.234 0.54 . . . . 0.0 110.844 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.78 HG23 ' CB ' ' A' ' 66' ' ' ALA . 4.2 mm -116.53 111.69 36.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.245 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.773 ' CE1' ' NH1' ' B' ' 119' ' ' ARG . 7.6 m170 -70.89 136.73 85.15 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.873 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.37 138.99 81.34 Favored 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 122.246 1.964 . . . . 0.0 113.119 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 42.19 25.33 0.25 Allowed Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.704 -1.135 . . . . 0.0 113.975 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 1.085 ' O ' ' N ' ' A' ' 66' ' ' ALA . 14.5 mm-40 -95.21 165.34 17.06 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.626 ' HB2' HD23 ' A' ' 41' ' ' LEU . 49.1 Cg_exo -31.25 2.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.036 1.824 . . . . 0.0 113.255 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.085 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.15 -36.44 19.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -99.01 -13.95 19.67 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.346 177.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.541 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 29.6 mtp180 -76.19 -26.24 55.97 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.817 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 1.048 ' HB2' HD12 ' A' ' 33' ' ' LEU . 28.0 t -93.3 -1.78 55.66 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 48.85 11.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.985 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.73 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -136.75 5.61 3.73 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.489 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 6.3 mt -94.72 150.61 20.04 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 117.925 0.862 . . . . 0.0 109.357 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 179.6 133.22 0.1 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.627 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 75' ' ' GLY . 3.2 p -60.67 159.5 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.98 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.511 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 105.99 -24.5 26.47 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.709 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.542 ' O ' HD12 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -88.33 149.88 23.52 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.755 0.788 . . . . 0.0 109.874 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.852 ' HB2' HG13 ' A' ' 112' ' ' VAL . . . -88.68 133.6 34.16 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.562 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.945 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -102.97 145.3 12.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.497 -178.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.953 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -146.02 -20.13 0.45 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.168 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.012 ' HB1' ' N ' ' A' ' 85' ' ' ASN . . . -163.88 176.27 9.62 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.778 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -154.06 153.15 8.83 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.594 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 0.2 OUTLIER 77.95 -49.45 0.49 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.625 -1.625 . . . . 0.0 112.264 178.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' C ' ' CG1' ' A' ' 84' ' ' VAL . . . -154.78 32.61 0.68 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 84' ' ' VAL . 1.4 p 48.46 73.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 126.781 2.033 . . . . 0.0 113.177 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 1.012 ' N ' ' HB1' ' A' ' 80' ' ' ALA . 14.9 p-10 -136.35 97.28 3.54 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 113.27 -1.787 . . . . 0.0 112.68 172.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.953 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 7.1 mt -116.71 88.28 2.87 Favored 'General case' 0 CA--C 1.469 -2.139 0 CA-C-N 124.273 3.215 . . . . 0.0 108.549 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.51 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -112.55 92.73 4.12 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 173.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.682 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -137.65 93.13 2.76 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.369 178.094 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 1.03 ' OG1' ' CG1' ' B' ' 115' ' ' VAL . 1.0 OUTLIER 14.82 -124.89 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.295 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.684 ' N ' ' OG1' ' A' ' 89' ' ' THR . 3.5 mttp -75.29 168.56 19.76 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.968 ' CE1' ' HB ' ' B' ' 118' ' ' THR . 0.1 OUTLIER -44.61 -50.07 9.92 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -175.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.988 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 0.0 OUTLIER -60.77 -20.49 61.52 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.019 -176.331 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.682 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -65.86 -24.96 66.98 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.531 178.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.495 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -76.34 -38.61 55.68 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.92 HG23 ' HA ' ' A' ' 92' ' ' LYS . 1.4 t -61.9 -44.94 99.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.588 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.668 HG22 ' O ' ' A' ' 93' ' ' GLU . 5.3 t -61.55 -36.32 80.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -68.98 -46.63 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.825 179.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.694 ' CG ' ' HA ' ' A' ' 95' ' ' VAL . 2.6 pp -74.88 -33.15 62.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.789 0.328 . . . . 0.0 111.522 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.538 ' N ' HD12 ' A' ' 98' ' ' LEU . 29.6 t -57.41 -53.69 55.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.226 0.536 . . . . 0.0 110.719 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -69.9 -40.02 75.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.743 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.588 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -55.71 156.01 5.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.42 ' HA ' ' NE ' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -141.51 167.2 22.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.04 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.21 -130.65 10.32 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.463 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -98.2 128.76 44.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 122.169 0.985 . . . . 0.0 113.473 -178.236 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.607 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 30.8 mm -97.54 112.7 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.778 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -93.75 117.6 30.31 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 178.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 31.6 m-85 -99.25 118.61 36.32 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.616 -176.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.994 ' HG3' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -107.06 116.61 32.23 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.487 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 14.5 m -122.13 145.23 29.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.403 -0.919 . . . . 0.0 113.213 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.689 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 7.8 t -117.02 152.13 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.051 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -87.04 117.46 25.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.136 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.852 HG13 ' HB2' ' A' ' 77' ' ' ALA . 4.9 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.055 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.826 0.346 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.416 ' C ' ' CB ' ' A' ' 92' ' ' LYS . 21.1 tt0 -101.85 12.36 37.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.403 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 1.03 ' CG1' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -145.91 67.21 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.499 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLN . . . . . 1.114 ' NE2' ' NE2' ' A' ' 51' ' ' HIS . 0.2 OUTLIER 168.29 124.06 0.01 OUTLIER 'General case' 0 C--N 1.359 0.979 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ASP . . . . . 0.524 ' HA ' ' CD2' ' A' ' 91' ' ' HIS . 14.6 m-20 52.6 150.68 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.988 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -169.02 157.33 7.82 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ARG . . . . . 0.773 ' NH1' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -133.74 121.32 21.72 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.992 178.485 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.673 HD21 HD22 ' A' ' 98' ' ' LEU . 2.4 mp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.814 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.31 134.64 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 C-N-CA 122.86 0.464 . . . . 0.0 111.239 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -142.45 122.22 13.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.177 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -106.11 119.46 39.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.149 0.976 . . . . 0.0 112.682 -178.529 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.734 HG11 ' C ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.5 118.28 57.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.854 177.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -89.86 110.06 21.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.926 0.869 . . . . 0.0 112.739 -177.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.002 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -115.39 115.46 26.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.488 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.554 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -118.66 101.57 8.21 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.636 0.731 . . . . 0.0 110.672 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.28 161.31 13.69 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.435 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.65 119.44 26.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.966 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 51.91 -137.75 1.16 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.528 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.44 41.63 1.08 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.75 0.31 . . . . 0.0 110.926 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -56.37 -22.93 34.32 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.05 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.0 174.86 31.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.148 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.784 HD22 HG12 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -111.62 -26.78 8.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 110.684 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 61' ' ' HIS . . . 65.29 33.1 85.82 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.784 HG12 HD22 ' A' ' 41' ' ' LEU . 1.8 pt -135.41 157.87 40.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 59' ' ' GLU . 1.7 t -130.61 147.72 52.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.667 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.732 HG13 HG22 ' B' ' 118' ' ' THR . 2.9 pt -137.58 159.92 34.6 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.634 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.722 ' HA ' ' HD2' ' A' ' 91' ' ' HIS . 69.4 p -160.29 135.75 8.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.686 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.873 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 165.42 170.16 30.0 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 119.807 -1.187 . . . . 0.0 112.944 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 148.63 -177.6 26.76 Favored Glycine 0 C--N 1.303 -1.255 0 CA-C-N 114.156 -1.022 . . . . 0.0 113.305 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -15.26 58.37 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 11.1 pt-20 -82.86 -35.73 26.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.991 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.59 ' CE1' ' OD1' ' B' ' 117' ' ' ASP . 30.9 m-70 -94.59 8.9 40.72 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.501 0.667 . . . . 0.0 109.562 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.29 55.31 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.828 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 54' ' ' PRO . 1.6 m -138.99 172.67 6.18 Favored Pre-proline 0 CA--C 1.513 -0.479 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.895 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.0 Cg_exo -86.55 166.98 8.9 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 124.761 3.641 . . . . 0.0 108.272 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.918 ' HB ' HG22 ' A' ' 78' ' ' ILE . 13.4 mm -72.46 99.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 117.756 -1.578 . . . . 0.0 107.122 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.87 137.1 44.32 Favored 'General case' 0 N--CA 1.405 -2.686 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.877 HD11 HG12 ' A' ' 78' ' ' ILE . 3.1 mp -72.33 134.15 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.911 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -139.75 -12.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.535 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 1.0 OUTLIER -134.49 116.08 14.68 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.317 0.58 . . . . 0.0 110.994 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.723 HG23 ' CB ' ' A' ' 66' ' ' ALA . 3.3 mm -123.18 112.15 32.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.788 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.814 ' CE1' ' CZ ' ' B' ' 119' ' ' ARG . 5.3 m170 -71.88 136.62 82.56 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.267 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -57.6 142.63 95.7 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.839 1.693 . . . . 0.0 112.561 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 46.36 19.84 0.49 Allowed Glycine 0 N--CA 1.432 -1.57 0 CA-C-N 115.216 -0.902 . . . . 0.0 114.23 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 1.11 ' O ' ' N ' ' A' ' 66' ' ' ALA . 12.7 mm-40 -96.04 165.93 15.39 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.729 ' HB3' HD21 ' A' ' 33' ' ' LEU . 31.9 Cg_exo -28.31 2.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.421 2.081 . . . . 0.0 113.734 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.11 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.93 -36.32 19.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 64' ' ' GLN . 4.6 t0 -102.19 -13.1 17.57 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.265 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -26.46 43.95 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.911 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 1.002 ' HB2' HD12 ' A' ' 33' ' ' LEU . 8.6 t -95.08 -1.53 51.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 48.94 10.07 0.12 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.464 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.734 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -133.47 7.42 4.97 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.063 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.668 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 5.5 mt -97.65 154.66 17.41 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 121.433 0.635 . . . . 0.0 110.844 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.97 126.65 0.06 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.253 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 75' ' ' GLY . 2.3 p -60.42 159.39 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.355 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 108.9 -24.29 21.84 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.27 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.568 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -85.03 150.43 24.88 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.704 0.764 . . . . 0.0 109.226 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 110' ' ' VAL . . . -88.06 137.55 32.23 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.137 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.918 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -100.47 149.19 6.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.884 -178.063 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.471 ' HA ' HD22 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -137.6 -50.89 0.62 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.363 -178.661 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.928 ' HB1' ' O ' ' A' ' 84' ' ' VAL . . . -147.81 175.93 10.53 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.006 1.114 . . . . 0.0 114.006 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -143.06 154.58 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.157 178.437 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.833 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 1.9 p-10 63.13 5.14 1.8 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.987 -1.46 . . . . 0.0 112.462 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' N ' ' CD ' ' A' ' 106' ' ' GLU . . . 102.4 5.71 48.59 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.82 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.928 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 21.1 t -123.8 136.53 59.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 117.004 0.402 . . . . 0.0 111.319 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.761 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 38.3 t-20 -61.39 133.29 55.64 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.8 HD13 ' HA ' ' A' ' 80' ' ' ALA . 6.1 mp -103.22 86.43 2.68 Favored 'General case' 0 CA--C 1.465 -2.325 0 C-N-CA 118.278 -1.369 . . . . 0.0 108.98 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 5.3 tpp85 -100.6 94.4 6.09 Favored 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 173.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.667 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 20.7 m-20 -134.25 96.46 3.61 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.699 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.958 HG23 ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER 29.28 -132.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.643 179.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.911 ' HB2' ' CB ' ' B' ' 116' ' ' GLN . 6.7 mttp -75.46 169.74 17.49 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.843 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.893 ' CE1' ' HB ' ' B' ' 118' ' ' THR . 0.1 OUTLIER -45.26 -49.97 12.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -175.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 1.029 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 0.3 OUTLIER -59.29 -20.04 51.1 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.847 -176.052 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.958 ' HG3' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER -66.51 -25.02 66.49 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.439 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 97' ' ' ILE . . . -82.59 -38.65 23.32 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.778 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.969 HG23 ' HA ' ' A' ' 92' ' ' LYS . 1.6 t -57.29 -43.48 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.035 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 93' ' ' GLU . 7.8 t -62.47 -36.24 81.84 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.561 ' O ' ' CG ' ' A' ' 101' ' ' GLN . 3.2 mm -69.49 -47.33 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.947 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.632 HD13 ' CD2' ' B' ' 120' ' ' LEU . 2.2 pp -73.0 -31.31 64.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.981 0.42 . . . . 0.0 111.561 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.43 ' N ' HD12 ' A' ' 98' ' ' LEU . 80.6 p -52.41 -47.99 65.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.828 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -123.35 6.49 9.04 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.561 ' CG ' ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -51.98 -61.55 2.19 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.987 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.07 176.44 11.89 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.716 0.293 . . . . 0.0 110.671 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.94 -33.5 41.18 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 119.992 -1.099 . . . . 0.0 111.286 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 31.4 tt0 -103.42 118.65 37.23 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.756 -1.222 . . . . 0.0 110.062 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.691 HG12 HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.16 121.67 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.613 0 CA-C-O 123.01 1.386 . . . . 0.0 108.99 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.833 ' HB3' ' HA ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -94.04 123.04 37.16 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 111.959 -2.382 . . . . 0.0 107.628 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 17.7 m-85 -98.26 117.64 33.09 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.582 -177.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -109.72 116.83 32.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 175.121 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 11.2 m -121.15 149.81 24.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 122.013 0.911 . . . . 0.0 113.439 -176.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.637 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 31.5 t -117.49 148.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 113.674 -1.603 . . . . 0.0 111.063 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -86.34 121.22 28.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.042 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 77' ' ' ALA . 4.7 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.127 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.905 0.383 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -58.81 -38.92 79.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.467 HG23 ' N ' ' B' ' 116' ' ' GLN . 13.4 m -61.48 -150.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.119 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLN . . . . . 0.911 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -150.81 98.26 2.58 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.999 0.428 . . . . 0.0 111.599 -179.061 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ASP . . . . . 0.753 ' HA ' ' CD2' ' A' ' 91' ' ' HIS . 10.8 m-20 -151.44 171.81 16.94 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' THR . . . . . 1.029 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -165.21 163.58 20.19 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 -178.284 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ARG . . . . . 0.814 ' CZ ' ' CE1' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -137.05 111.62 8.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.94 178.421 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.632 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.4 mp . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.704 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.92 138.68 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-O 122.067 0.937 . . . . 0.0 111.962 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.448 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 7.0 mtt-85 -138.04 118.54 13.86 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.391 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 5.7 mtpt -97.28 119.55 36.01 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 122.316 1.055 . . . . 0.0 112.167 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.689 HG11 ' C ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.95 117.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.897 177.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.83 110.39 22.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.419 0.628 . . . . 0.0 112.135 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.7 OUTLIER -113.33 115.68 28.51 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.101 178.27 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -118.1 105.46 11.86 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.315 -177.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -99.13 161.41 13.63 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.855 -1.521 . . . . 0.0 110.573 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -86.91 126.0 34.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.266 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 57.72 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.335 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.483 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . 9.3 p80 -177.3 40.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.019 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -65.91 62.71 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.283 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 38' ' ' HIS . . . 56.39 164.24 0.04 OUTLIER Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.597 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.897 HD13 HD23 ' B' ' 120' ' ' LEU . 0.3 OUTLIER -101.65 -66.09 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.527 0.664 . . . . 0.0 111.182 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.902 ' O ' HD13 ' A' ' 43' ' ' ILE . . . 110.61 16.82 9.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.925 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.953 HD12 HD13 ' A' ' 60' ' ' ILE . 18.0 mm -135.75 156.98 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.549 ' HB2' ' CZ ' ' B' ' 119' ' ' ARG . 32.8 t -130.11 148.64 51.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.759 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.604 HD11 HD11 ' B' ' 120' ' ' LEU . 0.9 OUTLIER -134.21 158.76 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.929 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.484 ' N ' ' HE1' ' A' ' 91' ' ' HIS . 17.3 p -155.2 137.81 15.14 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.807 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.777 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 144.57 176.52 18.66 Favored Glycine 0 N--CA 1.422 -2.26 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.301 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 142.96 -168.2 26.08 Favored Glycine 0 C--N 1.3 -1.431 0 CA-C-N 114.886 -0.657 . . . . 0.0 112.586 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -78.15 -2.15 36.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.465 0.174 . . . . 0.0 111.238 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 1.3 pt-20 -98.85 -33.45 10.87 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.481 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.778 ' NE2' ' OD1' ' B' ' 117' ' ' ASP . 29.6 m-70 -96.33 10.64 37.4 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.409 0.623 . . . . 0.0 110.02 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.58 24.66 53.5 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.356 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.9 OUTLIER -136.34 172.83 6.38 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-O 121.898 0.856 . . . . 0.0 113.029 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.903 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.0 Cg_exo -85.36 170.78 9.16 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 124.691 3.594 . . . . 0.0 108.543 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.083 HG23 ' CE1' ' A' ' 91' ' ' HIS . 33.5 mm -72.65 105.57 2.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 118.744 -1.182 . . . . 0.0 108.59 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.528 HD23 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -109.75 146.42 34.97 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.821 HD11 HG12 ' A' ' 78' ' ' ILE . 3.1 mp -72.45 134.87 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.418 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.2 p -137.78 -19.14 1.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.611 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 3.6 tt0 -136.27 115.61 12.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.0 110.07 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.953 HD13 HD12 ' A' ' 43' ' ' ILE . 1.9 mm -128.51 104.98 12.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.705 0.764 . . . . 0.0 111.623 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 1.028 ' NE2' ' NH2' ' B' ' 119' ' ' ARG . 74.8 m-70 -70.24 137.12 86.66 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.516 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.43 145.01 81.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.186 1.924 . . . . 0.0 111.182 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.01 6.25 9.37 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.967 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 1.136 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -96.59 166.81 13.35 Favored Pre-proline 0 N--CA 1.431 -1.411 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.758 ' HB2' HD11 ' A' ' 43' ' ' ILE . 29.8 Cg_exo -17.36 -4.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.053 3.169 . . . . 0.0 115.386 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.136 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -84.9 -35.76 21.92 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.32 -7.23 19.0 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.926 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 3.2 mmt180 -92.32 -26.28 18.18 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.688 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.787 ' HB2' HD12 ' A' ' 33' ' ' LEU . 35.3 t -107.0 7.4 29.84 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 43.18 14.28 0.02 OUTLIER Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.421 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.689 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -144.32 9.62 1.95 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 119.542 -1.313 . . . . 0.0 114.714 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.934 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 7.5 mt -98.71 153.71 18.51 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 117.948 0.874 . . . . 0.0 109.976 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.97 130.9 0.1 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.19 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 75' ' ' GLY . 2.7 p -61.4 159.4 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.792 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.515 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 100.24 -21.76 43.02 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.145 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -87.8 150.71 23.39 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.52 0.676 . . . . 0.0 109.633 178.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . . . -88.49 144.02 26.61 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.709 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.821 HG12 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -106.34 125.96 62.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.429 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.5 OUTLIER -97.37 -51.9 4.0 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.196 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.945 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -162.37 176.7 10.25 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 52.6 t -131.89 152.15 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.589 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.714 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 1.2 p-10 58.73 6.33 0.6 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.492 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.54 12.02 49.22 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.461 -0.875 . . . . 0.0 114.024 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.871 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 25.7 t -123.28 123.26 67.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 117.108 0.454 . . . . 0.0 111.202 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.945 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 7.5 p-10 -60.89 127.21 30.46 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.929 HD21 HG21 ' A' ' 97' ' ' ILE . 4.9 mp -106.64 86.16 2.29 Favored 'General case' 0 N--CA 1.416 -2.155 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 mmt-85 -98.63 94.84 6.88 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 89' ' ' THR . 4.8 m-20 -133.91 95.57 3.48 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.063 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 1.084 ' OG1' ' CG2' ' B' ' 115' ' ' VAL . 0.1 OUTLIER -2.56 -67.61 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.179 0.99 . . . . 0.0 111.803 178.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.772 ' N ' HG22 ' B' ' 115' ' ' VAL . 0.0 OUTLIER -75.13 134.4 41.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 113.482 -1.69 . . . . 0.0 111.626 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 1.083 ' CE1' HG23 ' A' ' 55' ' ' ILE . 6.7 t60 -64.11 -39.59 94.37 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.411 -1.722 . . . . 0.0 108.182 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.88 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -62.32 -22.01 65.72 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.189 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -64.64 -23.72 67.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.575 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -79.12 -45.77 19.35 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.816 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.88 HG23 ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -57.56 -45.6 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.874 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.6 t -60.3 -37.74 81.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.929 HG21 HD21 ' A' ' 86' ' ' LEU . 2.7 mt -69.85 -46.61 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.462 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.768 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 1.4 pp -76.12 -31.07 58.47 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.006 0.431 . . . . 0.0 111.642 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.8 t -53.68 -50.14 66.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -114.08 14.19 18.26 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.768 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -49.27 -86.49 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.87 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.411 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 4.7 ttt180 -151.63 176.55 11.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.6 -23.49 68.82 Favored Glycine 0 CA--C 1.504 -0.635 0 C-N-CA 119.528 -1.32 . . . . 0.0 112.428 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 20.7 mt-10 -104.09 117.52 34.47 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.267 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.677 HD12 ' OE1' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -98.43 116.72 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.926 0 CA-C-O 122.802 1.287 . . . . 0.0 107.565 178.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.714 ' HB3' ' HA ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -96.09 140.11 31.28 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 112.813 -1.994 . . . . 0.0 108.739 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 12.2 m-85 -124.71 118.03 25.53 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.603 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.799 ' OE2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -105.11 116.71 32.4 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 176.499 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 6.1 m -121.94 156.36 26.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -176.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.669 ' HB ' ' HB3' ' A' ' 77' ' ' ALA . 18.8 t -117.9 116.15 50.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.941 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -81.76 125.66 30.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.077 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.858 0.361 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.432 ' O ' ' NE2' ' B' ' 116' ' ' GLN . 0.0 OUTLIER -163.78 123.93 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 1.084 ' CG2' ' OG1' ' A' ' 89' ' ' THR . 99.2 t -46.13 133.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.33 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLN . . . . . 0.836 ' OE1' ' NZ ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -149.91 -139.07 0.09 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ASP . . . . . 0.778 ' OD1' ' NE2' ' A' ' 51' ' ' HIS . 80.4 m-20 -124.53 -172.83 2.64 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.169 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.64 ' HB ' ' CD2' ' A' ' 91' ' ' HIS . 7.1 m -155.65 156.51 35.12 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ARG . . . . . 1.028 ' NH2' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -136.74 125.62 24.16 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.892 178.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.897 HD23 HD13 ' A' ' 41' ' ' LEU . 3.7 mp . . . . . 0 C--O 1.255 1.392 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.965 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.421 ' CG1' ' HB3' ' A' ' 108' ' ' GLU . 0.6 OUTLIER -78.92 138.8 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-O 122.098 0.951 . . . . 0.0 111.903 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.663 ' HB2' HG22 ' A' ' 109' ' ' VAL . 13.6 mtt-85 -138.34 116.64 11.91 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.319 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.6 OUTLIER -96.65 119.86 35.91 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.567 1.175 . . . . 0.0 113.171 -178.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.776 HG12 ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -117.64 117.95 56.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 112.533 -2.121 . . . . 0.0 108.303 177.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mp -95.3 110.21 22.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.106 0.479 . . . . 0.0 111.483 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.834 HD12 ' HB2' ' A' ' 69' ' ' CYS . 1.2 tt -113.52 112.29 23.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.641 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 34' ' ' LEU . 3.9 mp -117.13 101.58 8.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.727 0.775 . . . . 0.0 111.614 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.38 130.86 45.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.538 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 38' ' ' HIS . 55.3 mt-10 -137.97 160.27 39.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.803 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 38' ' ' HIS . 0.8 OUTLIER 59.59 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.531 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 58.2 m-70 -34.47 -55.63 0.53 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.643 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 4.9 tp10 94.54 172.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.92 163.83 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.1 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.044 HD22 HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -105.7 -82.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.749 0.309 . . . . 0.0 111.364 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.44 22.86 1.04 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.044 HG22 HD22 ' A' ' 41' ' ' LEU . 13.5 tt -135.18 158.27 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 C-N-CA 122.79 0.436 . . . . 0.0 109.849 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.516 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 41.1 t -130.74 146.19 52.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.988 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.574 ' O ' ' CE1' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -139.88 159.09 26.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 CA-C-O 122.189 0.995 . . . . 0.0 112.634 -179.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.4 ' HA ' ' ND1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -161.74 137.27 7.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.748 178.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.836 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 151.4 168.96 16.48 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.492 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 141.03 -164.62 26.44 Favored Glycine 0 C--N 1.304 -1.238 0 CA-C-N 114.367 -0.917 . . . . 0.0 112.125 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -76.89 -17.44 58.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 0.0 110.041 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.444 ' HB2' ' HD3' ' A' ' 90' ' ' LYS . 2.7 tt0 -71.94 -42.7 66.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.947 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.749 ' NE2' ' OD1' ' B' ' 117' ' ' ASP . 21.3 m-70 -99.62 12.01 37.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.41 0.624 . . . . 0.0 110.178 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.93 23.9 40.12 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.75 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -131.83 173.63 5.65 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 121.923 0.868 . . . . 0.0 113.079 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.908 ' O ' HG23 ' A' ' 53' ' ' VAL . 4.4 Cg_exo -87.2 160.45 8.47 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.644 3.563 . . . . 0.0 108.256 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.011 HD11 ' HA ' ' A' ' 91' ' ' HIS . 25.2 mm -73.2 99.87 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.188 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 54' ' ' PRO . 6.9 mp -104.38 141.4 36.4 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.793 HD11 HG12 ' A' ' 78' ' ' ILE . 4.6 mp -71.12 129.3 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.198 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.63 -18.71 3.86 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 1.3 tt0 -137.27 115.88 12.07 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.737 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.749 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 2.8 mm -129.03 108.78 17.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.143 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.924 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 65.3 m-70 -70.0 137.15 87.23 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.089 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.44 145.15 80.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.212 1.941 . . . . 0.0 111.307 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.66 6.27 4.71 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.745 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 1.136 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -96.85 167.1 12.67 Favored Pre-proline 0 N--CA 1.429 -1.495 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.94 ' CG ' HD23 ' A' ' 41' ' ' LEU . 10.8 Cg_exo -11.7 -9.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 124.745 3.63 . . . . 0.0 116.079 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.136 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.4 -35.69 21.17 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.44 -5.47 20.31 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.082 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.513 ' HG2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -93.05 -26.48 17.47 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.339 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.834 ' HB2' HD12 ' A' ' 33' ' ' LEU . 41.6 t -106.79 6.13 29.24 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 45.05 14.22 0.04 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.075 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.733 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -144.9 7.03 1.64 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 119.605 -1.283 . . . . 0.0 114.86 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.892 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 8.2 mt -97.18 151.09 20.16 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 118.216 1.008 . . . . 0.0 109.428 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.92 130.76 0.06 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.268 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 57' ' ' ILE . 2.1 p -58.92 159.12 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.638 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 106.91 -23.98 26.34 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.724 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.88 149.65 22.54 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.676 0.75 . . . . 0.0 110.022 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.86 ' HB3' HG23 ' A' ' 110' ' ' VAL . . . -89.3 131.84 35.2 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.52 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 1.03 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -104.3 138.35 29.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.276 -178.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.092 ' HA ' HD12 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -148.22 -2.96 0.51 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.818 -177.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.038 ' CB ' ' HA ' ' A' ' 84' ' ' VAL . . . -157.2 138.05 13.32 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.865 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 21.5 t -140.28 143.85 28.78 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.11 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.597 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 5.6 p30 46.09 26.21 0.4 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.372 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.401 ' C ' ' CG1' ' A' ' 84' ' ' VAL . . . 128.05 44.86 0.21 Allowed Glycine 0 N--CA 1.464 0.525 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.38 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.038 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 1.5 p 43.37 77.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.452 1.101 . . . . 0.0 112.242 -177.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.66 ' H ' ' H ' ' A' ' 81' ' ' VAL . 19.8 m120 -130.98 92.76 3.27 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.092 HD12 ' HA ' ' A' ' 79' ' ' LEU . 2.0 mt -123.16 92.19 3.64 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 171.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.524 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -65.07 141.17 58.83 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.531 -176.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.16 96.33 10.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.084 -1.416 . . . . 0.0 114.475 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.869 HG22 ' H ' ' A' ' 90' ' ' LYS . 0.9 OUTLIER -157.6 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 112.601 -2.09 . . . . 0.0 105.828 174.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.869 ' H ' HG22 ' A' ' 89' ' ' THR . 25.2 mttm -132.48 168.28 18.47 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 1.011 ' HA ' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -47.36 -34.7 7.24 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.358 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.613 ' HA ' ' HB ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -58.43 -15.49 11.02 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.577 -177.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.778 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 9.6 mm-40 -64.16 -23.29 67.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.759 ' HB2' HD22 ' A' ' 86' ' ' LEU . . . -86.89 -39.42 15.81 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.895 HG22 HG21 ' B' ' 118' ' ' THR . 4.4 t -58.01 -46.02 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -61.95 -37.0 83.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.429 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -69.85 -47.15 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.746 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 1.078 HD22 HD21 ' B' ' 120' ' ' LEU . 2.7 pp -76.74 -35.99 57.42 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.463 ' N ' HD12 ' A' ' 98' ' ' LEU . 17.3 t -61.03 -54.23 47.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 101' ' ' GLN . 7.1 mm100 -85.12 -16.98 38.7 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.746 ' OE1' HD13 ' A' ' 105' ' ' ILE . 1.1 pt20 -54.63 -112.23 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.576 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -147.47 177.32 9.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.99 -4.42 7.47 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.449 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.439 ' CB ' ' HG ' ' A' ' 34' ' ' LEU . 32.1 tt0 -103.17 116.73 33.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.548 0.69 . . . . 0.0 111.306 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.746 HD13 ' OE1' ' A' ' 101' ' ' GLN . 26.1 mm -103.22 112.45 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.865 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -95.28 122.54 38.08 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.701 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 44.0 m-85 -109.99 117.81 34.76 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.702 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.633 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 1.3 mt-10 -108.66 115.85 30.88 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.663 HG22 ' HB2' ' A' ' 29' ' ' ARG . 10.4 m -121.68 147.89 25.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 114.562 -1.199 . . . . 0.0 114.192 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.975 HG22 HD21 ' A' ' 79' ' ' LEU . 27.6 m -117.4 152.1 19.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 113.649 -1.614 . . . . 0.0 111.342 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -82.19 126.75 32.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' A' ' 77' ' ' ALA . 21.9 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . 0.749 ' OD1' ' NE2' ' A' ' 51' ' ' HIS . 8.4 m-20 . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 118.819 -0.61 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.895 HG21 HG22 ' A' ' 95' ' ' VAL . 0.7 OUTLIER -167.66 166.59 13.84 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -178.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' ARG . . . . . 0.924 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -131.86 123.63 27.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.071 -1.877 . . . . 0.0 108.663 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 1.078 HD21 HD22 ' A' ' 98' ' ' LEU . 1.1 mp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.92 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 tt -80.19 138.71 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 122.024 0.916 . . . . 0.0 112.047 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.45 ' CB ' HG22 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -136.33 121.74 19.38 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.688 -1.597 . . . . 0.0 109.948 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -104.49 119.4 38.89 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.273 1.035 . . . . 0.0 112.475 -178.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.656 HG11 ' C ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.53 117.84 55.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 113.311 -1.768 . . . . 0.0 108.38 177.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mp -96.24 113.8 25.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.099 0.476 . . . . 0.0 111.438 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.755 HD12 ' HB2' ' A' ' 69' ' ' CYS . 2.2 tt -113.07 109.22 18.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HG ' ' CB ' ' A' ' 104' ' ' GLU . 3.1 mp -116.02 104.73 11.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.922 0.868 . . . . 0.0 110.961 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.76 161.32 13.71 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.704 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.97 136.17 33.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.626 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 47.7 25.3 0.67 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.516 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.501 ' CD2' ' HA2' ' A' ' 103' ' ' GLY . 2.4 m170 46.26 29.57 0.86 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.197 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.9 81.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.816 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' HIS . . . 55.61 170.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.382 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.114 HD22 HG22 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -108.59 -76.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.699 0.749 . . . . 0.0 111.38 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 121.64 23.88 2.47 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.114 HG22 HD22 ' A' ' 41' ' ' LEU . 14.9 tt -135.5 158.31 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -130.88 148.07 52.6 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.498 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.622 HD11 HD11 ' B' ' 120' ' ' LEU . 0.8 OUTLIER -135.0 159.01 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.265 -178.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.501 ' N ' ' HE1' ' A' ' 91' ' ' HIS . 67.5 p -156.22 137.33 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.36 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.813 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 151.85 169.1 16.96 Favored Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.314 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 144.73 -166.75 27.31 Favored Glycine 0 C--N 1.303 -1.297 0 CA-C-N 114.567 -0.816 . . . . 0.0 111.449 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.405 ' CB ' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -76.72 -14.76 59.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.983 0.392 . . . . 0.0 110.95 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -75.53 -41.41 55.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 110.27 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.49 ' O ' ' CG1' ' A' ' 53' ' ' VAL . 13.9 m-70 -98.9 11.32 39.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.519 0.676 . . . . 0.0 110.161 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.18 23.24 32.18 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.565 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 54' ' ' PRO . 1.1 m -128.19 170.94 9.33 Favored Pre-proline 0 CA--C 1.512 -0.496 0 CA-C-O 121.959 0.885 . . . . 0.0 113.014 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.919 ' O ' HG23 ' A' ' 53' ' ' VAL . 7.5 Cg_exo -83.09 173.72 9.82 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.579 3.519 . . . . 0.0 108.132 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.013 HG23 ' CE1' ' A' ' 91' ' ' HIS . 39.4 mm -72.76 107.71 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.524 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.86 145.83 34.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -177.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.871 HD11 HG12 ' A' ' 78' ' ' ILE . 3.8 mp -71.87 130.73 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.532 ' HA ' HG23 ' A' ' 74' ' ' VAL . 11.8 t -132.18 -22.45 2.27 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 44' ' ' SER . 0.2 OUTLIER -137.4 115.84 11.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.252 0.548 . . . . 0.0 110.21 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.883 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 3.4 mm -125.43 107.06 17.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.72 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.984 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 39.2 m-70 -71.41 137.04 83.72 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.39 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.43 141.36 89.77 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.157 1.905 . . . . 0.0 111.227 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.33 0.92 8.62 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.609 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 1.112 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -96.43 167.36 12.42 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.896 ' HG3' HD23 ' A' ' 41' ' ' LEU . 6.2 Cg_exo -10.92 -9.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 125.075 3.85 . . . . 0.0 116.216 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.112 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.02 -35.83 21.67 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -102.14 -8.7 21.14 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.494 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 10.4 mmt180 -92.69 -26.44 17.79 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.439 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.755 ' HB2' HD12 ' A' ' 33' ' ' LEU . 42.9 t -107.6 6.14 27.62 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 44.58 13.68 0.03 OUTLIER Glycine 0 C--N 1.336 0.557 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.35 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.656 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -149.63 12.25 1.0 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 119.431 -1.366 . . . . 0.0 115.152 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.79 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 10.0 mt -99.04 150.53 21.9 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 118.223 1.012 . . . . 0.0 110.159 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.1 t60 174.52 145.36 0.06 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.997 0.903 . . . . 0.0 111.611 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.584 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 7.3 p -65.4 147.49 12.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.951 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.79 -17.77 24.98 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.024 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -92.52 149.46 21.36 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.588 0.709 . . . . 0.0 110.324 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.999 ' HB3' HG23 ' A' ' 110' ' ' VAL . . . -89.68 134.39 34.18 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.501 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.871 HG12 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -105.82 119.99 55.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.628 0.728 . . . . 0.0 111.608 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.007 HD21 HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -96.16 -41.57 8.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.297 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.864 ' HB1' ' O ' ' A' ' 84' ' ' VAL . . . -162.61 176.94 9.85 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.919 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -140.95 154.89 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.604 178.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.792 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.2 p30 59.33 7.55 0.95 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.69 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.11 10.1 49.81 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.698 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.864 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 21.3 t -120.71 125.5 74.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.855 0.327 . . . . 0.0 110.769 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.743 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 14.6 p-10 -61.79 125.3 23.34 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.042 0.449 . . . . 0.0 109.945 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.032 HD21 HG21 ' A' ' 97' ' ' ILE . 4.0 mp -106.8 86.34 2.31 Favored 'General case' 0 N--CA 1.413 -2.278 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.004 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -83.58 96.67 8.71 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . 65.7 m-20 -132.61 99.31 4.6 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.675 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.405 ' OG1' ' CB ' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -56.42 -45.38 80.75 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.91 128.75 36.35 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 1.013 ' CE1' HG23 ' A' ' 55' ' ' ILE . 5.5 t60 -65.44 -40.32 93.14 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.063 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 1.06 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 1.3 mmtm -62.71 -22.35 66.45 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.856 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -65.27 -24.18 67.24 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.986 -0.685 . . . . 0.0 109.55 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.535 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -81.92 -45.09 15.92 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.262 0.553 . . . . 0.0 110.068 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.933 HG22 HG21 ' B' ' 118' ' ' THR . 2.0 t -57.31 -41.71 78.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.328 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -62.88 -38.6 91.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.003 0.906 . . . . 0.0 108.567 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.032 HG21 HD21 ' A' ' 86' ' ' LEU . 2.1 mm -69.87 -46.75 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.534 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.852 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 2.0 pp -75.21 -31.42 60.9 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.935 0.398 . . . . 0.0 111.756 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.418 ' N ' HD12 ' A' ' 98' ' ' LEU . 35.1 t -57.13 -53.72 54.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.79 2.85 30.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.852 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -50.64 -93.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.812 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.431 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -151.31 173.66 14.23 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.501 ' HA2' ' CD2' ' A' ' 38' ' ' HIS . . . -66.78 -12.14 58.98 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 119.594 -1.288 . . . . 0.0 112.881 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.452 ' CB ' ' HG ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -103.62 117.86 35.39 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.341 0.591 . . . . 0.0 111.777 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.745 HG13 HD11 ' A' ' 41' ' ' LEU . 20.2 mm -100.14 111.88 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.919 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -95.27 118.6 32.32 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.631 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 38.8 m-85 -102.49 117.57 34.98 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.532 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.643 ' CD ' ' HB3' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -103.0 115.45 30.63 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 175.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 6.9 m -124.34 156.99 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -175.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.007 HG22 HD21 ' A' ' 79' ' ' LEU . 1.8 m -128.37 152.24 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.247 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -89.0 118.53 28.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.112 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . 0.423 ' OD2' ' CE1' ' A' ' 51' ' ' HIS . 69.5 m-20 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 1.06 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 2.9 m -166.02 162.1 17.74 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' ARG . . . . . 0.984 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -135.1 129.25 33.65 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.102 178.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.801 HD21 HD22 ' A' ' 98' ' ' LEU . 2.8 mp . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.705 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.78 138.6 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 122.027 0.918 . . . . 0.0 112.019 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -139.59 118.72 12.68 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 113.652 -1.613 . . . . 0.0 110.35 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -100.34 119.49 38.51 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 122.307 1.051 . . . . 0.0 112.941 -178.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -115.62 118.05 57.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 113.308 -1.769 . . . . 0.0 107.924 176.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.24 115.82 28.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.975 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -113.72 124.33 52.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.861 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 4.8 mp -117.22 102.02 8.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.746 0.784 . . . . 0.0 111.742 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.19 161.2 13.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.3 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -137.96 148.19 45.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.027 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.432 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 13.1 t0 59.07 27.21 16.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.096 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.432 ' CG ' ' O ' ' A' ' 37' ' ' ASP . 21.0 p80 43.18 39.13 1.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.415 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.25 -21.27 47.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.92 178.81 16.41 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.532 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.779 HD22 HD22 ' B' ' 120' ' ' LEU . 1.2 tp -117.81 -19.07 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.116 0.458 . . . . 0.0 111.361 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.543 ' HA2' ' ND1' ' A' ' 61' ' ' HIS . . . 57.68 32.53 65.49 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.089 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.815 HG23 HD13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.14 157.52 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.474 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 5.4 t -130.87 147.87 52.57 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.465 0.65 . . . . 0.0 110.657 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.794 HG13 ' HB ' ' B' ' 118' ' ' THR . 0.5 OUTLIER -137.86 157.75 32.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.934 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.614 ' N ' ' HE1' ' A' ' 91' ' ' HIS . 21.9 p -160.94 152.36 19.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.482 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.767 ' CA ' HG22 ' A' ' 53' ' ' VAL . . . 139.16 -168.82 24.72 Favored Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.721 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 130.65 -169.03 21.54 Favored Glycine 0 C--N 1.3 -1.442 0 CA-C-N 114.098 -1.051 . . . . 0.0 113.199 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.42 -16.92 58.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.542 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 12.5 pt-20 -84.46 -34.42 23.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.973 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.675 ' O ' HG13 ' A' ' 53' ' ' VAL . 27.1 m-70 -95.71 9.72 39.39 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.492 0.663 . . . . 0.0 109.726 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.2 23.48 52.88 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.897 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -139.58 177.44 2.03 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-O 121.663 0.745 . . . . 0.0 112.862 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.834 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.8 Cg_exo -88.21 173.21 4.86 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 124.561 3.507 . . . . 0.0 109.012 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.114 HG23 ' CE1' ' A' ' 91' ' ' HIS . 32.5 mm -72.44 99.15 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.95 139.1 41.02 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.86 HD11 HG12 ' A' ' 78' ' ' ILE . 3.3 mp -71.82 129.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.431 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 p -137.02 -13.85 1.6 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.781 ' OE1' ' NH1' ' B' ' 119' ' ' ARG . 0.4 OUTLIER -137.13 116.1 12.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.371 0.605 . . . . 0.0 110.532 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.843 HG23 ' CB ' ' A' ' 66' ' ' ALA . 3.0 mm -117.76 109.72 28.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.308 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.99 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 7.4 m170 -71.53 136.56 83.52 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.829 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -53.08 139.67 61.53 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.836 1.691 . . . . 0.0 113.071 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.76 25.14 0.19 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 114.635 -1.166 . . . . 0.0 114.308 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 1.084 ' O ' ' N ' ' A' ' 66' ' ' ALA . 7.6 mm100 -94.97 165.41 17.08 Favored Pre-proline 0 N--CA 1.419 -1.977 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.874 ' HB3' HD21 ' A' ' 33' ' ' LEU . 37.2 Cg_exo -30.54 2.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.273 1.982 . . . . 0.0 113.593 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.084 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.29 -36.41 19.35 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -101.8 -12.92 17.94 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.37 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -26.13 36.94 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.006 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.975 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -90.63 -5.03 56.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.68 8.77 0.39 Allowed Glycine 0 CA--C 1.519 0.33 0 CA-C-N 114.945 -1.025 . . . . 0.0 113.128 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.533 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -129.9 -1.66 5.37 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.691 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.907 HD11 HD13 ' A' ' 33' ' ' LEU . 4.1 mt -94.81 151.37 19.3 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 121.785 0.802 . . . . 0.0 111.518 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.4 t60 176.73 139.43 0.07 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.468 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 57' ' ' ILE . 2.9 p -66.89 147.46 12.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 113.829 -1.532 . . . . 0.0 112.3 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.22 -21.1 10.25 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.539 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.655 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -89.17 150.67 22.58 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.577 0.703 . . . . 0.0 109.677 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 110' ' ' VAL . . . -88.59 130.76 35.19 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.179 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.898 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -106.62 122.77 60.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.703 0.763 . . . . 0.0 110.939 -178.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.495 ' O ' HD23 ' A' ' 79' ' ' LEU . 5.2 tt -101.39 -50.63 3.7 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.217 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.949 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -148.67 176.77 10.07 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.891 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -138.88 153.22 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.691 177.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.627 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 0.0 OUTLIER 73.99 -18.1 0.42 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.532 -179.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 81' ' ' VAL . . . 118.98 9.59 8.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.752 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.913 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 20.4 t -127.96 133.03 68.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.949 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 8.2 p30 -61.09 131.87 51.96 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.775 HD23 HD13 ' A' ' 97' ' ' ILE . 5.4 mp -102.92 85.95 2.63 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 118.161 -1.415 . . . . 0.0 111.411 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.13 94.87 7.78 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 172.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.64 ' HB2' ' HB3' ' A' ' 93' ' ' GLU . 19.6 m-20 -134.3 97.52 3.86 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.511 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.701 ' OG1' ' N ' ' A' ' 90' ' ' LYS . 0.3 OUTLIER 46.19 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.087 0.946 . . . . 0.0 109.515 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.701 ' N ' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -126.97 168.04 15.07 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.132 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 1.114 ' CE1' HG23 ' A' ' 55' ' ' ILE . 2.6 t-160 -46.06 -36.74 6.0 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 113.339 -1.755 . . . . 0.0 113.353 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.67 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -61.0 -23.89 65.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -64.3 -22.34 66.92 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -71.17 -46.81 60.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.001 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.084 HG22 ' OG1' ' B' ' 118' ' ' THR . 0.0 OUTLIER -59.84 -47.32 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.668 0.747 . . . . 0.0 109.68 178.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 93' ' ' GLU . 1.2 t -62.74 -36.12 81.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.898 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.775 HD13 HD23 ' A' ' 86' ' ' LEU . 1.4 mt -65.07 -47.23 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.764 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.948 HD22 HD21 ' B' ' 120' ' ' LEU . 0.9 OUTLIER -76.35 -40.53 50.97 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.776 0.322 . . . . 0.0 110.869 179.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.509 ' N ' HD12 ' A' ' 98' ' ' LEU . 75.3 m -55.75 -28.34 55.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.202 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -91.54 30.94 1.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER 178.1 151.62 0.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.875 0.369 . . . . 0.0 111.293 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.2 ptt-85 -126.04 160.91 28.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.41 -151.54 21.18 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.156 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 9.3 pt-20 -85.15 117.94 24.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.79 0.805 . . . . 0.0 111.901 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.635 HG12 HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.56 121.7 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.516 0 CA-C-O 122.734 1.254 . . . . 0.0 107.814 177.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.891 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -93.5 127.71 39.27 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.3 -2.227 . . . . 0.0 108.645 -178.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.582 ' HD2' HD11 ' A' ' 78' ' ' ILE . 17.7 m-85 -104.32 117.62 34.64 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.024 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.714 ' CD ' ' HB3' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -107.67 116.26 31.63 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 7.6 m -122.13 154.77 26.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.59 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 15.7 t -118.42 132.36 68.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.918 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -81.68 107.81 14.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.105 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . 0.568 ' OD2' ' CE1' ' A' ' 51' ' ' HIS . 6.4 m-20 . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 1.084 ' OG1' HG22 ' A' ' 95' ' ' VAL . 91.5 m -147.2 146.6 29.89 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' ARG . . . . . 0.99 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -142.87 109.35 5.36 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.523 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.948 HD21 HD22 ' A' ' 98' ' ' LEU . 1.2 mp . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.852 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 tp -82.19 138.37 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 122.124 0.964 . . . . 0.0 112.105 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.546 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 5.8 mtt180 -140.22 116.9 10.88 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.928 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.47 119.42 37.98 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 122.332 1.063 . . . . 0.0 112.75 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.978 HG12 ' O ' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -109.96 116.89 53.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 112.966 -1.924 . . . . 0.0 107.05 176.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.14 114.36 27.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.285 0.564 . . . . 0.0 111.816 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.885 HD13 ' HB3' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -113.16 119.04 36.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.316 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 34' ' ' LEU . 4.4 mp -110.96 101.66 10.2 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.804 0.811 . . . . 0.0 110.848 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.57 134.43 42.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.812 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 38' ' ' HIS . 15.2 mt-10 -138.84 138.08 37.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.995 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 38' ' ' HIS . 3.6 m-20 60.93 -79.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.258 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.558 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 60.0 m80 -15.47 -63.97 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.952 0.501 . . . . 0.0 112.34 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.558 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 6.0 tt0 96.82 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.656 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 48.79 -174.09 0.04 OUTLIER Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.608 -0.805 . . . . 0.0 111.935 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.666 HD11 HG13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -125.37 -67.26 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.27 0.535 . . . . 0.0 111.416 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 64' ' ' GLN . . . 112.51 20.07 6.73 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.647 HG22 HD23 ' A' ' 41' ' ' LEU . 20.2 tt -125.18 160.52 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.149 0 CA-C-O 121.144 0.497 . . . . 0.0 110.458 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.42 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 3.2 t -128.26 146.92 50.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.693 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.048 HD11 HD11 ' B' ' 120' ' ' LEU . 0.6 OUTLIER -138.69 160.37 30.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.098 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.453 ' N ' ' CE1' ' A' ' 91' ' ' HIS . 66.7 p -158.75 138.77 12.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.27 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.548 ' N ' ' HD1' ' A' ' 91' ' ' HIS . . . 163.26 -141.0 6.83 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 140.96 160.98 8.51 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.15 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.515 ' CB ' ' HA ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -80.35 -16.75 53.83 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.402 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.467 ' HG3' ' CD2' ' A' ' 51' ' ' HIS . 1.3 pt-20 -70.06 -35.81 74.53 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.394 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.681 ' HB2' HG13 ' A' ' 53' ' ' VAL . 21.3 m-70 -97.37 15.1 23.99 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.533 0.682 . . . . 0.0 109.833 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.73 18.34 31.34 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.554 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 54' ' ' PRO . 1.9 m -103.58 154.05 38.16 Favored Pre-proline 0 CA--C 1.513 -0.456 0 CA-C-O 122.02 0.914 . . . . 0.0 113.249 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.825 ' O ' HG23 ' A' ' 53' ' ' VAL . 22.4 Cg_exo -77.41 -172.49 1.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 124.551 3.5 . . . . 0.0 109.424 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.04 HG23 ' CE1' ' A' ' 91' ' ' HIS . 50.4 mm -84.64 120.38 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.599 HD21 ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -105.73 126.53 52.26 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.844 HD12 HG22 ' A' ' 78' ' ' ILE . 3.2 mt -70.34 131.44 34.26 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.594 ' HA ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -140.17 -15.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.896 ' OE1' ' NH1' ' B' ' 119' ' ' ARG . 1.7 tt0 -137.57 116.14 12.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.092 0.472 . . . . 0.0 111.087 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.666 HG23 ' CD ' ' A' ' 64' ' ' GLN . 3.2 mm -116.19 106.09 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.708 0.766 . . . . 0.0 111.118 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.909 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 2.9 m170 -73.28 118.75 71.37 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.974 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 61' ' ' HIS . 3.2 Cg_endo -45.77 114.0 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.748 1.632 . . . . 0.0 110.836 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' HA2' ' CB ' ' A' ' 67' ' ' ASP . . . 105.97 1.43 39.15 Favored Glycine 0 N--CA 1.422 -2.266 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.804 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 1.154 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -94.41 166.55 15.14 Favored Pre-proline 0 CA--C 1.492 -1.266 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.969 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 69.4 Cg_exo -12.46 -9.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 124.969 3.779 . . . . 0.0 115.739 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.154 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.35 -35.98 19.51 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.491 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . 4.7 t70 -91.2 -12.5 35.17 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.505 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.969 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 3.7 mtt-85 -77.48 1.05 20.47 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.305 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 4.0 t 77.76 -17.28 0.58 Allowed 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.978 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -43.79 -31.78 1.97 Allowed Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.029 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.696 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 86.34 29.89 23.64 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.176 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.693 HD12 ' CB ' ' A' ' 65' ' ' PRO . 1.6 mt -90.82 151.76 21.04 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 122.255 1.026 . . . . 0.0 112.142 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.647 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.9 t60 179.85 146.96 0.24 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.33 -1.759 . . . . 0.0 111.319 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.647 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 12.0 p -67.43 158.97 5.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.607 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.547 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 102.95 -19.18 47.57 Favored Glycine 0 C--N 1.316 -0.552 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.546 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.16 149.64 21.77 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.385 0.612 . . . . 0.0 109.989 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.507 ' HA ' HD13 ' A' ' 56' ' ' LEU . . . -89.15 129.37 35.76 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.684 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.849 HG23 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.15 113.82 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.527 0.679 . . . . 0.0 112.279 -177.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.004 HD21 HG23 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -89.64 -41.35 12.01 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.991 -178.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.944 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -162.67 177.53 9.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -175.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.045 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -133.71 154.49 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.367 178.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.723 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.6 p30 57.56 7.41 0.52 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.537 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.06 13.36 39.81 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.829 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.866 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 20.7 t -123.86 118.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.976 0.388 . . . . 0.0 111.511 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.944 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 2.7 m120 -61.33 124.7 21.33 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.884 HD21 HG21 ' A' ' 97' ' ' ILE . 4.6 mp -106.41 86.36 2.34 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.439 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -102.74 94.66 5.73 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 90' ' ' LYS . 1.1 m-20 -134.04 94.39 3.24 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.686 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.531 ' C ' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER 14.72 -80.35 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 124.444 1.09 . . . . 0.0 111.92 178.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -75.09 136.39 41.15 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 113.611 -1.631 . . . . 0.0 112.038 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 1.04 ' CE1' HG23 ' A' ' 55' ' ' ILE . 7.6 t60 -60.8 -36.31 78.7 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.657 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 1.008 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 1.7 mmtm -61.92 -22.6 65.73 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.267 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.492 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -64.97 -25.39 67.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.569 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -84.03 -44.16 14.4 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.746 HG23 ' CG2' ' B' ' 118' ' ' THR . 0.4 OUTLIER -57.2 -45.51 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.858 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.463 ' N ' ' CG1' ' A' ' 95' ' ' VAL . 14.6 t -61.42 -36.39 80.21 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.884 HG21 HD21 ' A' ' 86' ' ' LEU . 1.1 mt -69.49 -46.57 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.956 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.893 HD13 ' CD2' ' B' ' 120' ' ' LEU . 0.9 OUTLIER -75.22 -35.04 61.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.652 0.263 . . . . 0.0 111.161 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 93.5 p -57.31 -57.29 13.28 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.138 0.494 . . . . 0.0 110.439 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -66.26 -32.8 74.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.12 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -51.0 149.61 3.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.512 179.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.57 169.65 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.47 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.41 -132.13 12.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.453 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 1.1 pt-20 -84.73 126.46 33.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.666 HG13 HD11 ' A' ' 41' ' ' LEU . 20.7 mm -97.09 112.8 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 1.045 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -94.47 121.37 35.94 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.631 -179.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.565 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 34.5 m-85 -105.22 118.06 35.59 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.715 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.832 ' OE2' ' HB3' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -100.06 115.98 31.03 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 5.0 m -129.1 157.49 41.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.004 HG23 HD21 ' A' ' 79' ' ' LEU . 58.5 t -118.12 130.4 73.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.893 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -83.6 117.33 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.961 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.179 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 1.008 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -170.79 159.8 6.58 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' ARG . . . . . 0.909 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -124.28 165.44 17.64 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.512 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 1.048 HD11 HD11 ' A' ' 45' ' ' ILE . 5.9 mp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.247 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 tp -79.41 138.77 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.044 0.926 . . . . 0.0 112.028 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.487 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.9 OUTLIER -140.13 120.37 13.86 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.958 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -102.31 119.82 39.45 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 122.192 0.996 . . . . 0.0 112.661 -178.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.78 HG12 ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -113.58 117.94 56.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 113.342 -1.754 . . . . 0.0 108.673 177.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.3 112.0 23.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.41 0.624 . . . . 0.0 111.659 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.048 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.5 OUTLIER -114.42 115.42 27.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.02 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -116.69 100.59 7.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.004 0.907 . . . . 0.0 109.923 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -100.78 161.81 13.34 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.474 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -86.31 160.75 19.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.475 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -41.09 -26.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 1.3 t-160 -40.61 -57.1 1.95 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 1.0 OUTLIER 101.57 160.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.468 0.707 . . . . 0.0 111.111 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.73 129.15 4.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.403 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.776 HD22 ' CG2' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -120.35 -9.67 9.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.787 0.327 . . . . 0.0 111.673 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA2' ' ND1' ' A' ' 61' ' ' HIS . . . 47.09 37.62 10.34 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.703 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.776 ' CG2' HD22 ' A' ' 41' ' ' LEU . 9.3 tt -135.05 158.59 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.517 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 6.8 t -130.03 147.88 51.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.768 0.794 . . . . 0.0 111.185 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.712 ' O ' ' HE1' ' A' ' 91' ' ' HIS . 1.2 pt -138.16 160.96 32.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.729 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 45' ' ' ILE . 7.1 p -160.64 136.48 8.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.955 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.556 ' CA ' HG22 ' A' ' 53' ' ' VAL . . . 163.01 -141.4 7.13 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 53' ' ' VAL . . . 160.69 128.68 0.97 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.1 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -74.51 -10.79 59.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 109.942 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HG3' ' CD2' ' A' ' 51' ' ' HIS . 0.5 OUTLIER -102.65 -24.87 13.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.235 179.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.494 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 54.5 m-70 -91.61 21.3 4.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.436 0.636 . . . . 0.0 110.457 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.23 14.34 56.36 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.405 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -129.75 137.21 30.41 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.594 ' O ' HG23 ' A' ' 53' ' ' VAL . 77.7 Cg_exo -63.65 156.48 56.96 Favored 'Trans proline' 0 C--N 1.331 -0.357 0 C-N-CA 124.001 3.134 . . . . 0.0 111.069 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.945 ' HB ' HG22 ' A' ' 78' ' ' ILE . 24.9 mm -74.26 108.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.647 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 54' ' ' PRO . 8.0 mp -103.86 139.28 39.27 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.91 HD11 HG12 ' A' ' 78' ' ' ILE . 3.2 mp -72.01 131.62 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.017 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 m -136.79 -17.47 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.517 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 0.5 OUTLIER -137.27 116.11 12.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.234 0.54 . . . . 0.0 110.844 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.78 HG23 ' CB ' ' A' ' 66' ' ' ALA . 4.2 mm -116.53 111.69 36.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.245 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.773 ' CE1' ' NH1' ' B' ' 119' ' ' ARG . 7.6 m170 -70.89 136.73 85.15 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.873 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.37 138.99 81.34 Favored 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 122.246 1.964 . . . . 0.0 113.119 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 42.19 25.33 0.25 Allowed Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.704 -1.135 . . . . 0.0 113.975 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 1.085 ' O ' ' N ' ' A' ' 66' ' ' ALA . 9.1 mm100 -95.21 165.34 17.06 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.626 ' HB2' HD23 ' A' ' 41' ' ' LEU . 49.1 Cg_exo -31.25 2.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.036 1.824 . . . . 0.0 113.255 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.085 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.15 -36.44 19.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -99.01 -13.95 19.67 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.346 177.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.541 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 29.6 mtp180 -76.19 -26.24 55.97 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.817 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 1.048 ' HB2' HD12 ' A' ' 33' ' ' LEU . 28.0 t -93.3 -1.78 55.66 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 48.85 11.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.985 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.73 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -136.75 5.61 3.73 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.489 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 6.3 mt -94.72 150.61 20.04 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 117.925 0.862 . . . . 0.0 109.357 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 179.6 133.22 0.1 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.627 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 75' ' ' GLY . 3.2 p -60.67 159.5 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.98 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.511 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 105.99 -24.5 26.47 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.709 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.542 ' O ' HD12 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -88.33 149.88 23.52 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.755 0.788 . . . . 0.0 109.874 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.852 ' HB2' HG13 ' A' ' 112' ' ' VAL . . . -88.68 133.6 34.16 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.562 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.945 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -102.97 145.3 12.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.497 -178.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.953 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -146.02 -20.13 0.45 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.012 ' HB1' ' N ' ' A' ' 85' ' ' ASN . . . -163.88 176.27 9.62 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.778 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -154.06 153.15 8.83 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.594 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 0.2 OUTLIER 77.95 -49.45 0.49 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.625 -1.625 . . . . 0.0 112.264 178.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' C ' ' CG1' ' A' ' 84' ' ' VAL . . . -154.78 32.61 0.68 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 84' ' ' VAL . 1.4 p 48.46 73.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 126.781 2.033 . . . . 0.0 113.177 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 1.012 ' N ' ' HB1' ' A' ' 80' ' ' ALA . 14.9 p-10 -136.35 97.28 3.54 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 113.27 -1.787 . . . . 0.0 112.68 172.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.953 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 7.1 mt -116.71 88.28 2.87 Favored 'General case' 0 CA--C 1.469 -2.139 0 CA-C-N 124.273 3.215 . . . . 0.0 108.549 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.51 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -112.55 92.73 4.12 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 173.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.682 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -137.65 93.13 2.76 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.369 178.094 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.684 ' OG1' ' N ' ' A' ' 90' ' ' LYS . 1.0 OUTLIER 14.82 -124.89 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.684 ' N ' ' OG1' ' A' ' 89' ' ' THR . 3.5 mttp -75.29 168.56 19.76 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.768 ' NE2' ' HB ' ' B' ' 118' ' ' THR . 3.1 t-160 -44.61 -50.07 9.92 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -175.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.988 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 0.0 OUTLIER -60.77 -20.49 61.52 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.019 -176.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.682 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -65.86 -24.96 66.98 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.531 178.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.495 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -76.34 -38.61 55.68 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.92 HG23 ' HA ' ' A' ' 92' ' ' LYS . 1.4 t -61.9 -44.94 99.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.588 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.668 HG22 ' O ' ' A' ' 93' ' ' GLU . 5.3 t -61.55 -36.32 80.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -68.98 -46.63 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.825 179.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.694 ' CG ' ' HA ' ' A' ' 95' ' ' VAL . 2.6 pp -74.88 -33.15 62.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.789 0.328 . . . . 0.0 111.522 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.538 ' N ' HD12 ' A' ' 98' ' ' LEU . 29.6 t -57.41 -53.69 55.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.226 0.536 . . . . 0.0 110.719 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -69.9 -40.02 75.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.743 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.588 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -55.71 156.01 5.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.42 ' HA ' ' NE ' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -141.51 167.2 22.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.04 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.21 -130.65 10.32 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.463 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -98.2 128.76 44.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 122.169 0.985 . . . . 0.0 113.473 -178.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.607 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 30.8 mm -97.54 112.7 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.778 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -93.75 117.6 30.31 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 178.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 31.6 m-85 -99.25 118.61 36.32 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.616 -176.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.994 ' HG3' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -107.06 116.61 32.23 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.487 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 14.5 m -122.13 145.23 29.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.403 -0.919 . . . . 0.0 113.213 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.689 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 7.8 t -117.02 152.13 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.051 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -87.04 117.46 25.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.136 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.852 HG13 ' HB2' ' A' ' 77' ' ' ALA . 4.9 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.055 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . 0.526 ' HA ' ' CE1' ' A' ' 91' ' ' HIS . 14.6 m-20 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.988 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -169.02 157.33 7.82 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' ARG . . . . . 0.773 ' NH1' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -133.74 121.32 21.72 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.992 178.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.673 HD21 HD22 ' A' ' 98' ' ' LEU . 2.4 mp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.814 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.31 134.64 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 C-N-CA 122.86 0.464 . . . . 0.0 111.239 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -142.45 122.22 13.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.177 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -106.11 119.46 39.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.149 0.976 . . . . 0.0 112.682 -178.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.734 HG11 ' C ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.5 118.28 57.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.854 177.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -89.86 110.06 21.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.926 0.869 . . . . 0.0 112.739 -177.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.002 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -115.39 115.46 26.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.488 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -118.66 101.57 8.21 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.636 0.731 . . . . 0.0 110.672 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.28 161.31 13.69 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.435 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.65 119.44 26.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.966 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 51.91 -137.75 1.16 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.528 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.44 41.63 1.08 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.75 0.31 . . . . 0.0 110.926 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -56.37 -22.93 34.32 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.05 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.0 174.86 31.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.148 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.784 HD22 HG12 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -111.62 -26.78 8.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 110.684 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 61' ' ' HIS . . . 65.29 33.1 85.82 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.784 HG12 HD22 ' A' ' 41' ' ' LEU . 1.8 pt -135.41 157.87 40.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 59' ' ' GLU . 1.7 t -130.61 147.72 52.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.667 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.732 HG13 HG22 ' B' ' 118' ' ' THR . 2.9 pt -137.58 159.92 34.6 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.634 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.422 ' HA ' ' ND1' ' A' ' 91' ' ' HIS . 69.4 p -160.29 135.75 8.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.686 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.873 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 165.42 170.16 30.0 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 119.807 -1.187 . . . . 0.0 112.944 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 148.63 -177.6 26.76 Favored Glycine 0 C--N 1.303 -1.255 0 CA-C-N 114.156 -1.022 . . . . 0.0 113.305 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -15.26 58.37 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 11.1 pt-20 -82.86 -35.73 26.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.991 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.59 ' CE1' ' OD1' ' B' ' 117' ' ' ASP . 30.9 m-70 -94.59 8.9 40.72 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.501 0.667 . . . . 0.0 109.562 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.29 55.31 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.828 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 54' ' ' PRO . 1.6 m -138.99 172.67 6.18 Favored Pre-proline 0 CA--C 1.513 -0.479 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.895 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.0 Cg_exo -86.55 166.98 8.9 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 124.761 3.641 . . . . 0.0 108.272 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.918 ' HB ' HG22 ' A' ' 78' ' ' ILE . 13.4 mm -72.46 99.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 117.756 -1.578 . . . . 0.0 107.122 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.87 137.1 44.32 Favored 'General case' 0 N--CA 1.405 -2.686 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.877 HD11 HG12 ' A' ' 78' ' ' ILE . 3.1 mp -72.33 134.15 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.911 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -139.75 -12.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.535 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 1.0 OUTLIER -134.49 116.08 14.68 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.317 0.58 . . . . 0.0 110.994 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.723 HG23 ' CB ' ' A' ' 66' ' ' ALA . 3.3 mm -123.18 112.15 32.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.788 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.814 ' CE1' ' CZ ' ' B' ' 119' ' ' ARG . 5.3 m170 -71.88 136.62 82.56 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.267 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -57.6 142.63 95.7 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.839 1.693 . . . . 0.0 112.561 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 46.36 19.84 0.49 Allowed Glycine 0 N--CA 1.432 -1.57 0 CA-C-N 115.216 -0.902 . . . . 0.0 114.23 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 1.11 ' O ' ' N ' ' A' ' 66' ' ' ALA . 8.6 mm100 -96.04 165.93 15.39 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.729 ' HB3' HD21 ' A' ' 33' ' ' LEU . 31.9 Cg_exo -28.31 2.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.421 2.081 . . . . 0.0 113.734 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.11 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.93 -36.32 19.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 64' ' ' GLN . 4.6 t0 -102.19 -13.1 17.57 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.265 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -26.46 43.95 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.911 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 1.002 ' HB2' HD12 ' A' ' 33' ' ' LEU . 8.6 t -95.08 -1.53 51.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 48.94 10.07 0.12 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.464 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.734 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -133.47 7.42 4.97 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.063 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.668 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 5.5 mt -97.65 154.66 17.41 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 121.433 0.635 . . . . 0.0 110.844 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.97 126.65 0.06 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.253 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 75' ' ' GLY . 2.3 p -60.42 159.39 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.355 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 108.9 -24.29 21.84 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.27 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.568 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -85.03 150.43 24.88 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.704 0.764 . . . . 0.0 109.226 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 110' ' ' VAL . . . -88.06 137.55 32.23 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.137 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.918 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -100.47 149.19 6.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.884 -178.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -137.6 -50.89 0.62 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.363 -178.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.928 ' HB1' ' O ' ' A' ' 84' ' ' VAL . . . -147.81 175.93 10.53 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.006 1.114 . . . . 0.0 114.006 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -143.06 154.58 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.157 178.437 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.833 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.7 p30 63.13 5.14 1.8 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.987 -1.46 . . . . 0.0 112.462 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' N ' ' CD ' ' A' ' 106' ' ' GLU . . . 102.4 5.71 48.59 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.82 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.928 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 21.1 t -123.8 136.53 59.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 117.004 0.402 . . . . 0.0 111.319 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.761 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 38.3 t-20 -61.39 133.29 55.64 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.8 HD13 ' HA ' ' A' ' 80' ' ' ALA . 6.1 mp -103.22 86.43 2.68 Favored 'General case' 0 CA--C 1.465 -2.325 0 C-N-CA 118.278 -1.369 . . . . 0.0 108.98 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 5.3 tpp85 -100.6 94.4 6.09 Favored 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 173.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.667 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 20.7 m-20 -134.25 96.46 3.61 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.699 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.958 HG23 ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER 29.28 -132.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.643 179.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.743 ' N ' ' OG1' ' A' ' 89' ' ' THR . 6.7 mttp -75.46 169.74 17.49 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.843 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.693 ' NE2' ' HB ' ' B' ' 118' ' ' THR . 4.9 t-160 -45.26 -49.97 12.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -175.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 1.029 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 0.3 OUTLIER -59.29 -20.04 51.1 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.847 -176.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.958 ' HG3' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER -66.51 -25.02 66.49 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 97' ' ' ILE . . . -82.59 -38.65 23.32 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.778 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.969 HG23 ' HA ' ' A' ' 92' ' ' LYS . 1.6 t -57.29 -43.48 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.035 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 93' ' ' GLU . 7.8 t -62.47 -36.24 81.84 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.561 ' O ' ' CG ' ' A' ' 101' ' ' GLN . 3.2 mm -69.49 -47.33 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.947 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.632 HD13 ' CD2' ' B' ' 120' ' ' LEU . 2.2 pp -73.0 -31.31 64.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.981 0.42 . . . . 0.0 111.561 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.43 ' N ' HD12 ' A' ' 98' ' ' LEU . 80.6 p -52.41 -47.99 65.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.828 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -123.35 6.49 9.04 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.561 ' CG ' ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -51.98 -61.55 2.19 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.987 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.07 176.44 11.89 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.716 0.293 . . . . 0.0 110.671 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.94 -33.5 41.18 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 119.992 -1.099 . . . . 0.0 111.286 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 31.4 tt0 -103.42 118.65 37.23 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.756 -1.222 . . . . 0.0 110.062 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.691 HG12 HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.16 121.67 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.613 0 CA-C-O 123.01 1.386 . . . . 0.0 108.99 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.833 ' HB3' ' HA ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -94.04 123.04 37.16 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 111.959 -2.382 . . . . 0.0 107.628 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 17.7 m-85 -98.26 117.64 33.09 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.582 -177.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -109.72 116.83 32.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 175.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 11.2 m -121.15 149.81 24.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 122.013 0.911 . . . . 0.0 113.439 -176.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.637 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 31.5 t -117.49 148.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 113.674 -1.603 . . . . 0.0 111.063 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -86.34 121.22 28.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.042 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 77' ' ' ALA . 4.7 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.127 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . 0.59 ' OD1' ' CE1' ' A' ' 51' ' ' HIS . 10.8 m-20 . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 1.029 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -165.21 163.58 20.19 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 -178.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' ARG . . . . . 0.814 ' CZ ' ' CE1' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -137.05 111.62 8.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.94 178.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.632 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.4 mp . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.704 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.92 138.68 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-O 122.067 0.937 . . . . 0.0 111.962 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.448 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 7.0 mtt-85 -138.04 118.54 13.86 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.391 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 5.7 mtpt -97.28 119.55 36.01 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 122.316 1.055 . . . . 0.0 112.167 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.689 HG11 ' C ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.95 117.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.897 177.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.83 110.39 22.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.419 0.628 . . . . 0.0 112.135 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.7 OUTLIER -113.33 115.68 28.51 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.101 178.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.515 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -118.1 105.46 11.86 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.315 -177.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -99.13 161.41 13.63 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.855 -1.521 . . . . 0.0 110.573 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -86.91 126.0 34.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.266 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 57.72 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.335 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.483 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . 9.3 p80 -177.3 40.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.019 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -65.91 62.71 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.283 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 38' ' ' HIS . . . 56.39 164.24 0.04 OUTLIER Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.597 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.897 HD13 HD23 ' B' ' 120' ' ' LEU . 0.3 OUTLIER -101.65 -66.09 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.527 0.664 . . . . 0.0 111.182 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.902 ' O ' HD13 ' A' ' 43' ' ' ILE . . . 110.61 16.82 9.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.925 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.953 HD12 HD13 ' A' ' 60' ' ' ILE . 18.0 mm -135.75 156.98 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.549 ' HB2' ' CZ ' ' B' ' 119' ' ' ARG . 32.8 t -130.11 148.64 51.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.759 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.604 HD11 HD11 ' B' ' 120' ' ' LEU . 0.9 OUTLIER -134.21 158.76 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.929 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.484 ' N ' ' HE1' ' A' ' 91' ' ' HIS . 17.3 p -155.2 137.81 15.14 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.807 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.777 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 144.57 176.52 18.66 Favored Glycine 0 N--CA 1.422 -2.26 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.301 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 142.96 -168.2 26.08 Favored Glycine 0 C--N 1.3 -1.431 0 CA-C-N 114.886 -0.657 . . . . 0.0 112.586 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -78.15 -2.15 36.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.465 0.174 . . . . 0.0 111.238 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 1.3 pt-20 -98.85 -33.45 10.87 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.481 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.778 ' NE2' ' OD1' ' B' ' 117' ' ' ASP . 29.6 m-70 -96.33 10.64 37.4 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.409 0.623 . . . . 0.0 110.02 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.58 24.66 53.5 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.356 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.9 OUTLIER -136.34 172.83 6.38 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-O 121.898 0.856 . . . . 0.0 113.029 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.903 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.0 Cg_exo -85.36 170.78 9.16 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 124.691 3.594 . . . . 0.0 108.543 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.083 HG23 ' CE1' ' A' ' 91' ' ' HIS . 33.5 mm -72.65 105.57 2.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 118.744 -1.182 . . . . 0.0 108.59 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.528 HD23 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -109.75 146.42 34.97 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.821 HD11 HG12 ' A' ' 78' ' ' ILE . 3.1 mp -72.45 134.87 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.418 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.2 p -137.78 -19.14 1.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.611 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 3.6 tt0 -136.27 115.61 12.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.0 110.07 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.953 HD13 HD12 ' A' ' 43' ' ' ILE . 1.9 mm -128.51 104.98 12.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.705 0.764 . . . . 0.0 111.623 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 1.028 ' NE2' ' NH2' ' B' ' 119' ' ' ARG . 74.8 m-70 -70.24 137.12 86.66 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.516 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.43 145.01 81.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.186 1.924 . . . . 0.0 111.182 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.01 6.25 9.37 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.967 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 1.136 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -96.59 166.81 13.35 Favored Pre-proline 0 N--CA 1.431 -1.411 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.758 ' HB2' HD11 ' A' ' 43' ' ' ILE . 29.8 Cg_exo -17.36 -4.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.053 3.169 . . . . 0.0 115.386 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.136 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -84.9 -35.76 21.92 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.32 -7.23 19.0 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.926 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.401 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 3.2 mmt180 -92.32 -26.28 18.18 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.688 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.787 ' HB2' HD12 ' A' ' 33' ' ' LEU . 35.3 t -107.0 7.4 29.84 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 43.18 14.28 0.02 OUTLIER Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.421 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.689 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -144.32 9.62 1.95 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 119.542 -1.313 . . . . 0.0 114.714 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.934 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 7.5 mt -98.71 153.71 18.51 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 117.948 0.874 . . . . 0.0 109.976 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.97 130.9 0.1 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.19 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 75' ' ' GLY . 2.7 p -61.4 159.4 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.792 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.515 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 100.24 -21.76 43.02 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.145 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -87.8 150.71 23.39 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.52 0.676 . . . . 0.0 109.633 178.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . . . -88.49 144.02 26.61 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.709 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.821 HG12 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -106.34 125.96 62.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.429 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.5 OUTLIER -97.37 -51.9 4.0 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.196 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.945 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -162.37 176.7 10.25 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 52.6 t -131.89 152.15 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.589 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.714 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 1.2 p30 58.73 6.33 0.6 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.492 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.54 12.02 49.22 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.461 -0.875 . . . . 0.0 114.024 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.871 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 25.7 t -123.28 123.26 67.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 117.108 0.454 . . . . 0.0 111.202 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.945 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 7.5 p-10 -60.89 127.21 30.46 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.929 HD21 HG21 ' A' ' 97' ' ' ILE . 4.9 mp -106.64 86.16 2.29 Favored 'General case' 0 N--CA 1.416 -2.155 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 mmt-85 -98.63 94.84 6.88 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 89' ' ' THR . 4.8 m-20 -133.91 95.57 3.48 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.063 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.589 ' C ' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -2.56 -67.61 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.179 0.99 . . . . 0.0 111.803 178.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -75.13 134.4 41.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 113.482 -1.69 . . . . 0.0 111.626 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 1.083 ' CE1' HG23 ' A' ' 55' ' ' ILE . 6.7 t60 -64.11 -39.59 94.37 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.411 -1.722 . . . . 0.0 108.182 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.88 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -62.32 -22.01 65.72 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.189 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -64.64 -23.72 67.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.575 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -79.12 -45.77 19.35 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.816 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.88 HG23 ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -57.56 -45.6 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.874 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.6 t -60.3 -37.74 81.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.929 HG21 HD21 ' A' ' 86' ' ' LEU . 2.7 mt -69.85 -46.61 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.462 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.768 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 1.4 pp -76.12 -31.07 58.47 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.006 0.431 . . . . 0.0 111.642 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.8 t -53.68 -50.14 66.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -114.08 14.19 18.26 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.827 ' NE2' HD12 ' A' ' 105' ' ' ILE . 0.0 OUTLIER -49.27 -86.49 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.87 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.411 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 4.7 ttt180 -151.63 176.55 11.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.6 -23.49 68.82 Favored Glycine 0 CA--C 1.504 -0.635 0 C-N-CA 119.528 -1.32 . . . . 0.0 112.428 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 20.7 mt-10 -104.09 117.52 34.47 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.267 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.827 HD12 ' NE2' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -98.43 116.72 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.926 0 CA-C-O 122.802 1.287 . . . . 0.0 107.565 178.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.714 ' HB3' ' HA ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -96.09 140.11 31.28 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 112.813 -1.994 . . . . 0.0 108.739 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 12.2 m-85 -124.71 118.03 25.53 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.603 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.799 ' OE2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -105.11 116.71 32.4 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 176.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 6.1 m -121.94 156.36 26.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -176.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.669 ' HB ' ' HB3' ' A' ' 77' ' ' ALA . 18.8 t -117.9 116.15 50.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.941 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -81.76 125.66 30.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.077 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' ASP . . . . . 0.778 ' OD1' ' NE2' ' A' ' 51' ' ' HIS . 80.4 m-20 . . . . . 0 N--CA 1.472 0.657 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.64 ' HB ' ' CD2' ' A' ' 91' ' ' HIS . 7.1 m -155.65 156.51 35.12 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' ARG . . . . . 1.028 ' NH2' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -136.74 125.62 24.16 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.892 178.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.897 HD23 HD13 ' A' ' 41' ' ' LEU . 3.7 mp . . . . . 0 C--O 1.255 1.392 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.965 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.421 ' CG1' ' HB3' ' A' ' 108' ' ' GLU . 0.6 OUTLIER -78.92 138.8 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-O 122.098 0.951 . . . . 0.0 111.903 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.663 ' HB2' HG22 ' A' ' 109' ' ' VAL . 13.6 mtt-85 -138.34 116.64 11.91 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.319 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.6 OUTLIER -96.65 119.86 35.91 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.567 1.175 . . . . 0.0 113.171 -178.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.776 HG12 ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -117.64 117.95 56.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 112.533 -2.121 . . . . 0.0 108.303 177.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mp -95.3 110.21 22.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.106 0.479 . . . . 0.0 111.483 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.834 HD12 ' HB2' ' A' ' 69' ' ' CYS . 1.2 tt -113.52 112.29 23.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.641 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 34' ' ' LEU . 3.9 mp -117.13 101.58 8.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.727 0.775 . . . . 0.0 111.614 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.38 130.86 45.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.538 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 38' ' ' HIS . 55.3 mt-10 -137.97 160.27 39.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.803 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 38' ' ' HIS . 0.8 OUTLIER 59.59 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.531 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 58.2 m-70 -34.47 -55.63 0.53 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.643 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 4.9 tp10 94.54 172.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.92 163.83 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.1 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.044 HD22 HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -105.7 -82.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.749 0.309 . . . . 0.0 111.364 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.44 22.86 1.04 Allowed Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.044 HG22 HD22 ' A' ' 41' ' ' LEU . 13.5 tt -135.18 158.27 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 C-N-CA 122.79 0.436 . . . . 0.0 109.849 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.516 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 41.1 t -130.74 146.19 52.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.988 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.574 ' O ' ' CE1' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -139.88 159.09 26.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 CA-C-O 122.189 0.995 . . . . 0.0 112.634 -179.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.4 ' HA ' ' ND1' ' A' ' 91' ' ' HIS . 0.7 OUTLIER -161.74 137.27 7.59 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.748 178.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.836 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 151.4 168.96 16.48 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.492 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 141.03 -164.62 26.44 Favored Glycine 0 C--N 1.304 -1.238 0 CA-C-N 114.367 -0.917 . . . . 0.0 112.125 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -76.89 -17.44 58.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 0.0 110.041 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.447 ' OE2' HG11 ' B' ' 115' ' ' VAL . 2.7 tt0 -71.94 -42.7 66.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.947 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.749 ' NE2' ' OD1' ' B' ' 117' ' ' ASP . 21.3 m-70 -99.62 12.01 37.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.41 0.624 . . . . 0.0 110.178 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.93 23.9 40.12 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.75 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -131.83 173.63 5.65 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 121.923 0.868 . . . . 0.0 113.079 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.908 ' O ' HG23 ' A' ' 53' ' ' VAL . 4.4 Cg_exo -87.2 160.45 8.47 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.644 3.563 . . . . 0.0 108.256 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.011 HD11 ' HA ' ' A' ' 91' ' ' HIS . 25.2 mm -73.2 99.87 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.188 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 54' ' ' PRO . 6.9 mp -104.38 141.4 36.4 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.793 HD11 HG12 ' A' ' 78' ' ' ILE . 4.6 mp -71.12 129.3 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.198 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.63 -18.71 3.86 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 1.3 tt0 -137.27 115.88 12.07 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.737 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.749 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 2.8 mm -129.03 108.78 17.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.143 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.924 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 65.3 m-70 -70.0 137.15 87.23 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.089 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.44 145.15 80.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.212 1.941 . . . . 0.0 111.307 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.66 6.27 4.71 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.745 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 1.136 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -96.85 167.1 12.67 Favored Pre-proline 0 N--CA 1.429 -1.495 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.94 ' CG ' HD23 ' A' ' 41' ' ' LEU . 10.8 Cg_exo -11.7 -9.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 124.745 3.63 . . . . 0.0 116.079 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.136 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.4 -35.69 21.17 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.44 -5.47 20.31 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.082 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.513 ' HG2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -93.05 -26.48 17.47 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.339 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.834 ' HB2' HD12 ' A' ' 33' ' ' LEU . 41.6 t -106.79 6.13 29.24 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 45.05 14.22 0.04 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.075 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.733 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -144.9 7.03 1.64 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 119.605 -1.283 . . . . 0.0 114.86 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.892 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 8.2 mt -97.18 151.09 20.16 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 118.216 1.008 . . . . 0.0 109.428 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.92 130.76 0.06 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.268 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 57' ' ' ILE . 2.1 p -58.92 159.12 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.638 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 106.91 -23.98 26.34 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.724 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.88 149.65 22.54 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.676 0.75 . . . . 0.0 110.022 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.86 ' HB3' HG23 ' A' ' 110' ' ' VAL . . . -89.3 131.84 35.2 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.52 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.03 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -104.3 138.35 29.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.276 -178.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.092 ' HA ' HD12 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -148.22 -2.96 0.51 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.818 -177.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.038 ' CB ' ' HA ' ' A' ' 84' ' ' VAL . . . -157.2 138.05 13.32 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.865 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 21.5 t -140.28 143.85 28.78 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.11 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.597 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 5.6 p30 46.09 26.21 0.4 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.372 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.401 ' C ' ' CG1' ' A' ' 84' ' ' VAL . . . 128.05 44.86 0.21 Allowed Glycine 0 N--CA 1.464 0.525 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.38 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.038 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 1.5 p 43.37 77.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.452 1.101 . . . . 0.0 112.242 -177.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.66 ' H ' ' H ' ' A' ' 81' ' ' VAL . 19.8 m120 -130.98 92.76 3.27 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.092 HD12 ' HA ' ' A' ' 79' ' ' LEU . 2.0 mt -123.16 92.19 3.64 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 171.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.524 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -65.07 141.17 58.83 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.531 -176.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.16 96.33 10.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.084 -1.416 . . . . 0.0 114.475 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 1.025 ' CG2' ' OE1' ' B' ' 116' ' ' GLN . 0.9 OUTLIER -157.6 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 112.601 -2.09 . . . . 0.0 105.828 174.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.869 ' H ' HG22 ' A' ' 89' ' ' THR . 25.2 mttm -132.48 168.28 18.47 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 1.011 ' HA ' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -47.36 -34.7 7.24 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.358 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.865 ' HB2' ' CG ' ' B' ' 116' ' ' GLN . 0.0 OUTLIER -58.43 -15.49 11.02 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.577 -177.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.778 ' CG ' ' HB ' ' A' ' 89' ' ' THR . 9.6 mm-40 -64.16 -23.29 67.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.759 ' HB2' HD22 ' A' ' 86' ' ' LEU . . . -86.89 -39.42 15.81 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.895 HG22 HG21 ' B' ' 118' ' ' THR . 4.4 t -58.01 -46.02 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -61.95 -37.0 83.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.429 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -69.85 -47.15 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.746 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 1.078 HD22 HD21 ' B' ' 120' ' ' LEU . 2.7 pp -76.74 -35.99 57.42 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.463 ' N ' HD12 ' A' ' 98' ' ' LEU . 17.3 t -61.03 -54.23 47.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 101' ' ' GLN . 7.1 mm100 -85.12 -16.98 38.7 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.746 ' OE1' HD13 ' A' ' 105' ' ' ILE . 1.1 pt20 -54.63 -112.23 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.576 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -147.47 177.32 9.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.99 -4.42 7.47 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.449 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.439 ' CB ' ' HG ' ' A' ' 34' ' ' LEU . 32.1 tt0 -103.17 116.73 33.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.548 0.69 . . . . 0.0 111.306 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.746 HD13 ' OE1' ' A' ' 101' ' ' GLN . 26.1 mm -103.22 112.45 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.865 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -95.28 122.54 38.08 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.701 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 44.0 m-85 -109.99 117.81 34.76 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.702 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.633 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 1.3 mt-10 -108.66 115.85 30.88 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.663 HG22 ' HB2' ' A' ' 29' ' ' ARG . 10.4 m -121.68 147.89 25.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 114.562 -1.199 . . . . 0.0 114.192 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.975 HG22 HD21 ' A' ' 79' ' ' LEU . 27.6 m -117.4 152.1 19.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 113.649 -1.614 . . . . 0.0 111.342 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -82.19 126.75 32.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' A' ' 77' ' ' ALA . 21.9 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.781 0.324 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -100.33 -34.15 10.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.447 HG11 ' OE2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -63.32 -76.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.583 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLN . . . . . 1.025 ' OE1' ' CG2' ' A' ' 89' ' ' THR . 0.0 OUTLIER -175.92 -23.97 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . 0.749 ' OD1' ' NE2' ' A' ' 51' ' ' HIS . 8.4 m-20 -54.0 176.13 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 118.819 -0.61 . . . . 0.0 109.616 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.895 HG21 HG22 ' A' ' 95' ' ' VAL . 0.7 OUTLIER -167.66 166.59 13.84 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -178.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ARG . . . . . 0.924 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -131.86 123.63 27.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.071 -1.877 . . . . 0.0 108.663 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 1.078 HD21 HD22 ' A' ' 98' ' ' LEU . 1.1 mp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.92 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 tt -80.19 138.71 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 122.024 0.916 . . . . 0.0 112.047 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.45 ' CB ' HG22 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -136.33 121.74 19.38 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.688 -1.597 . . . . 0.0 109.948 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -104.49 119.4 38.89 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.273 1.035 . . . . 0.0 112.475 -178.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.656 HG11 ' C ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.53 117.84 55.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 113.311 -1.768 . . . . 0.0 108.38 177.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mp -96.24 113.8 25.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.099 0.476 . . . . 0.0 111.438 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.755 HD12 ' HB2' ' A' ' 69' ' ' CYS . 2.2 tt -113.07 109.22 18.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HG ' ' CB ' ' A' ' 104' ' ' GLU . 3.1 mp -116.02 104.73 11.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.922 0.868 . . . . 0.0 110.961 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.76 161.32 13.71 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.704 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.97 136.17 33.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.626 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 47.7 25.3 0.67 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.516 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.501 ' CD2' ' HA2' ' A' ' 103' ' ' GLY . 2.4 m170 46.26 29.57 0.86 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.197 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.9 81.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.816 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' HIS . . . 55.61 170.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.382 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.114 HD22 HG22 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -108.59 -76.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.699 0.749 . . . . 0.0 111.38 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 121.64 23.88 2.47 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.114 HG22 HD22 ' A' ' 41' ' ' LEU . 14.9 tt -135.5 158.31 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -130.88 148.07 52.6 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.498 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.622 HD11 HD11 ' B' ' 120' ' ' LEU . 0.8 OUTLIER -135.0 159.01 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.265 -178.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.501 ' N ' ' HE1' ' A' ' 91' ' ' HIS . 67.5 p -156.22 137.33 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.36 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.813 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 151.85 169.1 16.96 Favored Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.314 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 144.73 -166.75 27.31 Favored Glycine 0 C--N 1.303 -1.297 0 CA-C-N 114.567 -0.816 . . . . 0.0 111.449 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.405 ' CB ' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -76.72 -14.76 59.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.983 0.392 . . . . 0.0 110.95 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.581 ' HB3' ' HB2' ' B' ' 116' ' ' GLN . 1.5 tp10 -75.53 -41.41 55.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 110.27 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.499 ' NE2' ' O ' ' B' ' 115' ' ' VAL . 13.9 m-70 -98.9 11.32 39.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.519 0.676 . . . . 0.0 110.161 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.18 23.24 32.18 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.565 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 54' ' ' PRO . 1.1 m -128.19 170.94 9.33 Favored Pre-proline 0 CA--C 1.512 -0.496 0 CA-C-O 121.959 0.885 . . . . 0.0 113.014 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.919 ' O ' HG23 ' A' ' 53' ' ' VAL . 7.5 Cg_exo -83.09 173.72 9.82 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 124.579 3.519 . . . . 0.0 108.132 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.013 HG23 ' CE1' ' A' ' 91' ' ' HIS . 39.4 mm -72.76 107.71 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.524 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.86 145.83 34.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -177.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.871 HD11 HG12 ' A' ' 78' ' ' ILE . 3.8 mp -71.87 130.73 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.532 ' HA ' HG23 ' A' ' 74' ' ' VAL . 11.8 t -132.18 -22.45 2.27 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 44' ' ' SER . 0.2 OUTLIER -137.4 115.84 11.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.252 0.548 . . . . 0.0 110.21 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.883 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 3.4 mm -125.43 107.06 17.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.72 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.984 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 39.2 m-70 -71.41 137.04 83.72 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.39 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.43 141.36 89.77 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.157 1.905 . . . . 0.0 111.227 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.33 0.92 8.62 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.609 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 1.112 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -96.43 167.36 12.42 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.896 ' HG3' HD23 ' A' ' 41' ' ' LEU . 6.2 Cg_exo -10.92 -9.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 125.075 3.85 . . . . 0.0 116.216 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.112 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.02 -35.83 21.67 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -102.14 -8.7 21.14 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.494 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 10.4 mmt180 -92.69 -26.44 17.79 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.439 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.755 ' HB2' HD12 ' A' ' 33' ' ' LEU . 42.9 t -107.6 6.14 27.62 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 44.58 13.68 0.03 OUTLIER Glycine 0 C--N 1.336 0.557 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.35 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.656 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -149.63 12.25 1.0 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 119.431 -1.366 . . . . 0.0 115.152 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.79 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 10.0 mt -99.04 150.53 21.9 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 118.223 1.012 . . . . 0.0 110.159 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.1 t60 174.52 145.36 0.06 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.997 0.903 . . . . 0.0 111.611 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.584 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 7.3 p -65.4 147.49 12.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.951 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.79 -17.77 24.98 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.024 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -92.52 149.46 21.36 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.588 0.709 . . . . 0.0 110.324 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.999 ' HB3' HG23 ' A' ' 110' ' ' VAL . . . -89.68 134.39 34.18 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.501 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.871 HG12 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -105.82 119.99 55.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.628 0.728 . . . . 0.0 111.608 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.007 HD21 HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -96.16 -41.57 8.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.297 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.864 ' HB1' ' O ' ' A' ' 84' ' ' VAL . . . -162.61 176.94 9.85 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.919 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -140.95 154.89 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.604 178.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.792 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.2 p30 59.33 7.55 0.95 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.69 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.11 10.1 49.81 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.698 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.864 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 21.3 t -120.71 125.5 74.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.855 0.327 . . . . 0.0 110.769 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.743 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 14.6 p-10 -61.79 125.3 23.34 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.042 0.449 . . . . 0.0 109.945 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.032 HD21 HG21 ' A' ' 97' ' ' ILE . 4.0 mp -106.8 86.34 2.31 Favored 'General case' 0 N--CA 1.413 -2.278 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.004 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -83.58 96.67 8.71 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . 65.7 m-20 -132.61 99.31 4.6 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.675 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.835 ' O ' ' HG2' ' B' ' 116' ' ' GLN . 0.1 OUTLIER -56.42 -45.38 80.75 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' B' ' 116' ' ' GLN . 0.0 OUTLIER -73.91 128.75 36.35 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 1.013 ' CE1' HG23 ' A' ' 55' ' ' ILE . 5.5 t60 -65.44 -40.32 93.14 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.063 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 1.06 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 1.3 mmtm -62.71 -22.35 66.45 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.856 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -65.27 -24.18 67.24 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.986 -0.685 . . . . 0.0 109.55 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.535 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -81.92 -45.09 15.92 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.262 0.553 . . . . 0.0 110.068 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.933 HG22 HG21 ' B' ' 118' ' ' THR . 2.0 t -57.31 -41.71 78.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.328 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -62.88 -38.6 91.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.003 0.906 . . . . 0.0 108.567 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.032 HG21 HD21 ' A' ' 86' ' ' LEU . 2.1 mm -69.87 -46.75 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.534 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.852 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 2.0 pp -75.21 -31.42 60.9 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.935 0.398 . . . . 0.0 111.756 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.418 ' N ' HD12 ' A' ' 98' ' ' LEU . 35.1 t -57.13 -53.72 54.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.79 2.85 30.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.852 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -50.64 -93.1 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.812 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.431 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -151.31 173.66 14.23 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.501 ' HA2' ' CD2' ' A' ' 38' ' ' HIS . . . -66.78 -12.14 58.98 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 119.594 -1.288 . . . . 0.0 112.881 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.452 ' CB ' ' HG ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -103.62 117.86 35.39 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.341 0.591 . . . . 0.0 111.777 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.745 HG13 HD11 ' A' ' 41' ' ' LEU . 20.2 mm -100.14 111.88 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.919 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -95.27 118.6 32.32 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.631 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 38.8 m-85 -102.49 117.57 34.98 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.532 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.643 ' CD ' ' HB3' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -103.0 115.45 30.63 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 175.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 6.9 m -124.34 156.99 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -175.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.007 HG22 HD21 ' A' ' 79' ' ' LEU . 1.8 m -128.37 152.24 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.247 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -89.0 118.53 28.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.112 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.767 0.318 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.489 ' O ' HG12 ' B' ' 115' ' ' VAL . 0.4 OUTLIER -179.58 -47.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.759 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.629 ' O ' HG22 ' B' ' 115' ' ' VAL . 13.1 p 45.12 27.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.843 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLN . . . . . 0.835 ' HG2' ' O ' ' A' ' 89' ' ' THR . 0.0 OUTLIER 22.57 89.55 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 178.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . 0.423 ' OD2' ' CE1' ' A' ' 51' ' ' HIS . 69.5 m-20 -165.29 160.72 18.59 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.342 0.657 . . . . 0.0 109.677 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 1.06 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 2.9 m -166.02 162.1 17.74 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ARG . . . . . 0.984 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -135.1 129.25 33.65 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.102 178.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.801 HD21 HD22 ' A' ' 98' ' ' LEU . 2.8 mp . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.705 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.78 138.6 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 122.027 0.918 . . . . 0.0 112.019 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -139.59 118.72 12.68 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 113.652 -1.613 . . . . 0.0 110.35 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -100.34 119.49 38.51 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 122.307 1.051 . . . . 0.0 112.941 -178.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -115.62 118.05 57.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 113.308 -1.769 . . . . 0.0 107.924 176.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.24 115.82 28.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.975 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -113.72 124.33 52.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.861 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 4.8 mp -117.22 102.02 8.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.746 0.784 . . . . 0.0 111.742 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.19 161.2 13.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.3 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -137.96 148.19 45.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.027 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.432 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 13.1 t0 59.07 27.21 16.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.096 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.432 ' CG ' ' O ' ' A' ' 37' ' ' ASP . 21.0 p80 43.18 39.13 1.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.415 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.25 -21.27 47.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.92 178.81 16.41 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.532 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.779 HD22 HD22 ' B' ' 120' ' ' LEU . 1.2 tp -117.81 -19.07 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.116 0.458 . . . . 0.0 111.361 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.543 ' HA2' ' ND1' ' A' ' 61' ' ' HIS . . . 57.68 32.53 65.49 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.089 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.815 HG23 HD13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.14 157.52 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.474 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 5.4 t -130.87 147.87 52.57 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.465 0.65 . . . . 0.0 110.657 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.794 HG13 ' HB ' ' B' ' 118' ' ' THR . 0.5 OUTLIER -137.86 157.75 32.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.934 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.614 ' N ' ' HE1' ' A' ' 91' ' ' HIS . 21.9 p -160.94 152.36 19.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.482 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.767 ' CA ' HG22 ' A' ' 53' ' ' VAL . . . 139.16 -168.82 24.72 Favored Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.721 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 130.65 -169.03 21.54 Favored Glycine 0 C--N 1.3 -1.442 0 CA-C-N 114.098 -1.051 . . . . 0.0 113.199 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.42 -16.92 58.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.758 ' OE2' HG12 ' B' ' 115' ' ' VAL . 12.5 pt-20 -84.46 -34.42 23.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.973 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.675 ' O ' HG13 ' A' ' 53' ' ' VAL . 27.1 m-70 -95.71 9.72 39.39 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.492 0.663 . . . . 0.0 109.726 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.2 23.48 52.88 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.897 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -139.58 177.44 2.03 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-O 121.663 0.745 . . . . 0.0 112.862 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.834 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.8 Cg_exo -88.21 173.21 4.86 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 124.561 3.507 . . . . 0.0 109.012 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.114 HG23 ' CE1' ' A' ' 91' ' ' HIS . 32.5 mm -72.44 99.15 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.95 139.1 41.02 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.86 HD11 HG12 ' A' ' 78' ' ' ILE . 3.3 mp -71.82 129.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.431 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 p -137.02 -13.85 1.6 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.781 ' OE1' ' NH1' ' B' ' 119' ' ' ARG . 0.4 OUTLIER -137.13 116.1 12.36 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.371 0.605 . . . . 0.0 110.532 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.843 HG23 ' CB ' ' A' ' 66' ' ' ALA . 3.0 mm -117.76 109.72 28.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.308 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.99 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 7.4 m170 -71.53 136.56 83.52 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.829 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -53.08 139.67 61.53 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.836 1.691 . . . . 0.0 113.071 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 41.76 25.14 0.19 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 114.635 -1.166 . . . . 0.0 114.308 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 1.084 ' O ' ' N ' ' A' ' 66' ' ' ALA . 7.6 mm100 -94.97 165.41 17.08 Favored Pre-proline 0 N--CA 1.419 -1.977 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.874 ' HB3' HD21 ' A' ' 33' ' ' LEU . 37.2 Cg_exo -30.54 2.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.273 1.982 . . . . 0.0 113.593 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.084 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.29 -36.41 19.35 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -101.8 -12.92 17.94 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.37 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -26.13 36.94 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.006 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.975 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -90.63 -5.03 56.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.68 8.77 0.39 Allowed Glycine 0 CA--C 1.519 0.33 0 CA-C-N 114.945 -1.025 . . . . 0.0 113.128 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.533 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -129.9 -1.66 5.37 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.691 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.907 HD11 HD13 ' A' ' 33' ' ' LEU . 4.1 mt -94.81 151.37 19.3 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 121.785 0.802 . . . . 0.0 111.518 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.4 t60 176.73 139.43 0.07 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.468 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 57' ' ' ILE . 2.9 p -66.89 147.46 12.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 113.829 -1.532 . . . . 0.0 112.3 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.22 -21.1 10.25 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.539 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.655 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -89.17 150.67 22.58 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.577 0.703 . . . . 0.0 109.677 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 110' ' ' VAL . . . -88.59 130.76 35.19 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.179 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.898 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -106.62 122.77 60.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.703 0.763 . . . . 0.0 110.939 -178.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.495 ' O ' HD23 ' A' ' 79' ' ' LEU . 5.2 tt -101.39 -50.63 3.7 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.217 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.949 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -148.67 176.77 10.07 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.891 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -138.88 153.22 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.691 177.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.627 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 0.0 OUTLIER 73.99 -18.1 0.42 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.532 -179.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 81' ' ' VAL . . . 118.98 9.59 8.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.752 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.913 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 20.4 t -127.96 133.03 68.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.949 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 8.2 p30 -61.09 131.87 51.96 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.775 HD23 HD13 ' A' ' 97' ' ' ILE . 5.4 mp -102.92 85.95 2.63 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 118.161 -1.415 . . . . 0.0 111.411 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.13 94.87 7.78 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 172.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.64 ' HB2' ' HB3' ' A' ' 93' ' ' GLU . 19.6 m-20 -134.3 97.52 3.86 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.511 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.783 ' OG1' ' OE1' ' B' ' 116' ' ' GLN . 0.3 OUTLIER 46.19 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.087 0.946 . . . . 0.0 109.515 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.773 ' HB2' ' CB ' ' B' ' 116' ' ' GLN . 0.5 OUTLIER -126.97 168.04 15.07 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.132 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 1.114 ' CE1' HG23 ' A' ' 55' ' ' ILE . 2.6 t-160 -46.06 -36.74 6.0 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 113.339 -1.755 . . . . 0.0 113.353 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.753 ' HB2' ' CG ' ' B' ' 116' ' ' GLN . 0.0 OUTLIER -61.0 -23.89 65.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 88' ' ' ASP . 0.3 OUTLIER -64.3 -22.34 66.92 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -71.17 -46.81 60.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.001 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.084 HG22 ' OG1' ' B' ' 118' ' ' THR . 0.0 OUTLIER -59.84 -47.32 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.668 0.747 . . . . 0.0 109.68 178.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 93' ' ' GLU . 1.2 t -62.74 -36.12 81.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.898 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.775 HD13 HD23 ' A' ' 86' ' ' LEU . 1.4 mt -65.07 -47.23 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.764 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.948 HD22 HD21 ' B' ' 120' ' ' LEU . 0.9 OUTLIER -76.35 -40.53 50.97 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.776 0.322 . . . . 0.0 110.869 179.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.509 ' N ' HD12 ' A' ' 98' ' ' LEU . 75.3 m -55.75 -28.34 55.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.202 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -91.54 30.94 1.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER 178.1 151.62 0.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.875 0.369 . . . . 0.0 111.293 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.2 ptt-85 -126.04 160.91 28.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.41 -151.54 21.18 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.156 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 9.3 pt-20 -85.15 117.94 24.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.79 0.805 . . . . 0.0 111.901 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.635 HG12 HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.56 121.7 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.516 0 CA-C-O 122.734 1.254 . . . . 0.0 107.814 177.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.891 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -93.5 127.71 39.27 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.3 -2.227 . . . . 0.0 108.645 -178.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.582 ' HD2' HD11 ' A' ' 78' ' ' ILE . 17.7 m-85 -104.32 117.62 34.64 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.024 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.714 ' CD ' ' HB3' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -107.67 116.26 31.63 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 7.6 m -122.13 154.77 26.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.59 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 15.7 t -118.42 132.36 68.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.918 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -81.68 107.81 14.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.105 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.814 0.34 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 60.22 -176.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.758 HG12 ' OE2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -74.0 -167.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.613 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLN . . . . . 0.783 ' OE1' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -155.71 121.01 4.86 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.005 0.431 . . . . 0.0 111.727 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . 0.568 ' OD2' ' CE1' ' A' ' 51' ' ' HIS . 6.4 m-20 -158.9 -173.19 4.13 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.446 0.698 . . . . 0.0 109.278 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 1.084 ' OG1' HG22 ' A' ' 95' ' ' VAL . 91.5 m -147.2 146.6 29.89 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ARG . . . . . 0.99 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -142.87 109.35 5.36 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.523 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.948 HD21 HD22 ' A' ' 98' ' ' LEU . 1.2 mp . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.5 -0.762 . . . . 0.0 111.852 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 tp -82.19 138.37 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 122.124 0.964 . . . . 0.0 112.105 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.546 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 5.8 mtt180 -140.22 116.9 10.88 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.928 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.47 119.42 37.98 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 122.332 1.063 . . . . 0.0 112.75 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.978 HG12 ' O ' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -109.96 116.89 53.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 112.966 -1.924 . . . . 0.0 107.05 176.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.14 114.36 27.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.285 0.564 . . . . 0.0 111.816 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.885 HD13 ' HB3' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -113.16 119.04 36.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.316 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 34' ' ' LEU . 4.4 mp -110.96 101.66 10.2 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.804 0.811 . . . . 0.0 110.848 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.57 134.43 42.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.812 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 38' ' ' HIS . 15.2 mt-10 -138.84 138.08 37.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.995 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 38' ' ' HIS . 3.6 m-20 60.93 -79.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.258 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.558 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 60.0 m80 -15.47 -63.97 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.952 0.501 . . . . 0.0 112.34 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.558 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 6.0 tt0 96.82 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.656 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 48.79 -174.09 0.04 OUTLIER Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.608 -0.805 . . . . 0.0 111.935 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.666 HD11 HG13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -125.37 -67.26 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.27 0.535 . . . . 0.0 111.416 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 64' ' ' GLN . . . 112.51 20.07 6.73 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.647 HG22 HD23 ' A' ' 41' ' ' LEU . 20.2 tt -125.18 160.52 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.149 0 CA-C-O 121.144 0.497 . . . . 0.0 110.458 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.42 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 3.2 t -128.26 146.92 50.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.693 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.048 HD11 HD11 ' B' ' 120' ' ' LEU . 0.6 OUTLIER -138.69 160.37 30.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.098 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.453 ' N ' ' CE1' ' A' ' 91' ' ' HIS . 66.7 p -158.75 138.77 12.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.27 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.548 ' N ' ' HD1' ' A' ' 91' ' ' HIS . . . 163.26 -141.0 6.83 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 140.96 160.98 8.51 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.15 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.515 ' CB ' ' HA ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -80.35 -16.75 53.83 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.402 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.643 ' HB3' HG11 ' B' ' 115' ' ' VAL . 1.3 pt-20 -70.06 -35.81 74.53 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.394 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 1.043 ' NE2' ' OE1' ' B' ' 116' ' ' GLN . 21.3 m-70 -97.37 15.1 23.99 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.533 0.682 . . . . 0.0 109.833 178.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.73 18.34 31.34 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.554 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 54' ' ' PRO . 1.9 m -103.58 154.05 38.16 Favored Pre-proline 0 CA--C 1.513 -0.456 0 CA-C-O 122.02 0.914 . . . . 0.0 113.249 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.825 ' O ' HG23 ' A' ' 53' ' ' VAL . 22.4 Cg_exo -77.41 -172.49 1.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 124.551 3.5 . . . . 0.0 109.424 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.04 HG23 ' CE1' ' A' ' 91' ' ' HIS . 50.4 mm -84.64 120.38 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.599 HD21 ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -105.73 126.53 52.26 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.844 HD12 HG22 ' A' ' 78' ' ' ILE . 3.2 mt -70.34 131.44 34.26 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.594 ' HA ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -140.17 -15.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.896 ' OE1' ' NH1' ' B' ' 119' ' ' ARG . 1.7 tt0 -137.57 116.14 12.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.092 0.472 . . . . 0.0 111.087 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.666 HG23 ' CD ' ' A' ' 64' ' ' GLN . 3.2 mm -116.19 106.09 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.708 0.766 . . . . 0.0 111.118 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.909 ' NE2' ' NH1' ' B' ' 119' ' ' ARG . 2.9 m170 -73.28 118.75 71.37 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.974 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 61' ' ' HIS . 3.2 Cg_endo -45.77 114.0 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.748 1.632 . . . . 0.0 110.836 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' HA2' ' CB ' ' A' ' 67' ' ' ASP . . . 105.97 1.43 39.15 Favored Glycine 0 N--CA 1.422 -2.266 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.804 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 1.154 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -94.41 166.55 15.14 Favored Pre-proline 0 CA--C 1.492 -1.266 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.969 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 69.4 Cg_exo -12.46 -9.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 124.969 3.779 . . . . 0.0 115.739 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.154 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.35 -35.98 19.51 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.491 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . 4.7 t70 -91.2 -12.5 35.17 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.505 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.969 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 3.7 mtt-85 -77.48 1.05 20.47 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 120.496 -0.481 . . . . 0.0 111.305 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 4.0 t 77.76 -17.28 0.58 Allowed 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.978 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -43.79 -31.78 1.97 Allowed Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.029 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.696 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 86.34 29.89 23.64 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.176 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.693 HD12 ' CB ' ' A' ' 65' ' ' PRO . 1.6 mt -90.82 151.76 21.04 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 122.255 1.026 . . . . 0.0 112.142 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.647 ' CD2' ' O ' ' A' ' 74' ' ' VAL . 1.9 t60 179.85 146.96 0.24 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.33 -1.759 . . . . 0.0 111.319 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.647 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 12.0 p -67.43 158.97 5.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.607 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.547 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 102.95 -19.18 47.57 Favored Glycine 0 C--N 1.316 -0.552 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.546 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.16 149.64 21.77 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.385 0.612 . . . . 0.0 109.989 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.507 ' HA ' HD13 ' A' ' 56' ' ' LEU . . . -89.15 129.37 35.76 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.684 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.849 HG23 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.15 113.82 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 121.527 0.679 . . . . 0.0 112.279 -177.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.004 HD21 HG23 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -89.64 -41.35 12.01 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.991 -178.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.944 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -162.67 177.53 9.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -175.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.045 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -133.71 154.49 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.367 178.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.723 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.6 p30 57.56 7.41 0.52 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.537 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.06 13.36 39.81 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.829 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.866 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 20.7 t -123.86 118.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.976 0.388 . . . . 0.0 111.511 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.944 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 2.7 m120 -61.33 124.7 21.33 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.884 HD21 HG21 ' A' ' 97' ' ' ILE . 4.6 mp -106.41 86.36 2.34 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.439 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -102.74 94.66 5.73 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 90' ' ' LYS . 1.1 m-20 -134.04 94.39 3.24 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.686 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 1.083 ' OG1' ' CG2' ' B' ' 115' ' ' VAL . 0.1 OUTLIER 14.72 -80.35 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 124.444 1.09 . . . . 0.0 111.92 178.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.756 ' HB3' ' HA ' ' B' ' 115' ' ' VAL . 0.0 OUTLIER -75.09 136.39 41.15 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 113.611 -1.631 . . . . 0.0 112.038 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 1.04 ' CE1' HG23 ' A' ' 55' ' ' ILE . 7.6 t60 -60.8 -36.31 78.7 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.657 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 1.008 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 1.7 mmtm -61.92 -22.6 65.73 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.267 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.492 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -64.97 -25.39 67.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.569 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -84.03 -44.16 14.4 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.746 HG23 ' CG2' ' B' ' 118' ' ' THR . 0.4 OUTLIER -57.2 -45.51 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.858 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.463 ' N ' ' CG1' ' A' ' 95' ' ' VAL . 14.6 t -61.42 -36.39 80.21 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.884 HG21 HD21 ' A' ' 86' ' ' LEU . 1.1 mt -69.49 -46.57 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.956 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.893 HD13 ' CD2' ' B' ' 120' ' ' LEU . 0.9 OUTLIER -75.22 -35.04 61.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.652 0.263 . . . . 0.0 111.161 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 93.5 p -57.31 -57.29 13.28 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.138 0.494 . . . . 0.0 110.439 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -66.26 -32.8 74.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.12 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -51.0 149.61 3.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.512 179.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.57 169.65 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.47 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.41 -132.13 12.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.453 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 1.1 pt-20 -84.73 126.46 33.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.666 HG13 HD11 ' A' ' 41' ' ' LEU . 20.7 mm -97.09 112.8 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 1.045 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -94.47 121.37 35.94 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.631 -179.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.565 ' CE1' ' CG2' ' A' ' 105' ' ' ILE . 34.5 m-85 -105.22 118.06 35.59 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.715 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.832 ' OE2' ' HB3' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -100.06 115.98 31.03 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 5.0 m -129.1 157.49 41.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.004 HG23 HD21 ' A' ' 79' ' ' LEU . 58.5 t -118.12 130.4 73.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.893 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -83.6 117.33 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.961 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.179 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.748 0.309 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 63.85 -77.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 1.083 ' CG2' ' OG1' ' A' ' 89' ' ' THR . 0.3 OUTLIER -156.94 28.17 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.906 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLN . . . . . 1.043 ' OE1' ' NE2' ' A' ' 51' ' ' HIS . 0.8 OUTLIER -167.97 164.6 13.8 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . . . . . . . . . 6.6 t70 70.66 138.71 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.228 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 1.008 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -170.79 159.8 6.58 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ARG . . . . . 0.909 ' NH1' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -124.28 165.44 17.64 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.512 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 1.048 HD11 HD11 ' A' ' 45' ' ' ILE . 5.9 mp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.247 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 tp -79.41 138.77 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.044 0.926 . . . . 0.0 112.028 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.487 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.9 OUTLIER -140.13 120.37 13.86 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.958 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -102.31 119.82 39.45 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 122.192 0.996 . . . . 0.0 112.661 -178.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.78 HG12 ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -113.58 117.94 56.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 113.342 -1.754 . . . . 0.0 108.673 177.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -91.3 112.0 23.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.41 0.624 . . . . 0.0 111.659 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.048 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.5 OUTLIER -114.42 115.42 27.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.02 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -116.69 100.59 7.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.004 0.907 . . . . 0.0 109.923 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -100.78 161.81 13.34 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.474 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -86.31 160.75 19.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.475 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -41.09 -26.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 1.3 t-160 -40.61 -57.1 1.95 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 38' ' ' HIS . 1.0 OUTLIER 101.57 160.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.468 0.707 . . . . 0.0 111.111 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.73 129.15 4.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.403 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.776 HD22 ' CG2' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -120.35 -9.67 9.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.787 0.327 . . . . 0.0 111.673 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA2' ' ND1' ' A' ' 61' ' ' HIS . . . 47.09 37.62 10.34 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.703 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.776 ' CG2' HD22 ' A' ' 41' ' ' LEU . 9.3 tt -135.05 158.59 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.517 ' HB3' ' CB ' ' A' ' 59' ' ' GLU . 6.8 t -130.03 147.88 51.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.768 0.794 . . . . 0.0 111.185 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.712 ' O ' ' HE1' ' A' ' 91' ' ' HIS . 1.2 pt -138.16 160.96 32.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.729 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 45' ' ' ILE . 7.1 p -160.64 136.48 8.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.955 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.556 ' CA ' HG22 ' A' ' 53' ' ' VAL . . . 163.01 -141.4 7.13 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 53' ' ' VAL . . . 160.69 128.68 0.97 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.1 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -74.51 -10.79 59.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 0.0 109.942 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HG3' ' CD2' ' A' ' 51' ' ' HIS . 0.5 OUTLIER -102.65 -24.87 13.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.235 179.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.964 ' NE2' ' OE1' ' B' ' 116' ' ' GLN . 54.5 m-70 -91.61 21.3 4.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.436 0.636 . . . . 0.0 110.457 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.23 14.34 56.36 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.405 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -129.75 137.21 30.41 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.594 ' O ' HG23 ' A' ' 53' ' ' VAL . 77.7 Cg_exo -63.65 156.48 56.96 Favored 'Trans proline' 0 C--N 1.331 -0.357 0 C-N-CA 124.001 3.134 . . . . 0.0 111.069 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.945 ' HB ' HG22 ' A' ' 78' ' ' ILE . 24.9 mm -74.26 108.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.647 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 54' ' ' PRO . 8.0 mp -103.86 139.28 39.27 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.91 HD11 HG12 ' A' ' 78' ' ' ILE . 3.2 mp -72.01 131.62 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.017 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 m -136.79 -17.47 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.517 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 0.5 OUTLIER -137.27 116.11 12.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.234 0.54 . . . . 0.0 110.844 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.78 HG23 ' CB ' ' A' ' 66' ' ' ALA . 4.2 mm -116.53 111.69 36.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.245 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.773 ' CE1' ' NH1' ' B' ' 119' ' ' ARG . 7.6 m170 -70.89 136.73 85.15 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.873 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.37 138.99 81.34 Favored 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 122.246 1.964 . . . . 0.0 113.119 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 42.19 25.33 0.25 Allowed Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.704 -1.135 . . . . 0.0 113.975 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 1.085 ' O ' ' N ' ' A' ' 66' ' ' ALA . 9.1 mm100 -95.21 165.34 17.06 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.626 ' HB2' HD23 ' A' ' 41' ' ' LEU . 49.1 Cg_exo -31.25 2.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.036 1.824 . . . . 0.0 113.255 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.085 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -86.15 -36.44 19.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -99.01 -13.95 19.67 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.346 177.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.541 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 29.6 mtp180 -76.19 -26.24 55.97 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.817 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 1.048 ' HB2' HD12 ' A' ' 33' ' ' LEU . 28.0 t -93.3 -1.78 55.66 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 48.85 11.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.985 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.73 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -136.75 5.61 3.73 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.489 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 6.3 mt -94.72 150.61 20.04 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 117.925 0.862 . . . . 0.0 109.357 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 179.6 133.22 0.1 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.627 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 75' ' ' GLY . 3.2 p -60.67 159.5 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.98 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.511 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 105.99 -24.5 26.47 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.709 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.542 ' O ' HD12 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -88.33 149.88 23.52 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.755 0.788 . . . . 0.0 109.874 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.852 ' HB2' HG13 ' A' ' 112' ' ' VAL . . . -88.68 133.6 34.16 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.562 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.945 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -102.97 145.3 12.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.497 -178.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.953 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -146.02 -20.13 0.45 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.012 ' HB1' ' N ' ' A' ' 85' ' ' ASN . . . -163.88 176.27 9.62 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.778 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -154.06 153.15 8.83 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.594 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 0.2 OUTLIER 77.95 -49.45 0.49 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.625 -1.625 . . . . 0.0 112.264 178.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' C ' ' CG1' ' A' ' 84' ' ' VAL . . . -154.78 32.61 0.68 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 84' ' ' VAL . 1.4 p 48.46 73.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 126.781 2.033 . . . . 0.0 113.177 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 1.012 ' N ' ' HB1' ' A' ' 80' ' ' ALA . 14.9 p-10 -136.35 97.28 3.54 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 113.27 -1.787 . . . . 0.0 112.68 172.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.953 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 7.1 mt -116.71 88.28 2.87 Favored 'General case' 0 CA--C 1.469 -2.139 0 CA-C-N 124.273 3.215 . . . . 0.0 108.549 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.51 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -112.55 92.73 4.12 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 173.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.682 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -137.65 93.13 2.76 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.369 178.094 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 1.03 ' OG1' ' CG1' ' B' ' 115' ' ' VAL . 1.0 OUTLIER 14.82 -124.89 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.684 ' N ' ' OG1' ' A' ' 89' ' ' THR . 3.5 mttp -75.29 168.56 19.76 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.768 ' NE2' ' HB ' ' B' ' 118' ' ' THR . 3.1 t-160 -44.61 -50.07 9.92 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -175.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.988 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 0.0 OUTLIER -60.77 -20.49 61.52 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.019 -176.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.682 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -65.86 -24.96 66.98 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.531 178.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.495 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -76.34 -38.61 55.68 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.92 HG23 ' HA ' ' A' ' 92' ' ' LYS . 1.4 t -61.9 -44.94 99.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.588 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.668 HG22 ' O ' ' A' ' 93' ' ' GLU . 5.3 t -61.55 -36.32 80.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -68.98 -46.63 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.825 179.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.694 ' CG ' ' HA ' ' A' ' 95' ' ' VAL . 2.6 pp -74.88 -33.15 62.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.789 0.328 . . . . 0.0 111.522 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.538 ' N ' HD12 ' A' ' 98' ' ' LEU . 29.6 t -57.41 -53.69 55.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.226 0.536 . . . . 0.0 110.719 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -69.9 -40.02 75.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.743 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.588 ' HG2' ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -55.71 156.01 5.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.789 0.328 . . . . 0.0 110.717 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.42 ' HA ' ' NE ' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -141.51 167.2 22.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.04 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.21 -130.65 10.32 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.463 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -98.2 128.76 44.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 122.169 0.985 . . . . 0.0 113.473 -178.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.607 ' CG2' ' CE1' ' A' ' 107' ' ' PHE . 30.8 mm -97.54 112.7 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.778 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -93.75 117.6 30.31 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 178.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 31.6 m-85 -99.25 118.61 36.32 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.616 -176.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.994 ' HG3' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -107.06 116.61 32.23 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.487 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 14.5 m -122.13 145.23 29.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.403 -0.919 . . . . 0.0 113.213 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.689 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 7.8 t -117.02 152.13 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.051 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -87.04 117.46 25.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.136 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.852 HG13 ' HB2' ' A' ' 77' ' ' ALA . 4.9 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.055 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.826 0.346 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.416 ' C ' ' CB ' ' A' ' 92' ' ' LYS . 21.1 tt0 -101.85 12.36 37.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.403 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 1.03 ' CG1' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -145.91 67.21 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.499 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLN . . . . . 0.964 ' OE1' ' NE2' ' A' ' 51' ' ' HIS . 0.0 OUTLIER 168.29 124.06 0.01 OUTLIER 'General case' 0 C--N 1.359 0.979 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . 0.526 ' HA ' ' CE1' ' A' ' 91' ' ' HIS . 14.6 m-20 52.6 150.68 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.988 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -169.02 157.33 7.82 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ARG . . . . . 0.773 ' NH1' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -133.74 121.32 21.72 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.992 178.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.673 HD21 HD22 ' A' ' 98' ' ' LEU . 2.4 mp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.814 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.31 134.64 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 C-N-CA 122.86 0.464 . . . . 0.0 111.239 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -142.45 122.22 13.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.177 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -106.11 119.46 39.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.149 0.976 . . . . 0.0 112.682 -178.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.734 HG11 ' C ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.5 118.28 57.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.854 177.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -89.86 110.06 21.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.926 0.869 . . . . 0.0 112.739 -177.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.002 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -115.39 115.46 26.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.488 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -118.66 101.57 8.21 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.636 0.731 . . . . 0.0 110.672 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.28 161.31 13.69 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.435 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -86.65 119.44 26.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.966 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 51.91 -137.75 1.16 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.528 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.44 41.63 1.08 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.75 0.31 . . . . 0.0 110.926 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -56.37 -22.93 34.32 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.05 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.0 174.86 31.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.148 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.784 HD22 HG12 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -111.62 -26.78 8.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 110.684 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 61' ' ' HIS . . . 65.29 33.1 85.82 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.784 HG12 HD22 ' A' ' 41' ' ' LEU . 1.8 pt -135.41 157.87 40.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 59' ' ' GLU . 1.7 t -130.61 147.72 52.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.667 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.732 HG13 HG22 ' B' ' 118' ' ' THR . 2.9 pt -137.58 159.92 34.6 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.634 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.422 ' HA ' ' ND1' ' A' ' 91' ' ' HIS . 69.4 p -160.29 135.75 8.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.686 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.873 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 165.42 170.16 30.0 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 119.807 -1.187 . . . . 0.0 112.944 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 148.63 -177.6 26.76 Favored Glycine 0 C--N 1.303 -1.255 0 CA-C-N 114.156 -1.022 . . . . 0.0 113.305 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -15.26 58.37 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 11.1 pt-20 -82.86 -35.73 26.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.991 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.59 ' CE1' ' OD1' ' B' ' 117' ' ' ASP . 30.9 m-70 -94.59 8.9 40.72 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.501 0.667 . . . . 0.0 109.562 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.29 55.31 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.828 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 54' ' ' PRO . 1.6 m -138.99 172.67 6.18 Favored Pre-proline 0 CA--C 1.513 -0.479 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.895 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.0 Cg_exo -86.55 166.98 8.9 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 124.761 3.641 . . . . 0.0 108.272 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.918 ' HB ' HG22 ' A' ' 78' ' ' ILE . 13.4 mm -72.46 99.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 117.756 -1.578 . . . . 0.0 107.122 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.87 137.1 44.32 Favored 'General case' 0 N--CA 1.405 -2.686 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.877 HD11 HG12 ' A' ' 78' ' ' ILE . 3.1 mp -72.33 134.15 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.911 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -139.75 -12.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.535 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 1.0 OUTLIER -134.49 116.08 14.68 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.317 0.58 . . . . 0.0 110.994 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.723 HG23 ' CB ' ' A' ' 66' ' ' ALA . 3.3 mm -123.18 112.15 32.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.788 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.814 ' CE1' ' CZ ' ' B' ' 119' ' ' ARG . 5.3 m170 -71.88 136.62 82.56 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.267 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -57.6 142.63 95.7 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.839 1.693 . . . . 0.0 112.561 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 46.36 19.84 0.49 Allowed Glycine 0 N--CA 1.432 -1.57 0 CA-C-N 115.216 -0.902 . . . . 0.0 114.23 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 1.11 ' O ' ' N ' ' A' ' 66' ' ' ALA . 8.6 mm100 -96.04 165.93 15.39 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.729 ' HB3' HD21 ' A' ' 33' ' ' LEU . 31.9 Cg_exo -28.31 2.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.421 2.081 . . . . 0.0 113.734 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.11 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -85.93 -36.32 19.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 64' ' ' GLN . 4.6 t0 -102.19 -13.1 17.57 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.265 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -26.46 43.95 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.911 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 1.002 ' HB2' HD12 ' A' ' 33' ' ' LEU . 8.6 t -95.08 -1.53 51.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 48.94 10.07 0.12 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.464 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.734 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -133.47 7.42 4.97 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.063 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.668 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 5.5 mt -97.65 154.66 17.41 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 121.433 0.635 . . . . 0.0 110.844 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 178.97 126.65 0.06 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.253 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 75' ' ' GLY . 2.3 p -60.42 159.39 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.355 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 108.9 -24.29 21.84 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.27 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.568 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -85.03 150.43 24.88 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.704 0.764 . . . . 0.0 109.226 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 110' ' ' VAL . . . -88.06 137.55 32.23 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.137 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.918 HG22 ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -100.47 149.19 6.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.884 -178.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -137.6 -50.89 0.62 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.363 -178.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.928 ' HB1' ' O ' ' A' ' 84' ' ' VAL . . . -147.81 175.93 10.53 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.006 1.114 . . . . 0.0 114.006 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -143.06 154.58 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.157 178.437 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.833 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 2.7 p30 63.13 5.14 1.8 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.987 -1.46 . . . . 0.0 112.462 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' N ' ' CD ' ' A' ' 106' ' ' GLU . . . 102.4 5.71 48.59 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.82 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.928 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 21.1 t -123.8 136.53 59.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 117.004 0.402 . . . . 0.0 111.319 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.761 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 38.3 t-20 -61.39 133.29 55.64 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.8 HD13 ' HA ' ' A' ' 80' ' ' ALA . 6.1 mp -103.22 86.43 2.68 Favored 'General case' 0 CA--C 1.465 -2.325 0 C-N-CA 118.278 -1.369 . . . . 0.0 108.98 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 5.3 tpp85 -100.6 94.4 6.09 Favored 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 173.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.667 ' CB ' ' HB3' ' A' ' 93' ' ' GLU . 20.7 m-20 -134.25 96.46 3.61 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.699 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.958 HG23 ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER 29.28 -132.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.643 179.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.911 ' HB2' ' CB ' ' B' ' 116' ' ' GLN . 6.7 mttp -75.46 169.74 17.49 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.843 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.693 ' NE2' ' HB ' ' B' ' 118' ' ' THR . 4.9 t-160 -45.26 -49.97 12.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -175.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 1.029 ' NZ ' ' OG1' ' B' ' 118' ' ' THR . 0.3 OUTLIER -59.29 -20.04 51.1 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.847 -176.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.958 ' HG3' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER -66.51 -25.02 66.49 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 97' ' ' ILE . . . -82.59 -38.65 23.32 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.778 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.969 HG23 ' HA ' ' A' ' 92' ' ' LYS . 1.6 t -57.29 -43.48 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.035 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 93' ' ' GLU . 7.8 t -62.47 -36.24 81.84 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.561 ' O ' ' CG ' ' A' ' 101' ' ' GLN . 3.2 mm -69.49 -47.33 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.947 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.632 HD13 ' CD2' ' B' ' 120' ' ' LEU . 2.2 pp -73.0 -31.31 64.41 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.981 0.42 . . . . 0.0 111.561 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.43 ' N ' HD12 ' A' ' 98' ' ' LEU . 80.6 p -52.41 -47.99 65.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.828 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -123.35 6.49 9.04 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.561 ' CG ' ' O ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -51.98 -61.55 2.19 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.987 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.07 176.44 11.89 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.716 0.293 . . . . 0.0 110.671 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.94 -33.5 41.18 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 119.992 -1.099 . . . . 0.0 111.286 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 31.4 tt0 -103.42 118.65 37.23 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.756 -1.222 . . . . 0.0 110.062 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.691 HG12 HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.16 121.67 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.613 0 CA-C-O 123.01 1.386 . . . . 0.0 108.99 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.833 ' HB3' ' HA ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -94.04 123.04 37.16 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 111.959 -2.382 . . . . 0.0 107.628 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 17.7 m-85 -98.26 117.64 33.09 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.582 -177.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -109.72 116.83 32.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 175.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 11.2 m -121.15 149.81 24.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 122.013 0.911 . . . . 0.0 113.439 -176.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.637 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 31.5 t -117.49 148.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 113.674 -1.603 . . . . 0.0 111.063 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -86.34 121.22 28.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.042 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 77' ' ' ALA . 4.7 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.127 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.905 0.383 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -58.81 -38.92 79.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.467 HG23 ' N ' ' B' ' 116' ' ' GLN . 13.4 m -61.48 -150.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.119 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLN . . . . . 0.911 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -150.81 98.26 2.58 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.999 0.428 . . . . 0.0 111.599 -179.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . 0.59 ' OD1' ' CE1' ' A' ' 51' ' ' HIS . 10.8 m-20 -151.44 171.81 16.94 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 1.029 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -165.21 163.58 20.19 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 116.644 2.091 . . . . 0.0 116.644 -178.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ARG . . . . . 0.814 ' CZ ' ' CE1' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -137.05 111.62 8.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.94 178.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.632 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.4 mp . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.704 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.92 138.68 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-O 122.067 0.937 . . . . 0.0 111.962 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.448 ' HB2' ' CG2' ' A' ' 109' ' ' VAL . 7.0 mtt-85 -138.04 118.54 13.86 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.391 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 5.7 mtpt -97.28 119.55 36.01 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 122.316 1.055 . . . . 0.0 112.167 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.689 HG11 ' C ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.95 117.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.897 177.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.83 110.39 22.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.419 0.628 . . . . 0.0 112.135 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' HB2' ' A' ' 69' ' ' CYS . 0.7 OUTLIER -113.33 115.68 28.51 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.101 178.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.515 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -118.1 105.46 11.86 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.315 -177.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -99.13 161.41 13.63 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.855 -1.521 . . . . 0.0 110.573 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -86.91 126.0 34.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.266 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 57.72 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.335 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.483 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . 9.3 p80 -177.3 40.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.019 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -65.91 62.71 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.283 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 38' ' ' HIS . . . 56.39 164.24 0.04 OUTLIER Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.597 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.897 HD13 HD23 ' B' ' 120' ' ' LEU . 0.3 OUTLIER -101.65 -66.09 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.527 0.664 . . . . 0.0 111.182 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.902 ' O ' HD13 ' A' ' 43' ' ' ILE . . . 110.61 16.82 9.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.925 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.953 HD12 HD13 ' A' ' 60' ' ' ILE . 18.0 mm -135.75 156.98 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.549 ' HB2' ' CZ ' ' B' ' 119' ' ' ARG . 32.8 t -130.11 148.64 51.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.759 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.604 HD11 HD11 ' B' ' 120' ' ' LEU . 0.9 OUTLIER -134.21 158.76 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.929 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.484 ' N ' ' HE1' ' A' ' 91' ' ' HIS . 17.3 p -155.2 137.81 15.14 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.807 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.777 ' HA2' HG22 ' A' ' 53' ' ' VAL . . . 144.57 176.52 18.66 Favored Glycine 0 N--CA 1.422 -2.26 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.301 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . 142.96 -168.2 26.08 Favored Glycine 0 C--N 1.3 -1.431 0 CA-C-N 114.886 -0.657 . . . . 0.0 112.586 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -78.15 -2.15 36.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.465 0.174 . . . . 0.0 111.238 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CG ' ' CD2' ' A' ' 51' ' ' HIS . 1.3 pt-20 -98.85 -33.45 10.87 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.481 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.778 ' NE2' ' OD1' ' B' ' 117' ' ' ASP . 29.6 m-70 -96.33 10.64 37.4 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.409 0.623 . . . . 0.0 110.02 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.58 24.66 53.5 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.356 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 54' ' ' PRO . 0.9 OUTLIER -136.34 172.83 6.38 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-O 121.898 0.856 . . . . 0.0 113.029 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.903 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.0 Cg_exo -85.36 170.78 9.16 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 124.691 3.594 . . . . 0.0 108.543 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.083 HG23 ' CE1' ' A' ' 91' ' ' HIS . 33.5 mm -72.65 105.57 2.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 118.744 -1.182 . . . . 0.0 108.59 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.528 HD23 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -109.75 146.42 34.97 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.821 HD11 HG12 ' A' ' 78' ' ' ILE . 3.1 mp -72.45 134.87 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.418 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.2 p -137.78 -19.14 1.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.611 ' OE1' ' NE ' ' B' ' 119' ' ' ARG . 3.6 tt0 -136.27 115.61 12.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.0 110.07 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.953 HD13 HD12 ' A' ' 43' ' ' ILE . 1.9 mm -128.51 104.98 12.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.705 0.764 . . . . 0.0 111.623 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 1.028 ' NE2' ' NH2' ' B' ' 119' ' ' ARG . 74.8 m-70 -70.24 137.12 86.66 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.516 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.43 145.01 81.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.186 1.924 . . . . 0.0 111.182 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.01 6.25 9.37 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.967 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 1.136 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -96.59 166.81 13.35 Favored Pre-proline 0 N--CA 1.431 -1.411 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.758 ' HB2' HD11 ' A' ' 43' ' ' ILE . 29.8 Cg_exo -17.36 -4.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.053 3.169 . . . . 0.0 115.386 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.136 ' N ' ' O ' ' A' ' 64' ' ' GLN . . . -84.9 -35.76 21.92 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.32 -7.23 19.0 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.926 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' HB2' ' HA ' ' A' ' 65' ' ' PRO . 3.2 mmt180 -92.32 -26.28 18.18 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.688 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.787 ' HB2' HD12 ' A' ' 33' ' ' LEU . 35.3 t -107.0 7.4 29.84 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 43.18 14.28 0.02 OUTLIER Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.421 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.689 ' C ' HG11 ' A' ' 31' ' ' VAL . . . -144.32 9.62 1.95 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 119.542 -1.313 . . . . 0.0 114.714 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.934 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 7.5 mt -98.71 153.71 18.51 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 117.948 0.874 . . . . 0.0 109.976 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.97 130.9 0.1 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.19 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 75' ' ' GLY . 2.7 p -61.4 159.4 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.792 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.515 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 100.24 -21.76 43.02 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.145 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -87.8 150.71 23.39 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.52 0.676 . . . . 0.0 109.633 178.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . . . -88.49 144.02 26.61 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.709 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.821 HG12 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -106.34 125.96 62.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.429 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.5 OUTLIER -97.37 -51.9 4.0 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.196 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.945 ' HB2' ' HA ' ' A' ' 85' ' ' ASN . . . -162.37 176.7 10.25 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 52.6 t -131.89 152.15 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.589 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.714 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 1.2 p30 58.73 6.33 0.6 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.492 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.54 12.02 49.22 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.461 -0.875 . . . . 0.0 114.024 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.871 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 25.7 t -123.28 123.26 67.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 117.108 0.454 . . . . 0.0 111.202 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.945 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 7.5 p-10 -60.89 127.21 30.46 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.929 HD21 HG21 ' A' ' 97' ' ' ILE . 4.9 mp -106.64 86.16 2.29 Favored 'General case' 0 N--CA 1.416 -2.155 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 mmt-85 -98.63 94.84 6.88 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 89' ' ' THR . 4.8 m-20 -133.91 95.57 3.48 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.063 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 1.084 ' OG1' ' CG2' ' B' ' 115' ' ' VAL . 0.1 OUTLIER -2.56 -67.61 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.179 0.99 . . . . 0.0 111.803 178.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.772 ' N ' HG22 ' B' ' 115' ' ' VAL . 0.0 OUTLIER -75.13 134.4 41.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 113.482 -1.69 . . . . 0.0 111.626 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 1.083 ' CE1' HG23 ' A' ' 55' ' ' ILE . 6.7 t60 -64.11 -39.59 94.37 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.411 -1.722 . . . . 0.0 108.182 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.88 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -62.32 -22.01 65.72 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.189 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -64.64 -23.72 67.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.575 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -79.12 -45.77 19.35 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.816 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.88 HG23 ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -57.56 -45.6 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.874 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.6 t -60.3 -37.74 81.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.929 HG21 HD21 ' A' ' 86' ' ' LEU . 2.7 mt -69.85 -46.61 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.462 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.768 ' HA ' ' HG2' ' A' ' 101' ' ' GLN . 1.4 pp -76.12 -31.07 58.47 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.006 0.431 . . . . 0.0 111.642 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.8 t -53.68 -50.14 66.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -114.08 14.19 18.26 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.827 ' NE2' HD12 ' A' ' 105' ' ' ILE . 0.0 OUTLIER -49.27 -86.49 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.87 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.411 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 4.7 ttt180 -151.63 176.55 11.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.6 -23.49 68.82 Favored Glycine 0 CA--C 1.504 -0.635 0 C-N-CA 119.528 -1.32 . . . . 0.0 112.428 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 20.7 mt-10 -104.09 117.52 34.47 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.267 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.827 HD12 ' NE2' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -98.43 116.72 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.926 0 CA-C-O 122.802 1.287 . . . . 0.0 107.565 178.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.714 ' HB3' ' HA ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -96.09 140.11 31.28 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 112.813 -1.994 . . . . 0.0 108.739 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 12.2 m-85 -124.71 118.03 25.53 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.603 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.799 ' OE2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -105.11 116.71 32.4 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 176.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 29' ' ' ARG . 6.1 m -121.94 156.36 26.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -176.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.669 ' HB ' ' HB3' ' A' ' 77' ' ' ALA . 18.8 t -117.9 116.15 50.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.941 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -81.76 125.66 30.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.077 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.858 0.361 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.432 ' O ' ' NE2' ' B' ' 116' ' ' GLN . 0.0 OUTLIER -163.78 123.93 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 1.084 ' CG2' ' OG1' ' A' ' 89' ' ' THR . 99.2 t -46.13 133.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.33 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLN . . . . . 0.836 ' OE1' ' NZ ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -149.91 -139.07 0.09 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ASP . . . . . 0.778 ' OD1' ' NE2' ' A' ' 51' ' ' HIS . 80.4 m-20 -124.53 -172.83 2.64 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.169 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.64 ' HB ' ' CD2' ' A' ' 91' ' ' HIS . 7.1 m -155.65 156.51 35.12 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ARG . . . . . 1.028 ' NH2' ' NE2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -136.74 125.62 24.16 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.892 178.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.897 HD23 HD13 ' A' ' 41' ' ' LEU . 3.7 mp . . . . . 0 C--O 1.255 1.392 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.965 -178.859 . . . . . . . . 1 1 . 1 stop_ save_